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FOREWORD 
 
The School of Pharmacy and Pharmaceutical Sciences, Cardiff University, is the only 
school of pharmacy in Wales and is one of the top schools of pharmacy in the UK. Our 
students graduate well-prepared and satisfied, as seen by the consistently high pass rate 
in the pharmacist registration examination and high ranking in the National Student Survey 
respectively. 
 
In addition to supporting individual pharmacists in their initial and ongoing education and 
development, the School is active in research that has been independently judged to be 
predominantly of international standing, more than half of which is recognised as world-
leading or internationally excellent and with many interdisciplinary and external 
collaborators. Research at the School encompasses medicinal chemistry, drug delivery 
and microbiology, pharmacology and physiology, and pharmacy practice and clinical 
pharmacy, and it impacts on healthcare and pharmaceutical sciences throughout the UK 
and the world. Further information on the School’s research activities and degree 
programmes, along with contact details for academic staff can be found at 
http://www.cardiff.ac.uk/phrmy. 
 
At the Cardiff School of Pharmacy and Pharmaceutical Sciences, the combination of these 
strengths allows us to successfully deliver research-led learning and teaching. All of our 
MPharm students undertake a significant, independent Masters level research project in 
the final year of the four year degree, and present and defend their research. The large 
numbers of well-qualified UK, EU and international students that we attract to our 
postgraduate diplomas and degrees also contribute significantly to our research output. 
 
This is the 14th year in which we have published the abstracts of our students’ research. 
Within this publication the student is the first named author, and collaborators and 
supervisors follow. An alphabetical list of authors appears in the index. 
 
Many thanks to my colleagues for their assistance in collating this book. 
 
Rebecca Price-Davies 
July 2014 
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Reflection in research: a thematic analysis 
Henna Ahmed and R Price-Davies 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
At the Cardiff School of Pharmacy and Pharmaceutical Sciences, significant weighting is put on the research 
project that students undertake in their final year, the main aim of which is to understand the process of 
research. The aims of this project were to explore the views of the students to find what themes arise from 
learning in the fourth year research project. 
In order to achieve this, students’ reflections on learning were thematically analysed to identify the common 
and essential themes. This allowed key features of the data to be summarised whilst still offering a detailed 
description. They were then mapped to identify relationships between them. Lastly results were discussed as 
to whether the learning students reflected upon had any relevance to pharmacy or the aims of the module.  
Research processes was a strong theme. This included the understanding of research and suggested 
students felt they now appreciated how research is carried out. Skills gained were also a strong theme, of 
the skills mentioned, organisation and communication were those that the majority of students identified that 
they had learnt or developed. They also felt many of these skills would greatly benefit them in the future.  
Student’s ability to reflect varied greatly; many lacked the ability to go beyond listing what practices they had 
been involved with in their projects. The importance of being able to reflect upon negatives of an experience 
is a key step of effective learning from practice in healthcare but mentioning what was challenging during the 
experience was not common amongst the students. This led to the possibility of students lacking confidence 
and the honesty of writing a true reflective account as literature suggests reflection is done poorly when it is 
to be assessed as well as without any facilitation [2,3]. 
1. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative research in psychology. 2006;3(2):77--101. 
2. Bowman M, Addyman B. Academic reflective writing: a study to examine its usefulness. British Journal of Nursing. 2014;23(6):304--
309. 
3. Humanities.manchester.ac.uk. Learning | Reflective Learning | Study Skills. University of Manchester [Internet]. 2014 [25 April 
2014]. Available from: http://www.humanities.manchester.ac.uk/studyskills/essentials/reflective_learning/reflective_learning.html 
 
A-level results as an indicator of academic success for undergraduates in 
healthcare degree programmes 
Ayesha Ali and MW Smith 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB Wales, UK 
Evidence in the literature suggests that students work in different ways, with for example, some students 
better engaging with didactic material and therefore are more successful at passing “traditional” exams, such 
as A-levels, while others may develop more strongly when exposed to experiential learning [1]. Despite A-
levels being the predominant selection criteria by which most students are accepted onto degree 
programmes, once enrolled on the course, A-level results are largely ignored [2]. This project seeks to 
understand whether A-level results are important to academic success on the Cardiff MPharm programme, 
by looking at the number of A’s and subject studied at A-level and degree classifications awarded to 571 
MPharm students by the Cardiff School of Pharmacy and Pharmaceutical Sciences over a period of 5 years. 
Student results submitted to Cardiff University through UCAS were liaised with the Cardiff officer and 
confirmed that anonymised student data can be used under the Data Protection Act, were put onto Cardiff 
University Business Objects Online. Data was extracted of students enrolling between years 05-06 and 09-
10 onto the MPharm Degree at Cardiff. Inclusion Criteria was A-levels upon entry and awarded degree 
classification. Tables were made in Excel spreadsheet and the SPSS programme was used to determine 
correlations between A-levels and degree outcomes. 
The results suggest that there is a correlation between A-level results and degree classification. Despite all 4 
science subjects being the most popular to study for this degree, there is no correlation between subjects 
studied at A-level and degree outcome.  
Over 50% of the MPharm degree is contributed by exams for which learning by rote is required to pass well, 
these are in many ways similar to A-levels [3]. Therefore, students who are particularly skilled at taking these 
sorts of exams will thrive in the MPharm degree at Cardiff. 
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1. Busato VV, Prinsb FJ, Elshout JJ, Hamaker C. Intellectual ability, learning style, personality, achievement motivation and academic 
success of psychology students in higher education. Personality and Individual Differences. 2000; 29: 1057–68. 
2. Gill T. 2012. Uptake of two-subject combinations of the most popular A levels in 2011, by candidate and school characteristics. 
Cambridge: Research Division Assessment, Research and Development Cambridge Assessment. 
3. Cardiff School of Pharmacy & Pharmaceutical Sciences. Student Handbook 2013-14 [booklet]. Cardiff: Cardiff School of Pharmacy 
& Pharmaceutical Sciences; 2013. 
 
An evaluation of interprofessional learning: vital signs 
Daniel Allen and MW Smith 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Interprofessional education (IPE) can be defined as when “two or more professions learn with, from and 
about each other to improve collaboration and the quality of care" [1]. Exposure of students to IPE is a 
requirement of both the medical and pharmacy degrees [2,3]. Sessions with fourth-year pharmacy students 
and first-year medical students involved the reading and interpretation of vital signs. The aim of this project 
was to evaluated students' views on the session, their views on IPE at Cardiff University, as well as their 
general views on the concept of IPE  
 
Anonymous questionnaires were distributed to 156 students, with eight 5-point Likert items and a written 
comments box. Ethics approval was obtained. Answers from medics and pharmacists were compared, as 
well as medics who had worked solely with medics against medics working with pharmacists. Data from 
these forms were analysed by Mann-Whitney U test to determine significance of answers. Questionnaire 
data were used to drive discussion in semi-structured interviews. Three pharmacy students were recruited by 
convenience sampling for interview. 
 
Students responded positively overall, with statistically significant differences found including pharmacists  
being more negative to statements involving learning from the session, and learning specifically from 
students of the other profession. Most agreed that IPE could help working relationships after qualification, 
and that more IPE should be implemented between the two Schools. Interviews with pharmacy students 
provided insight into feedback. Repetition of previous work and inexperience of the medical students 
contributed to negative feedback. 
 
Feedback was positive, more from medics than pharmacists. Reasons for this included repetition of topics, 
and inexperienced colleagues, although workshop facilities and staff were praised. Future study into the 
attitudes of medical students when exposed to other healthcare professionals is suggested. Suggestions for 
improvement from pharmacists include moving session earlier in the degree. 
 
1. Barr H, Low H. 2011. The Definition and Principles of Interprofessional Education. Available: <http://caipe.org.uk/about-us/the-
definition-and-principles-of-interprofessional-education>. Last accessed 28/11/2013  
2. General Medical Council. 2009. Tomorrow’s doctors. London: General Medical Council  
3. General Pharmaceutical Council 2013. The accreditation of pharmacy courses leading to registration and annotation in Great 
Britain. London: General Pharmaceutical Council 
 
Simulation of the mechanical properties of topical microneedles of different 
geometries 
John Charles Urban Ashton-Barnett,1 E Loizidou2 and CJ Allender1 
1Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff  
CF10 3NB and 2Cardiff School of Engineering, Cardiff University, Queens Buildings, The Parade, Cardiff CF24 3AA, 
Wales, UK 
Microneedles (MNs) need to puncture viscoelastic skin without bending or breaking. Usefulness of sugar 
MNs, commonly used in topical applications, is therefore limited by structural strength and susceptibility to 
mechanical failure [1]. Stronger materials can achieve equal penetration without failing under large stress [2], 
however they cannot dissolve in skin. Using computer simulations, this study aims to characterize the 
relationship between geometry of dissolving sugar MNs and their subsequent predicted failure through 
buckling or fracture. 
Using COMSOL Multiphysics software, a series of carboxymethyl cellulose and trehalose dihydrate 
(CMC/TRD 1:1) single MNs and 3x3 MN arrays were designed with a range of regular base shapes (vertices 
n=3,4,5,6,7,8 and ∞) and array spacings. Epidermal and dermal skin layers were simulated using known 
Young’s modulus, Poisson’s ratio and density values [3]. Failure by buckling and fracture upon insertion into 
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skin were simulated for each MN and array using Structural Mechanics module, yielding critical load factors 
and Von Mises stresses. 
Conical MNs (vertices n=∞) had greatest critical load factors as expected, followed by shapes with 
decreasing vertices. Single conical MNs had lowest Von Mises stresses upon skin insertion, followed by 
hexagonal MNs then shapes with vertices n=8,7,5,4,3. Conical MNs showed greater critical load factors in 
3x3 arrays than hexagonal equivalents. Larger array spacing yielded bigger critical load factors, however 
placed more stress on skin upon insertion. 400µm spacing exerted the least stress on skin however stress 
increased at denser 200µm spacing. 
Conical MNs were mechanically strongest and therefore most resilient to failure by buckling and fracture. 
Hexagonal bases may yield the best performing MNs in reality due to having sharp edges and good 
mechanical strength. Increasing MN array spacing causes a decrease in array failure by buckling. 
Decreasing MN array spacing causes less skin stress on insertion, until spacing becomes too close and MNs 
act as one structure due to ‘bed of nails’ effect [4], increasing skin stress. 
1. Gittard, S.D. Chen, B. et al. 2013. The effects of geometry on skin penetration and failure of polymer microneedles. J Adhes Sci 
Technol. 27(3). pp. 227-243. 
2. Choi, S-O. Kim, Y.C. et al. 2010. An electrically active microneedle array for electroporation. Biomed. Microdevices. 12(2). pp. 263-
273 
3. Geerligs, M et al. 2011. In vitro indentation to determine the mechanical properties of epidermis. J. Biomech. 44. pp. 1176-1181. 
4. Sivamani, R. Liepmann, D. and Maibach, H. 2007. Microneedles and transdermal applications. Expert Opin. Drug Deliv. 4(1). pp. 
19-25. 
 
Determining the effect of excipient particle size on the properties of direct-
compression paracetamol tablets 
Esa Badr and JC Birchall 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Tablet manufacture through direct-compression is the leading form of solid oral dosage form manufacture. 
This is attributable to the ease of manufacture and low cost [1,2]. For powders to display compatibility for 
direct compression, they must have a number of key characteristics to enable compression and formation of 
a solid mass [3]. Pure paracetamol powder is known to have poor compression properties, which leads to 
capping upon compression [4]. The aim of this project was to investigate what effect excipient particle size 
has on direct-compression paracetamol tablets. A series of formulations with varying active:excipient ratios 
were tested to determine the most suitable composition to obtain robust tablets. The compression excipient 
chosen for this experiment was Pearlitol. 
Tablets were manufactured on a Riva MiniPress. The prepared tablets were subjected to a range of tests 
from the British Pharmacopoeia (BP) to determine their respective properties and to establish a relationship 
between tablet performance and excipient particle size. Table hardness (non-BP test), tablet weight 
uniformity and thickness uniformity were investigated; this gave an indication of powder flow. A tablet 
dissolution method was adapted from the BP; this investigated the porosity and solubility of the tablet. 
Scanning electron microscopy was used to investigate particle morphology, relative size and surface 
topography. 
An active:excipient ratio of 15:85 produced tablets with suitable properties. However, powder flow was poor 
with all formulations, resulting in manual filling during tabletting. Tablet dissolution data revealed that 
excipient particles of smaller size achieved higher levels of dissolution at 45 minutes compared with their 
larger counterparts; the same was observed with tablet disintegration testing after 15 minutes of testing.  
These findings indicate that excipient particle size does affect tablet properties. However, all tablets failed to 
comply with all the BP requirements; this may be attributable to the poor flow and compressibility of the pure 
paracetamol powder. 
1. Ansel H, Popovich N, Allen L. Pharmaceutical dosage forms and drug delivery systems. Lea & Febiger Philadelphia. 1990.  
2. Botting R. Mechanism of action of acetaminophen: is there a cyclooxygenase 3?. Clinical Infectious Diseases. 2000;31(Supplement 
5):202-210.  
3. Pan X, Huang Y, Dong Y, Wang Z, Zhu C, Li G et al. Process Investigation of a Novel Compaction Technique With Pellet-
Containing Granules. Therapeutic Innovation & Regulatory Science. 2013;47(5):593-601.  
4. Aulton M. Aulton's pharmaceutics. 1st ed. Edinburgh: Churchill Livingstone; 2007. 
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Factors affecting delivery from elastomeric ambulatory devices 
Peter James Baker and R Price-Davies 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, 
Cardiff CF10 3NB, UK 
The I-Flow Homepump® Eclipse is a type of disposable Elastomeric Ambulatory Device (EAD). Its use in the 
delivery of continuous infusions of medications such as chemotherapeutic agents, antibiotics and analgesics 
has increased over the last decade [1]. The benefits of using the device are well known, particularly its 
portability which enables patients to be treated at home, however there still remains uncertainty over their 
accuracy and reliability [2]. The aim of the study is to identify and assess whether the conditions encountered 
by the device will have an effect on its flow rate. Objectives for achieving this are to investigate a range of 
temperatures, viscosities of infusates and fill volumes. 
Eclipses® were exposed to different temperatures that could be encountered during storage and use (15°C, 
24°C, 31°C and 37°C) and flow rate determined. The flow rate was also assessed when filled with infusates 
of varying viscosities (normal saline, water for injection, glucose 5%, 20%, 35% and 50%) and when filled to 
different volumes (33mL, 66mL, 100mL and 125mL). Flow rate was calculated by measuring the volume of 
dispensed fluid collected for a given time. 
All of the factors tested had an effect on the device’s flow rate, as they deviated from the optimal conditions 
stated in the manufacturer’s guidelines [3]. The viscosity of the infusate had the greatest effect, with the 
device failing to exhaust its fluid reservoir when filled with glucose 35% and 50%. 
Every effort should be made to ensure that the manufacturer’s guidelines are followed and that both 
healthcare practitioners and patients are made aware of the effects that deviations can have on the delivery 
performance of the device. 
1. Remerand F, Vuitton AS, Palud M, Buchet S, Pourrat X, Baud A, et al. Elastomeric pump reliability in postoperative regional 
anesthesia: a survey of 430 consecutive devices. Anesth Analg. 2008 Dec;107(6):2079-84. 
2. Skryabina EA, Dunn TS. Disposable infusion pumps. Am J Health Syst Pharm. 2006 Jul 1;63(13):1260-8. 
3. I-Flow Corporation. Homepump® Eclipse Disposable and Ambulatory Elastomeric Infusion System. I-Flow Corporation; 2011. p. 6. 
 
The role of clathrin-independent endocytosis in Alzheimer’s disease 
Charlotte Bell, RS Thomas, E Kirkham and EJ Kidd 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Alzheimer’s disease (AD) is a neurodegenerative disease caused by beta-amyloid protein (Aβ), formed from 
the cleavage of APP (amyloid precursor protein) by β- and γ-secretase [1]. Uptake of material into a cell is 
mediated via clathrin-dependent or –independent endocytosis [2]. Caveolin and flotillin, which mediate forms 
of clathrin-independent endocytosis, are upregulated in AD [3,4]. The aim was to examine the effects of 
reduced caveolins and flotillins on the intracellular location of proteins involved in AD. 
MOG-G-UVW cells were transfected with siRNA to reduce caveolin-1, flotillin-1 and flotillin-2 levels. 
Immunocytochemistry was performed to label caveolin-1, flotillin-1, flotillin-2, APP, BACE1 (β-secretase) and 
presenilin 1 (γ-secretase). Primary antibodies were detected with biotinylated secondary antibodies and 
avidin FITC. Filipin was used to stain free cholesterol. Coverslips were mounted onto slides and viewed 
under a fluorescent microscope. 
Results showed knockdown of all three proteins. No significant changes were observed in APP location in 
siRNA-treated cells. In caveolin 1 siRNA-treated cells, presenilin 1 had greater accumulation around the 
nucleus than controls. In flotillin-1 siRNA-treated cells, there was less BACE1 accumulated near the plasma 
membrane compared to controls. There was reduced cholesterol staining in caveolin-1, flotillin-1 and flotillin-
2 siRNA-treated cells. 
Caveolin-1 reduction may result in less presenilin1 trapped in caveolin-mediated endocytic vesicles. This 
allows more presenilin 1 to transport to late endosomes, located close to the nucleus, where it cleaves APP 
which increased Aβ levels. Flotillin-1 reduction may reduce raft-mediated endocytosis of BACE1 and result in 
less available to cleave APP in early endosomes, located near the plasma membrane, decreasing Aβ levels. 
Reduction of caveolins and flotillins may disrupt cholesterol-rich lipid rafts on the plasma membrane. In 
conclusion, caveolin- and flotillin-mediated endocytosis may contribute to AD pathogenesis through effects 
on presenilin 1 and BACE1 location. 
MPharm 
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1. Rajendran,L. and Annaert, W. 2012. Membrane Trafficking Pathways in Alzheimer’s Disease. Traffic. 13. p. 759-770. 
2. Le Roy, C. and Wrana, J.L. 2005. Clathrin-and non-clathrin-mediated endocytic regulation of cell signalling. Nature Reviews 
Molecular Cell Biology. 6 (2), p.112-126 
3. Gaudreault, S.B. et al. 2004. Increased caveolin-1 expression in Alzheimer’s disease brain. Neurobiology of Aging. 25, p. 753-759. 
4. Kokubo, H. et al. 2000. Localization of flotillins in human brain and their accumulation with the progression of Alzheimer’s disease 
pathology. Neuroscience Letters. 290, p.93-96 
 
Evaluating interprofessional education for pharmacy and medicine undergraduates 
at Cardiff University 
Kavil Bhudia, DN John and SA Coulman 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, 
Cardiff CF10 3NB, Wales, UK  
Interprofessional health education is the collaboration between members of two different healthcare 
professions in order to share knowledge and develop a professional relationship [1]. IPE is a required feature 
of both the pharmacy and medicine undergraduate degree programmes [2,3]. An IPE session involving 
clinical cases was conducted with pharmacy and medical students in the first semester of the 2013/14 
academic year. Students were either 3rd year medical students or 3rd/4th year pharmacy students. This 
project aimed to evaluate these IPE sessions by exploring the views of both the students and facilitators that 
attended the IPE sessions. 
A Likert-scale questionnaire, also containing a small number of open questions for students to provide 
written feedback, was distributed to the students at the end of the IPE session. Likert-scale responses 
provided quantitative data, which was inputted into SPSS. A Mann-Whitney U test was used to compare 
responses from pharmacy and medicine students. Semi-structured interviews were conducted with 
facilitators, to explore their views and compare them to students, as facilitators views are often overlooked 
[4]. An interview schedule, information sheet and consent form were prepared. Ethical approval was 
obtained from Cardiff School of Pharmacy and Pharmaceutical Sciences. 
Four hundred and fifty students were provided with a questionnaire and a response rate of 95.6% was 
achieved. Students from both professions enjoyed (83.4%) the sessions and found them useful (89.3%). 
However medical students found the session to be more useful. Students from both courses (n=170) 
identified a need for more IPE in the curriculums. The area requiring most improvement was organisation of 
the session (n=97), in particular the partner pairing procedure. Both groups of students commented that the 
most useful aspect of the session was working with another healthcare professional.  
Overall, students were positive about the session, and expressed that they should be continued in the future. 
This evaluation will be submitted to the school of pharmacy to inform and improve future sessions. 
1. Barr H, Low H. Introducing Interprofessional Education. Centre for Advancement of Interprofessional Education. 2013 
2. Greiner AC, Knebel E. Health Professions Education: A Bridge to Quality. Washington, DC: The National Academic Press; 2003. 
3. General Medical Council. Outcomes and standards for undergraduate medical education. Tomorrows Doctors. General Medical 
Council. 2009, p27-28. 
4. Diack, H et al. 2008. The Aberdeen interprofessional health and social intiative – final report. Available at: 
http://www.caipe.org.uk/silo/files/the-aberdeen-interpofessional-health-and-social-care-education-initiative-final-report-june-2008.pdf 
[Accessed on 17th April 2014] 
 
Cardiff MPharm graduates’ preparedness for pharmacy practice measured against 
learning outcomes for undergraduate pharmacy education in the UK: perceptions of 
employers 
Melissa Boulton and E Mantzourani 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
In the UK, there is no published literature regarding the level of graduate preparedness for pharmacy 
practice using the perceptions of employers, however, there is one study concerning such preparedness 
based on the perceptions of final year students from pharmacy schools across the UK [1]. The General 
Pharmaceutical Council (GPhC) published educational outcomes for MPharm and pre-registration students 
in 2011, which have never been used to measure the level of graduate preparedness [2]. The aim of this 
study is to explore the perceptions of employers with regard to preparedness of Cardiff University graduates 
for pharmacy practice using the learning outcomes outlined by the GPhC.  
MPharm 
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Ethical approval was obtained from the School’s Research Ethics Committee. Non-probability purposive then 
snowball sampling recruited fourteen participants who have been involved in the training of pre-registration 
pharmacists from both hospital and community pharmacies across South Wales. Each participant took part 
in a semi-structured interview after consent; each interview was subsequently transcribed ad verbatim [3]. 
The transcriptions were then coded and thematic analysis undertaken from the codes [4].  
Participants perceived Cardiff University pharmacy graduates to be prepared for most of the GPhC 
outcomes. All participants thought Cardiff graduates were prepared for pharmaceutical calculations with 
other areas of preparedness including team working and CPD. Participants perceived graduates to be least 
prepared for leadership, communicating with other healthcare professionals and multidisciplinary team 
working. The perceptions of hospital and community pharmacists were comparable in most areas. 
Suggestions for improvement to the Cardiff MPharm degree were provided, the most common being the 
need for a greater exposure to practice especially more experiential placements. 
Overall, employers thought Cardiff University graduates were prepared for pharmacy practice with some 
elements stronger than others. The need for changes to the Cardiff MPharm degree would ensure that 
graduates are equally prepared for all areas of pharmacy practice. 
1. Willis S et al. 2009. Using learning outcomes for the undergraduate pharmacy education to assess final-year students’ perceptions 
of their preparedness for pharmacy practice. International Journal of Pharmacy Practice 17:351-358. 
2. General Pharmaceutical Council. Future pharmacists: Standards for the initial education and training of pharmacists. London: 
General Pharmaceutical Council. 
3. Poland B. 1995. Transcription Quality as an aspect of rigor in qualitative research. Qualitative Inquiry 1: 290-310. 
4. Guest G et al. 2012. Applied Thematic Analysis. London: Sage. 
 
Profiling CD44 isoforms (CD44s and CD44v6) in novel models of endocrine resistant 
breast cancer 
Adam Brelsford, M Davies, S Kyme, P Finlay, H Mottram, L Farrow, C Dutkowski and JMW Gee 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, 
Cardiff CF10 3NB, Wales, UK 
CD44 and its variant isoforms have a controversial status in breast cancer, and are largely unexplored in 
endocrine resistance [1]. CD44s is overexpressed in short-term tamoxifen resistance in vitro, [2] but little is 
known about expression in other endocrine resistant states, especially taking longer treatment duration and 
genotype into consideration. This study will establish CD44s and CD44v6 expression in novel endocrine 
resistance models to determine any relation between these isoforms and oestrogen receptor (ER) status, 
aggressive behaviour, and endocrine treatment type and duration, considering whether any findings show 
genotypic parity. 
ER, CD44s and CD44v6 expression were examined in acquired tamoxifen resistant (TamR), Faslodex 
resistant (FasR) and oestrogen deprived resistant (X/SFCSR) cells modelling shorter (2 year) and longer (3 
year) treatment in MCF7 and T47D genotypes, using immunocytochemical analysis. Aggressiveness of the 
cell lines was examined by modified Boyden chamber migration assays. 
MCF7-derived TamR, FasR and X models expressed significantly higher levels of CD44s and CD44v6 
versus parental cells, irrespective of anti-hormone, but there was a significant decrease in longer-term 
resistant models versus shorter-term resistance. T47D-derived longer-term models also expressed relatively 
low levels of CD44s and CD44v6 in tamoxifen and Faslodex resistance. There was no consistent association 
between CD44 expression, ER status and aggressiveness, although substantial CD44s and CD44v6 were 
retained in ER-, highly migratory, T47D-derived SFCSR cells. 
Overexpression of CD44s and CD44v6 in MCF7-derived resistant models indicates these isoforms may have 
a role in early acquisition of endocrine resistance. Their contribution to endocrine resistant behaviour may 
vary, with contextual cues determining whether this is beneficial or detrimental. In general, their contribution 
to resistance may diminish with increasing treatment, irrespective of genotype. If any functional contribution 
to endocrine resistance can be confirmed, monitoring CD44 levels or targeting the molecule may have 
clinical utility in overcoming resistance. 
1.  Louderbrough JM, Schroeder JA. Understanding the dual nature of CD44 in breast cancer progression. Mol Cancer Res. 
2011;9:1573 – 86. 
2.  Hiscox S, Baruha B, Smith C, Bellerby R, Goddard L, Jordan N et al. Overexpression of CD44 accompanies acquired tamoxifen 
resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan. BMC Cancer. 
2012;12:458. 
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Patient experience: satisfaction with their medicines management during their 
hospital stay and satisfaction with information about their medicines provided on 
discharge from hospital 
Ross Burrows, RS Dewdney and ML Hughes 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Medicines Management is a standard of care [1] that involves the pharmacy teams ensuring patients’ 
medicines are being dealt with correctly and that patients are educated about their medicines. The aim of 
this study is to evaluate these aspects of pharmaceutical care so areas of improvement can be identified and 
patients can received the best care. 
Recently discharged medical patients from two hospitals; (Ysbyty Gwynedd (YG) and Wrexham Maelor 
(WM)) were identified, basic demographics noted and an anonymised questionnaire incorporating a 
validated tool to assess satisfaction with information about medicine [2] was mailed to them. Responses 
were analysed using SPSS. Mann-Whitney U, Kruskal-Wallis and Chi-squared statistical tests were 
performed to compare quantitative data against patient demographics, hospital and other answers. Any 
comments were thematically analysed to identify areas where services can be improved. 
Of 380 patients contacted, 151 (40%) responded, evenly distributed between hospital and gender. Mean age 
was 71 years old (SD 15.09) on a mean number of medicines 8 (SD 4.48). Overall satisfaction was 92%. 
More patients experienced problems with their medicines in YG than in WM (p=0.016) due to delays with 
discharge medicines and issues with administering medicines. Patients were more satisfied with the 
management of their medicines if they had contact with pharmacy staff (p=0.002) and the opportunity to 
discuss their medicines with them (p<0.001). Fewer patients were satisfied with information related to side 
effects compared to information related to drug actions and uses. From patients’ comments, problems 
identified related to long delays in dispensing medicines on discharge, incorrect doses and insufficient 
information provision. Positive comments related to the advantages of speaking with a member of the 
pharmacy team. 
Although satisfaction was high, there are several recommendations that can be implemented in order to 
further improve satisfaction and ensure standards of care are being met for all patients.  
1. Hart E. Doing Well , Doing Better [Internet]. 2010 [cited 2014 Apr 28]. p. 10–1. Available from: 
http://www.weds.wales.nhs.uk/sitesplus/documents/1076/doc doing well doing better.pdf 
2. Horne R, Hankins M, Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit 
and research. Qual Heal Care. 2001;10:135–40. 
 
MMP expression and activation in drug-sensitive versus drug-resistant breast 
cancer 
Felicity Cameron, R Young and S Hiscox 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
The majority of ER+ breast cancers treated with endocrine agents develop resistance. Resistant forms are 
more aggressive and behave more invasively [1]. Evidence suggests matrix metalloproteinase (MMP) 
involvement in pro-invasive pathways due to their ability to degrade the extracellular matrix, facilitating 
invasion and metastasis [2]. MMP-2 and -9 correlate with poorer prognosis and have potential therapeutic 
applications [3,4]. Since MMPs are linked with aggressive forms of breast cancer we hypothesised that they 
are up-regulated in resistant forms which are inherently more aggressive. We aimed to investigate 
expression of MMP-2/-9 in drug-resistant versus drug-sensitive breast cancer models. 
PCR was used to investigate MMP expression at gene level and to confirm ER status of the cell lines. 
Gelatin zymography was used to highlight MMP-2/-9 activity via a gelatin-containing gel which was physically 
degraded. A uPA activity colorimetric assay was run to elucidate information about MMP activity generally 
since it is a common regulator of MMPs. 
All cell lines were ER+ except for the FasR cells, which were ER-. MMP-9 expression was higher in TamR 
and X cells compared to MCF-7, and negative in FasR cells. MMP-9 expression at both gene and protein 
level were consistent. The uPA assay detected the highest activity in the drug-sensitive model. 
MMP-2 was not detected in any experiment. 
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MMP-9 expression appeared to correlate with ER status since it was only expressed by the ER+ 
models. Increased expression in TamR and X cells suggests that MMP-9 is important to their 
resistant phenotypes, but not FasR. Data therefore suggests that different forms of resistance 
associate with different MMPs. MMP-9 expression did not correlate with in vitro aggressiveness, or 
the uPA activity assay, which appeared inconclusive due to low activity levels. Further investigation of 
MMPs in drug-resistant breast cancer may highlight a target up-regulated in all forms to exploit 
clinically. 
1. Gee JMW, Shaw VE, Hiscox SE, McCelland RA, Rushmere NK, Nicholson RI. Deciphering antihormone-induced compensatory 
mechanisms in breast cancer and their therapeutic implications. Endocr Relat Cancer. 2006;13:S77-S88 . 
2. Nicholson RI, Hutcheson IR, Britton D, Knowden JM, Jones HE, Harper ME, et al. Growth factor signalling networks in breast 
cancer and resistance to endocrine agents: new therapeutic strategies. J Steroid Biochem Mol Biol. 2005;93:257-62. 
3. Stankovic S, Konjevic G, Gopcevic K, Jovic V, Inic M, Jurisic V. Activity of MMP-2 and MMP-9 in sera of breast cancer patients. 
Pathol Res Pract. 2010;206:241-7. 
4. Patel S, Sumitra G, Koner BC, Saxena A. Role of serum matrix metalloproteinase-2 and -9 to predict breast cancer progression. 
Clin Biochem. 2011;44:869-72. 
 
An evaluation of the measurement of equivalence of electronic versions of paper-
based patient-reported outcome measures 
Niloufar Campbell1, F Ali2, AY Finlay2, RS Dewdney1 and MS Salek1 
1Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff CF10 
3NB and  2School of Medicine, Cardiff University, UHW Main Building, Heath Park, Cardiff CF14 4XN, Wales, UK  
The transfer of patient reported outcome (PRO) instruments from paper-based to electronic formats confers 
benefits to both clinicians and patients [1]. However, any new version should be validated before use, which 
can be done by demonstrating measurement equivalence between the formats [2]. This review aims to 
examine studies investigating format measurement equivalence in order to identify the methodologies used 
and the results achieved.  
A search was undertaken of three bibliographic databases (PubMed, OvidSP and Web of Science) using an 
identical set of keywords. The abstracts and, if available, the full text of results were examined for 
compliance with inclusion criteria. Articles or abstracts were included if they directly compared a screen-
based electronic PRO instrument with its paper-based original on the basis of measurement equivalence. 
Papers published before 2007 were excluded as a previous meta-analysis examined papers published 
before this time [3]. Data were extracted from studies using a template.   
55 publications were identified, investigating 79 different PRO instruments. 75% were full text journal articles, 
60% investigated only one instrument per study and 75% used a population of adult patients. 85% used a 
crossover study design and the most commonly used formats for the electronic version were Internet 
formats. The most common correlation measure used was the intraclass correlation coefficient. Of the 30 
studies that provided preference data, 87% found that overall patients preferred the electronic format. 78% of 
studies suggested that the different formats showed evidence of equivalence, as judged by the study 
authors.  
From the literature examined, it appears that generally the process of transferring PRO instruments between 
formats is successful, resulting in electronic versions that produce equivalent results to the paper originals. 
Patients appear to prefer electronic versions, supporting their implementation, and it seems likely that as 
technology improves, the use of electronic PRO instruments will increase.  
1. Leidy NK, Vernon M. Perspectives on patient-reported outcomes: Content validity and qualitative research in a changing clinical trial 
environment. Pharmacoeconomics. 2008; 26(5); 363-370 
2. Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Lenderking WR, Cella D, Basch E. Recommendations on 
evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) 
measures: ISPOR ePRO Good Research Practices Task Force Report. Value in Health. 2009; 12(4); 419-429 
3. Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome 
measures: A meta-analytic review. Value in Health. 2008; 11(2); 322-333 
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Effects of nitric oxide donors in myocardial ischaemia reperfusion injury: a review 
of the human studies using a systematic approach 
Georgia Chamberlain, BR Jones, JS Bice and GF Baxter 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Nitric oxide donors have shown beneficial cardio-protective effects in reducing myocardial ischaemia-
reperfusion injury. Following an ischaemic event, due to a myocardial infarction or unstable angina, 
reperfusion techniques used to restore blood flow can cause further myocardial damage. Nitric oxide can 
exert various protective mechanisms and therefore, targeting these in a clinical setting has the potential to 
limit injury and improve myocardial outcomes [1,2]. The aim of this project was to undertake a 
comprehensive review of human studies, using a systematic approach, to investigate the effects of 
exogenous nitric oxide donors as an adjunct to reperfusion and whether these therapies are beneficial to the 
myocardium.  
A comprehensive search strategy was developed, using search terms based around keywords within the 
project title. Using these terms, Medline, Web of Science, Cochrane and Embase were searched, and results 
from each database were uploaded into Endnote Web and the duplicates were removed. All literature was 
screened at title level for initial relevance and then at abstract level, using strict inclusion/exclusion criteria 
that had been developed. Identified articles were assessed at full-text using a specific critical appraisal tool. 
Following discussion with an independent reviewer, the studies deemed fully appropriate were analysed and 
discussed.   
The initial database search identified 3,771 human studies. Of these, 185 were deemed appropriate for 
abstract level screening and 32 studies were further assessed at full-text level using the critical appraisal 
tool. Seven clinical studies were regarded as high quality and relevance and were analysed, interpreted and 
reviewed. 
Studies showed that nitric oxide donors have no effect on reducing infarct size, when determined by enzyme 
markers. However, there is significant reduction of inflammation, incidence of post-operative atrial fibrillation 
and highly improved clinical outcomes reported. These achieved outcomes demonstrate the potential of nitric 
oxide donors to improve and protect the myocardium from ischemia-reperfusion.   
1. Ferdinandy P, Schulz R and Baxter GF. 2007. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, 
preconditioning, and postconditioning. Pharmacological Reviews. 59(4): 418-458 
2. Burley DS, Ferdinandy P and Baxter GF. 2007. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: 
opportunities and obstacles for survival signalling. British Journal of Pharmacology. 152(6): 855-869 
 
Assessing the quality of life of families of patients with renal disease using the 
FROM-16 
Catherine Elizabeth Chandler1, WR Ford1, N Aawar2, MS Salek1 and S Riley2 
1Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB and 2Department of Urology, School of Medicine, Cardiff University, Cardiff, CF14 4XW 
The symptom and treatment burdens of end-stage renal disease are large, and the impact on both patient 
and family member quality of life is common and significant [1]. The purpose of this study was to assess the 
impact of ESRD on family member quality of life. 
This was a case-controlled, single site study using four different patient treatment groups- Unit 
Haemodialysis (UHD), healthy Transplant patients (Tx), Continuous Ambulatory Peritoneal Dialysis (CAPD) 
patients and stage 4 and 5 ESRD pre-dialysis (PRED) patients. The study included 17 pairs of patients and 
their family members. Family member quality of life was scored using the first generic family quality of life 
assessment tool, the Family Reported Outcome Measure (FROM-16) [2]. Patient quality of life scores were 
measured using the Renal Quality of Life Profile [3]. 
Family member quality of life was found to be lowest in the UHD group followed closely by PRED, then by 
CAPD. Family members of the Tx patient group had the highest quality of life scores.  
Family member quality of life showed correlation with patient quality of life (R=0.473) but did not reach 
significance (P=0.055) using spearman’s rank correlation. Significant findings using this test were a 
decreasing family member quality of life with a reduction in the ability of the patient to join in with leisure 
activities and go on holiday (R=0.527, P=0.030). Family member quality of life was found to significantly 
MPharm 
12 
correlate with decreasing patient physical ability (R=0.493, P=0.044) and increasing hours of care (R=0.844, 
P=0.001). However; decreasing patient physical ability did not significantly correlate with increasing hours of 
care (R=0.628, P=0.07) which leads us to conclude that family member quality of life is affected by their 
perception of the patient’s quality of life. 
1.  Rees J, O’Boyle C, MacDonagh R. Quality of Life: Impact of Chronic Illness on the Partner. Journal of the Royal Society of 
Medicine. 2001;94(11): 563-566. 
2.  Golics CJ, Basra MK, Finlay AY, Salek S. The Development and Validation of the Family Reported Outcome Measure (FROM-16) 
to Assess the Impact of Disease on the Partner or Family Member. Quality of Life Research. 2013 Jun. 
3.  Salek S. Renal Quality of Life Profile: User Manual. 2000. Jansen Cilag, Oxford outcomes. 
 
MMP expression and activation in breast cancer subtypes 
Catrin Chapple and S Hiscox 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Breast cancer is the most common cancer among females and is a heterogeneous disease characterised by 
four major subtypes including Luminal A, Luminal B, HER2+ and triple negative breast cancer [1]. A limitation 
in regards to cancer therapy is the lack of success in treating metastatic disease [1]. This led to the possible 
targeting of matrix metalloproteases (MMPs). These are endopeptidases capable of degrading the 
extracellular matrix (ECM), an essential step in the metastatic cascade [2]. Therefore this project aimed to 
identify the expression of gelatinases (MMP-2 and 9) in a range of cancer cell lines representative of the 
dominant clinical subtypes. We hypothesised that the breast cancer subtype with the poorest prognosis 
would express the highest level of MMPs.  
MMP gene and protein expression were assessed using PCR and zymography respectively. Expression of 
urokinase-type plasminogen activator (uPA), a major activator of MMPs, was determined using a 
colourimetric ELISA-based assay. MMP/uPA expression was investigated in a panel of breast cancer cell 
lines reflecting major breast cancer subtypes. These were: MCF7 (Luminal A), BT474 (Luminal B), SKBR 
(HER2+) and MDA231 (triple negative). Experimental data was statistically analysed using SPSS and t-
testing where replicates allowed.  
Our data showed that SKBR cells, a model of HER2+ breast cancer that has a poor prognosis, expressed 
the highest level of MMP9 gene product which MMP9 gene expression was low or absent across the other 
models. MMP9 protein expression was again seen at relatively high levels in SKBR3 and MCF7 cells. No 
MMP2 was detected at either the gene or protein level in any of the cell lines used. uPA expression was 
detectable in all cell lines but at a low level.  
These data suggest a potential role for MMP9 in Her2+ breast cancer although there was a general lack of 
correlation between MMP expression at either gene or protein level and the inherent aggressive ness of the 
breast cancer cell lines.  
1. Susan G. Komen. Understanding breast cancer: molecular subtypes of breast cancer. Komen Perspectives; 2014 [accessed 02nd 
April 2014]. Available from: http://ww5.komen.org/BreastCancer/SubtypesofBreastCancer.html 
2. Roy R, Yang J, Moses M. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. Journal 
of clinical oncology. 2009;27:5287-5297. 
 
The puncture properties and shedding of particles of capsules in dry powder 
inhaler, effect of capsule type and moisture content  
Jeng Lin Chong and BE Jones 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
The use of gelatin and HPMC hard shell capsules in dry powder inhalers (DPIs) is well established. 
However, there have been complaints about throat irritation caused by inhaled particles produced from 
gelatin capsules due to their brittleness at low moisture contents [1]. This project was designed to compare 
the puncturing properties of inhalation grade gelatin and HPMC hard shell capsules. The dimensional 
characteristics of particle fragments produced after capsules had been punctured by Zwick® machine and 
Plastiape® 2-pin DPI were investigated. 
Capsule samples were conditioned in normal and low relative humidity conditions. They were then punctured 
using the DPI and Zwick® machine. The puncture and force-displacement profiles were recorded using the 
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Zwick® machine [2,3]. The visible fragment pieces produced were analysed quantitatively using the ImageJ 
software from the images captured with the AmScope Microscope. The particles were also assessed with a 
scanning electron microscope (SEM). 
The study demonstrated that gelatin capsules required significantly greater puncture forces compared to the 
HPMC ones and the pin had to move a greater distance (an extra 70%) from the shell end wall at their lower 
moisture content. Gelatin capsules also produced significantly greater numbers of fragment pieces: no 
visible particles were seen with the HPMC capsules. Analysis using the SEM managed to identify fragments 
from both capsules that were not visible to the naked eye. 
The results show that gelatin capsules stored in low humidity conditions have a higher tendency to produce 
more and larger sized fragments, because of their brittleness. It is clear from this work that HPMC capsules 
have superior puncturing properties compared to gelatin capsules. This work contributes to knowledge of the 
characterization of fragment particles produced during capsule puncturing. 
1.  Jones, B.E and Diez, F. 2010. Pulmonary delivery and dry powder inhalers: advances in hard-capsule technology. On Drug Delivery 
22, 16-18. 
2.  Birchall, J.C. et al. 2008. A comparison of the puncturing properties of gelatin and hypromellose capsules for use in dry powder 
inhalers. Drug Development and Industrial Pharmacy 34, 870-876. 
3.  Torrisi, B.M. et al. 2013. The development of a sensitive methodology to characterise hard shell capsule puncture by dry powder 
inhaler pins. International Journal of Pharmaceutics 456, 545-552.  
 
An evaluation of how ‘Quality Information’ training is implemented in NHS 
production areas 
Shirlyn Chua and AG Cosslett 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
In NHS production areas today, ‘Quality Information’ training has become essential for the continuous 
improvement of medicinal product quality. This concept is used to provide a basic understanding and some 
hands-on activities around Aseptic Principles, Good Manufacturing Practice (GMP), Preparation of CIVAS, 
Parenteral Nutrition and Cytotoxic – a must for any grade of staff linked to these services [1,2].  In 2006, 
online learning for healthcare was launched, providing a way by which quality training could be delivered to 
NHS workforce [3]. The aim was to identify how ‘Quality Information’ training is currently implemented in NHS 
production areas in Wales and England, additionally; to explore the perceptions of the personnel regarding 
the need to develop or use online learning tools in NHS production areas. 
An anonymous, self-completion questionnaire, including 5-point Likert scale, open-ended and close-ended 
questions, was sent to all production area personnel in Wales and England via email (n=400), giving 
participants two weeks to respond. A reminder email was sent one week after the initial invitation. 
Quantitative data were analysed using Microsoft Excel. Qualitative data were entered into Microsoft Word. 
A questionnaire response rate of 25% was achieved. Over 70% stated that pharmacy technicians are the 
most important staff group with regards providing production area training to all grades of staff; 95% 
indicated that this current method was delivered informally. The majority of participants found online learning 
useful in NHS production areas, especially when it was supported by alternative learning formats. 
This study shows the need for ‘Quality Information’ training to be implemented for all pharmacists and 
technicians. Specialist training should also be available for pharmacy managers and senior technicians. 
Online learning was beneficial and should be developed in NHS production areas. It should however be 
supported by other learning formats and countermeasures to provide more equal opportunities, especially for 
employees who are relatively new to online learning [4].  
1. Beaney AM. Quality Assurance of Aseptic Preparation Services: Fourth Edition. London: Pharmaceutical Press; 2006. 
2. Medicines and Healthcare Products Regulatory Agency. Rules and Guidance for Pharmaceutical Manufacturers and Distributors. 
London: Pharmaceutical Press; 2007. 
3. E-learning for Healthcare. E-learning for Healthcare Projects Booklet. London: E-learning for Healthcare; 2013. 
4. Lim C. The Current Status and Future Prospects of Corporate e-Learning in Korea. The International Review of Research in Open 
and Distance Learning. 2007; 8(1): 1492-3831.  
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What are the factors that motivate final year undergraduate students in relation to 
the MPharm degree? 
Sylvia Chua Ying Ying and DN John 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Academic motivation plays a crucial role in student learning and there are various factors influencing the 
academic motivation of undergraduate students in university [1]. To date, no research has been reported in 
the UK in relation to pharmacy undergraduates. Thus, the present study sought to explore, understand and 
identify what factors motivated final year Cardiff students in relation to the MPharm degree. 
One-to-one semi-structured interview were used following a favorable opinion from the Cardiff School of 
Pharmacy and Pharmaceutical Sciences research ethics committee. Pre pilot and pilot interviews were 
conducted to provide practice in interviewing and to test the interview guide. A mixture of purposive and 
convenience sampling was employed. Recruitment emails were sent to the potential interviewees with 
participant information sheet and consent form. Interviews were then conducted, captured via audio recorder 
and transcribed ad verbatim and anonymised. The results were analyzed thematically using inductive and 
deductive analysis [2]. Data were coded and arranged into themes and subthemes.  
Through the interviews, factors that were found to potentially affect students’ academic motivation were 
classified into four major themes, a total of eleven subthemes and six sub-subthemes. The four major 
themes were self-motivation (eg., interest), motivation from others (eg., lecturers), academic factors (eg., 
grades) and other factors (eg., weather). They could be further classified into intrinsic and extrinsic 
motivation. Students who are intrinsically motivated engage in an activity because he/she is interested and 
enjoy the activity [2] whereas extrinsic motivation relates to the engagement in activities for instrumental or 
other external reasons [3,4].  
These results suggest there were a number of factors affect students’ academic motivation. There is much to 
learn about academic motivation and thus, additional studies need to be done. In particularly, increase the 
number of students and get students from other years involved to explore further academic motivation. 
1. Bormann, J. M., Moser, D. W., & Bates, K. E. 2013. Factors affecting student performance in an undergraduate genetics course. 
Journal of animal science 91(5), pp.2438-2443. 
2. Braun, V. and Clarke, V. (2006) Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2). pp. 77-101.  
3. Eccles, J. S., & Wigfield, A. 2002. Motivational beliefs, values, and goals. Annual review of psychology 53(1), pp.109-132. 
4. Pintrich, P.R. 2003. A motivational science perspective on the role of student motivation in learning and teaching contexts. Journal 
of Educational Psychology 95(4), pp.667 
 
The development of a peracetic acid and spore germinant mixture as an 
environmentally friendly decontaminant to eliminate bacterial spores from hospital 
surfaces 
Ji-Ann Chuah, DM Houston and L Baillie 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, 
Cardiff CF10 3NB, Wales, United Kingdom 
This study demonstrates the feasibility of utilizing peracetic acid as an environmentally friendly 
decontaminant to eliminate bacterial spores from hospital surfaces. Problems arise with current methods of 
decontamination against selective bacterial strains namely the bacilli and clostridia. This is due to the 
formation of dormant spores by the bacteria. Spores formed have unique endospore structure that is able to 
resist antimicrobial agents [2,3]. Thus, the developments of new techniques are required to eradicate the 
bacteria. In 2008, Wheeldon et al. demonstrated that germination of dormant spores to vegetative cells 
showed a reduce resistance to antimicrobial agents. Based on the approach, we hypothesized that co-
administration of germinants will improve the efficacy of peracetic acid as an antimicrobial agent to eliminate 
bacterial spores.  
Two treatments were tested - Treatment 1 (0.039% Peracetic Acid) and Treatment 2 (0.039% Peracetic Acid, 
100mM L-alanine and 5mM Inosine) with different suspension time (5, 30 and 60 minutes). 1mL of spore 
suspension was placed into 9mL of treatment. Solutions were vortex mixed and kept at room temperature at 
5, 30 and 60 minutes. Next, the solutions were vortex mixed again. 1mL of aliquot of the solution was 
removed and added to 9mL of neutraliser. The resulting mixture was vortex mixed again and left to stand for 
another 5 minutes. Lastly, 100μL was removed, and spore enumeration was performed. Remaining solution 
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in the centrifuge was subjected to heat shock treatment in a water bath. Spore enumeration was performed 
once more after. 
Treatment 1 was found to be ineffective in reducing the counts of bacilli spores at all standing times. 
Furthermore, different Bacilli spp. reacted differently towards the germinants used – Bacillus cereus G9241 
did not show signs of germination. However it was found in the Bacilli thuringiensis strains that germinants 
used effectively germinate spore and increased peracetic acid’s efficacy as an antimicrobial agent in 
Treatment 2.  
In conclusion, the addition of germinants to peracetic acid enhanced its efficacy as an antimicrobial agent. 
The study supports the hypothesis that preceded the study. The cause of ineffectiveness of germinant found 
with Bacillus cereus G9241 remains inconclusive. It is hoped that the study will stimulate further 
investigations in this field.   
1. Anna Moir. 2005. How do spores germinate? Journal of Applied Microbiology (101); pp 526-530. 
2. David Allison. 2011. Bacteria. In: S.P. Denyer, W.B. Hugo. Hugo and Russell’s Pharmaceutical Microbiology. 8th Edition. Wiley 
Blackwell, pp 31. 
3. J-Y Maillard. 2011. Innate resistance to sporicides and potential failure to decontaminate. Journal of Hospital Infection 2011 (77); 
pp. 204-209.   
4. L.J Wheeldon et al. 2008. Physical and chemical factors influencing the germination of C.difficile spores. Journal of Applied 
Microbiology 2008 (105); pp. 2223-2230. 
 
Is age a factor in the use of non-motor medication antidepressants in Parkinson’s 
patients? 
Abbie Cockerill and EL Lane 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Parkinson’s disease (PD) is considered a motor disorder however patients experience a range of non-motor 
symptoms, including depression [1]. Many are linked to neurological damage from Lewy body inclusions, 
spreading in a predictable sequence detailed by the Braak staging system [2]. Aging increases the risk of PD 
however relationships between non-motor symptoms and age are unclear. This study aimed to analyse the 
influence of age on antidepressant use in Parkinson’s patients. 
Data was extracted from a database of movement disorders patients in South Wales, separating patients 
with PD from benign essential tremor (BET) used as a control. A list of search terms was used to separate 
those with antidepressants, those with untreated depressive symptoms and those without depression. Age of 
diagnosis was calculated as was time from diagnosis to initiation of antidepressants. Ethics approval was 
obtained.  
Incidence of depression was higher in PD, affecting 49.25% compared to 27.88% in BET. BET showed no 
relationship with age however incidence in PD peaked at 45-49 years and decreased with age. In both 
groups depression was most commonly pre-existing and age did not affect results. BET showed no trend 
after diagnosis whereas in PD 10.19% were diagnosed in the same year as antidepressant prescribing and 
rate declined with time. 
Depression affects 20% of chronic condition patients due to reduction in quality of life [3]. This is significantly 
increased in Parkinson’s to 30-50% and is likely related to degeneration in mood regulating brain regions [1, 
4]. This damage precedes degeneration in movement centres and hence depression affects patients prior to 
diagnosis [2]. Importantly, this was also seen in BET patients implying an unrecognised premotor phase to 
this condition. In conclusion, this study shows that age of onset clearly impacts upon depression in PD and 
younger patients have a greater use of antidepressant medication.  
1. Chadhuri K, Healy D, Schapira A. Non-motor symptoms of Parkinson's disease: diagnosis and management. The Lancet Neurology. 
2006;5(3):235-245. 
2. Braak H, Tredici K, Rüb U, Vos R, Jansen Steur E, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. 
Neurobiology of Aging. 2003;24(2):197-211. 
3. National Institute for Health and Care Excellence. Depression in Adults Quality Standards QS8. London: National Institute for Health 
and Care Excellence; 2011 [accessed 19 Feb 2014]. Available from: http://publications.nice.org.uk/depression-in-adults-quality-
standard-qs8. 
4. Gallagher D, Schrag A. Depression, anxiety and apathy in Parkinson’s disease. In: Chadhuri K, Tolosa E, Schapira A, Poewe W, 
editors. Non-motor symptoms of Parkinson’s disease. New York: Oxford University Press; 2009. p. 107-120. 
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Profiling CD44s and CD44v3 in novel models of endocrine resistant breast cancer 
Mari Davies, A Brelsford, S Kyme, P Finlay, H Mottram, L Farrow, C Dutkowski and JMW Gee 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Acquired endocrine resistance is a major obstacle in the treatment of oestrogen receptor (ER) positive breast 
cancer, and is linked to aggressiveness and ER loss in approximately 20% of patients with tamoxifen relapse 
[1]. Isoforms of adhesion glycoprotein CD44 may contribute: CD44s has previously been linked to ER 
negativity [2] and CD44v3 to poor clinical response to tamoxifen [3]. However, these findings are 
controversial and knowledge of their role in endocrine resistance is relatively unknown. This study aimed to 
determine CD44s and CD44v3 profiles to compare with ER status and aggressiveness in new models of 
acquired resistance considering different types and duration of anti-hormonal therapy.  
 
A novel in vitro panel comprising MCF7 cells previously grown with tamoxifen, Faslodex or oestrogen 
deprivation to produce 2-year shorter-term (TamR, FasR, X) and 3-year longer-term (TamRLT, FasRLT, 
XLT) models of acquired resistance, and an equivalent T47D–derived panel of 3-year resistant models 
(T47DTamRLT, T47DFasRLT, T47DSFCS) were used. CD44s and CD44v3 levels and ER status were 
determined by immunocytochemistry with H-scoring. Aggressiveness was determined by monitoring 
migration with a modified Boyden Chamber assay.  
 
The MCF7 and T47D model panels showed a link between ER loss and increased migration in resistance. 
While increased in all earlier-resistant models, both panels had decreased CD44s and CD44v3 with longer-
term resistance, although there was no clear relationship to ER loss or aggressiveness. Interestingly, long-
term oestrogen-deprived T47D SFCS retained high levels of CD44 alongside ER loss and being highly 
migratory, contrasting MCF7-derived XLT.  
 
The lack of apparent link to ER loss or aggressiveness suggests CD44 contribution to resistance is complex, 
functioning differently between different resistant cell types, involving additional CD44 isoforms or other 
context-related factors [4]. Its role also appears time-dependent. CD44 expression in T47D SFCS shows 
CD44 may play a role in some aggressive endocrine resistant tumours which would be interesting to study 
further. 
1. Drury SC, Detre S, Leary A, Salter J, Reis J, Barbashina V, et al. Changes in breast cancer biomarkers in the IGF1R/PI3K pathway 
in recurrent breast cancer after tamoxifen treatment. Endocrine-Related Cancer. 2011;18(5):565-77.                 
2. Joensuu H, Klemi PJ, Toikkanen S, Jalkanen S. Glycoprotein CD44 expression and its association with survival in breast cancer. 
American Journal of Pathology. 1993 Sep;143(3):867-74. 
3. Hiscox S, Baruha B, Smith C, Bellerby R, Goddard L, Jordan N, et al. Overexpression of CD44 accompanies acquired tamoxifen 
resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan. BMC Cancer. 
2012;12:458. 
4. Louderbough JMV, Schroeder JA. Understanding the Dual Nature of CD44 in Breast Cancer Progression. Molecular Cancer 
Research. 2011;9(12):1573-86. 
 
Patient experience: satisfaction with their medicines management during their 
hospital stay and satisfaction with information about their medicines provided on 
discharge from hospital 
Rebeca Davies, RS Dewdney and ML Hughes 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Patient satisfaction is an essential component for achieving high-quality care. Standards for Health Services 
in Wales stated that: ‘’there is timely, accessible and appropriate medicines advice and information for 
patients’’ [1]. This study will be part of an All-Wales project requested and supported by the NHS Wales 
hospital pharmacy services. The aim of this study was to assess in-patient satisfaction with their experience 
relating to their medicines and the information provided to them about their medicines on discharge. 
This study was conducted in Hywel Dda University Health Board. A questionnaire was used as a research 
tool to target a specified population of recently discharged patients from an acute hospital site. Part of the 
questionnaire used the validated instrument, the Satisfaction with Information about Medicine Scale (SIMS) 
to assess patient satisfaction with medicines information [2]. The inclusion criteria consisted of adult patients 
discharged home on at least one prescribed drug. Full ethical approval was obtained. 
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A questionnaire response rate of 39.5% was achieved. The results indicate that respondents are more likely 
to be satisfied with information given at discharge when they have had the opportunity to interact with 
pharmacy staff, receive clear written information and receive verbal information. The opportunity for 
discussion with pharmacy staff was a significant find in the results. When a patient had the opportunity to 
interact with pharmacy staff their total satisfaction with medication information, calculated by the SIMS 
questionnaire, was statistically significantly improved. 
These results support the findings that whilst patients were generally satisfied with the information provided 
at discharge regarding medication, it was evident that there were inconsistencies in relation to potential 
problems they might experience. This information gap will possibly have a negative impact on their 
adherence to medicines. 
1. NHS Wales. 2010. Doing Well, Doing Better. [pdf] NHS Wales. 2010 [Accessed 29/04/2014] Available at: 
http://www.weds.wales.nhs.uk/sitesplus/documents/1076/doc%20doing%20well%20doing%20better.pdf 
2. Horne R, Hankins M, and Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for 
audit and research. Quality in Health Care 2001;10;3;135-140. 
 
Measuring the general public’s views about the community pharmacist  
 
William Ashley Davies and DH James  
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales  
 
Contractual changes in 2005 [1] expanded the role of the community pharmacist to increase their 
involvement in public health. Recent studies indicate the utilisation of these additional services by the 
general public is poor [2]. In order to determine what barriers exist to service uptake the public’s perception 
of the community pharmacist must be explored. The aim of this study was to establish public perception of 
the role of the community pharmacist.  
 
A combination of purposive and snowball sampling was implemented to recruit participants. Phase 1 
(qualitative); one-to-one interviews following a semi-structured interview schedule based on themes derived 
from a previous study [3]. Phase 2 (quantitative): data collected and analysed informed the design of a 
structured questionnaire. This consisted of attitudinal (measured by a Likert scale) plus factual questions 
(with categorical response options). This was piloted and redrafted to achieve the final draft.  
 
Nine individuals took part. Phase 1 data revealed similar themes to previous work in that the public were 
aware of the traditional role of the pharmacist: dispensing and minor ailment advice, but little knowledge 
existed of the expanded role. Pharmacists were recognised as highly trained professionals, but the 
connection to available expertise was not apparent. Preference towards independent and small chain 
pharmacies was expressed, with distrust shown towards supermarkets. Two new themes emerged: the 
frustration of GP time constraints, and the inability to differentiate between the pharmacist and pharmacy 
support staff. 
 
These findings generally concurred with previous studies [4]. The main limitation was sample size, indicating 
the need for more diversity in socio-economic groups and ethnic minorities. Further qualitative research is 
required with wider sampling for potential identification of new themes. The profound lack of awareness of 
services available suggests the need for greater promotion. The questionnaire will be used in future projects 
to capture the views of the public on a larger scale. 
 
1 NHS Employers. Community Pharmacy Contractual Framework. UK: NHS Employers; 2011. [accessed 21 Nov 2013]. Available 
from: http://www.nhsemployers.org/payandcontracts/communit ypharmacyContract/CPCFservicedevelopments2011/Pages/CPCF-
service-developments-2011_12.aspx.  
2 Eades CE, Ferguson JS, O'Carroll RE. Public health in community pharmacy: a systematic review of pharmacist and consumer 
views. BMC Public Health. 2011;11:582. 
3 Kember J, James D, Hodson K.  Public perception of community pharmacy: a qualitative study. IJPP 2013; 21:50. 
4 Gidman W, Cowley J. A qualitative exploration of opinions on the community pharmacists' role amongst the general public in 
Scotland. IJPP. 2013; 21:288-296. 
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Development and evaluation of a computer-assisted learning (CAL) package on 
angina management 
Neil Dawson and RDE Sewell 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Computer assisted learning (CAL) is a teaching method which employs the use of a computer to improve the 
users academic learning through explanation and testing of a subject matter, often without the involvement 
of a human teacher [1]. The aim was to develop and evaluate an informed and interactive computer assisted 
learning package, on the management of angina to be used by pharmacy students within the United 
Kingdom. 
The CAL package was built using Microsoft Powerpoint® and contained accurate, up-to-date and reliable 
evidence based information on the management of angina [2,3]. Aspects of the package such as structure, 
length, visual appearance and interactivity were taken into consideration [4]. A questionnaire was developed 
using a 5 point Likert scale and free text box for comments, assessing the package presentation/layout, 
content and overall impression/use of CAL. 
A total of 21 online questionnaires were completed by MPharm II students: eight (38%) from males and 
thirteen (62%) by females, producing a response rate of 18%. The mean, mode, standard deviation and 
frequency were obtained. All students felt that the package was well presented. 86% of students (n=18) 
agreed that the package was engaging and interactive and the package content was felt to be relevant and 
beneficial to MPharm II. The majority disagreed that CAL should replace lectures (52% n=11) and would 
prefer to attend a lecture rather than complete a CAL package (71% n=15). However 95% (n=20) agreed 
that the package would be useful as a revision aid and 86% (n=18) would use CAL in the MPharm degree. 
This CAL package on the management of angina has been shown to be an effective learning tool in the 
MPharm II year group, and provides a valuable insight into the views and opinions of the students regarding 
CAL. 
1. Hartley, R. The evolution and redefining of ‘CAL’: a reflection on the interplay of theory and practice. J Comput Assist Lear. 
2010;23(1):4-17 
2. National Institute for Health and Care Excellence (NICE). Management of stable angina. National Institute for Health and Care 
Excellence. Report number: CG126. 2011. 
3. NICE. Unstable angina and NSTEMI. National Institute for Health and Care Excellence. Report number: CG94. 2010. 
4. Clarke, A. Designing Computer-based Learning Materials. Hampshire: Gower Publishing Company; 2001. 
 
Can food affect 5-HT receptor pharmacology in the gastrointestinal tract? 
Celia Doyle and WR Ford 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
5-hydroxytriptamine (5-HT) is responsible for an extensive range of actions within the body. The diversity of 
its role can be attributed to the abundance of different receptor subtypes. 5-HT has long been implicated in 
disorders of the gastrointestinal (GI) tract involving gut motility. Excessive amounts of 5-HT increase 
peristalsis leading to diarrhoea [1,2]. Conversely a reduction in 5-HT leads to decreased gut transit and 
subsequently constipation [1,3]. Although 5-HT has been a focal point of research for decades, there is much 
to be learned of its function. 
Non-cumulative concentration response curves (CRC’s) were performed using the ileum of two sets of 
Dunkin Hartley guinea pigs (350-800g). One set had free access to food, the other set were food deprived 
for twelve hours. CRC’s were performed in response to 5-HT (1x10-9 – 3x10-4M), 5-HT + LY 266097 
hydrochloride (5-HT2B antagonist, 1x10-7M), 5-HT + Y25130 hydrochloride (5-HT3 antagonist, 1x10-5M), 5-HT 
+ GR 113808 (5-HT4 antagonist, 1x10-7M) and 5-HT + GR 113808 + LY 266097. 
No differences were seen in the mean EC50 values or the EC50 value shifts between the two sets of guinea 
pigs with the exception of Y25130, which produced a large rightward shift suggesting an increase in receptor 
affinity. GR113808 antagonised the relaxant response at high 5-HT concentrations in food deprived guinea 
pigs which suggests the 5-HT4 subtype is involved in mediating relaxation following food deprivation but not 
in fed guinea pigs. In every instance a higher mean maximum contractile response (g) was produced in food 
deprived guinea pigs indicating a change in intercellular coupling. 
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Following a series of unpaired, two-tailed t-tests, none of the differences gained statistical significance (P 
>0.05) indicating no change in 5-HT receptor pharmacology. However, this was probably because the study 
was underpowered. Further investigations need to be performed to ascertain any differences. 
1. Magro F, Vieira-Coelho MA, Fraga S, Serrao MP, Veloso FT, Ribeiro T, et al. Impaired synthesis or cellular storage of 
norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig Dis Sci. 2002; 47(1): 216-24 
2. Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA. Altered 5-Hydroxytryptamine Signaling in Patients With Constipation- 
and Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterology. 2006;130(1): 34-43. 
3. Dunlop SP, Singh G, Marsden C, Spiller R. Abnormalities of mucosal 5-hydroxytryptamine (5HT) metabolism in post-infective and 
constipated IBS. Gastroenterology. 2004;1 26(4): A220-A. 
 
Evaluating the reliability and validity of a contextualised numeracy diagnostic for 
undergraduate students at a school of pharmacy 
Jade Edwards and SA Coulman 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Pharmacy students in the UK must uphold a standard of core transferable pharmaceutical numeracy skills to 
comply with the General Pharmaceutical Council’s accreditation requirements [1]. First year students at 
Cardiff School of Pharmacy and Pharmaceutical Sciences (CSPPS) sit a numeracy diagnostic to identify if 
they have the adequate skills to endure the numeracy demands of the course.  This project aims to establish 
if the diagnostic is valid, reliable and able to discriminate. 
Ethical approval was granted from CSPPS ethics committee. Data was collected from 4 cohorts who had 
taken the test at CSPPS. Item analysis was carried out by measuring item difficulty and item discrimination. 
Reliability was measured by test-retest analysis and by measuring internal consistency using Cronbach’s 
Alpha. Validity was measured by analysing written feedback and conducting interviews with first year 
students.  
The distribution of overall scores was skewed to the right. This is desirable as the diagnostic aims to 
discriminate the weakest performers and therefore distribution needs to be widest amongst the lowest 
scores. Test-retest analysis found the diagnostic to decrease in reliability between years one and three. 
Internal consistency was 0.77, this is over the critical value of 0.7 [2], meaning the test is reliable. Interviews 
found items 4 and 8 to be ambiguous, therefore lacking validity and these are proposed for review.  
Overall the diagnostic was found to be reliable, valid and able to discriminate. The items are difficult enough 
to produce the desired discrimination to fit the purpose of the diagnostic. All items are reliable. All items are 
valid except for 4 and 8, which are recommended for review.  
1. General Pharmaceutical Council. Future pharmacists: Standards for the initial education and training of pharmacists. General 
Pharmaceutical Council. London. 2011 p.52 
2. Tavakol M, Dennick R 'Making sense of Cronbach’s alpha', International Journal of Medical Education. 2011;2, p.53-55 [Accessed: 
22/4/2014] Available at: http://www.ijme.net/archive/2/cronbachs-alpha.pdf  
 
Validation of the ‘FfraMedd’: a framework for conducting patient consultations 
through the medium of Welsh 
Lisa Evans and DH James 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
The Medication-Related Consultation Framework (MRCF) is a framework designed to evaluate the 
consultation skills of pharmacists [1]. It is based on the Calgary-Cambridge model [2] but with more 
emphasis on medication issues. The MRCF was translated to Welsh and is known as the ‘FfraMedd’. It is a 
support tool for pharmacists who wish to provide additional services for Welsh speaking patients [3]. The aim 
of this study was to determine if the ‘FfraMedd’ is fit for purpose in pharmacies in Wales. 
Pharmacy undergraduates from Cardiff University along with pharmacists (plus one General Practitioner) 
from across Wales were asked to participate. Semi-structured interviews were conducted which were audio 
recorded. Practitioners either participated in one-to-one interviews or telephone interviews depending on 
their location. Students were also asked to complete a written feedback form before the interview to 
encourage them to review the ‘FfraMedd’. The interviews were transcribed verbatim before two separate 
thematic analyses were performed. 
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Ten students plus eleven practitioners participated in the study (n=21). Similar themes emerged from both 
students and practitioners; however there were varying sub-themes and an additional theme appearing from 
the student data. Participants believe that the ‘FfraMedd’ is a vital support tool which encourages 
practitioners to conduct Welsh language consultations. Participants were pleased with the ‘FfraMedd’, 
however minor changes are required before the ‘FfraMedd’ is fit for purpose.  
The minor changes required regard the length of the ‘FfraMedd’ and the translation of certain words. A 
shorter version of the ‘FfraMedd’ exists which may be more suitable for practitioners. Overall, the translation 
was easily understood. The participants believed that certain words were wrongly translated such as the 
word ‘colli’ for missed doses. Practitioners were eager for more support tools in Welsh; therefore making the 
‘FfraMedd’ available would only encourage more consultations through the medium of Welsh. 
1. Abdel-Tawab, R. et al. 2011. Development and validation of the Medication-Related Consultation Framework (MRCF).  Patient 
Education & Counselling 83(3), pp.451-457. 
2. Kurtz, S. et al. 2003. Marrying content and process in clinical method teaching: Enhancing the Calgary-Cambridge guides. 
Academic Medicine 78(8), pp. 802-809. 
3. Sullivan, C. 2012. Consultation: Overview of responses. More than just words...Strategic Framework for Welsh Language Services 
in Health, Social Services and Social Care [Online] Cardiff: Welsh Government. Available at: 
http://wales.gov.uk/docs/dhss/consultation/121011overviewn.pdf [Accessed: 15 April 2014].  
 
Predicting the efficacy of local vs. systemic delivery of antibiotics for the treatment 
of respiratory tract infections 
Shôn Glyn Evans, M Gumbleton and G Taylor 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
The potential for local delivery of antibiotics by inhalation is of therapeutic interest as the respiratory tract has 
several favourable characteristics for local deposition, such as achieving higher drug concentrations [1]. With 
recent advances in device technology, new aerosol production systems allow for more effective delivery of 
pharmaceuticals into the respiratory tract [2]. The aim of this study was to use systemic dosing to predict the 
efficacy of local delivery of antibiotics to the respiratory tract, and consequently consider if current systemic 
antibiotics could be inhaled. 
Primary data on plasma concentrations seen after systemic dosing of antibiotics used in the respiratory tract 
was gathered by performing an electronic article search. The results, along with various pharmacokinetic 
(PK) factors, were used to predict what inhaled daily dose would achieve the same concentration unbound of 
an antibiotic in the lung fluid. The predicted doses were then compared with reported doses of inhaled 
antibiotics to find correlations. 
Thirty-five readings of plasma concentrations were obtained for twelve systemic drugs. Seventeen readings 
of plasma concentrations were obtained for four of these drugs following inhalation. The estimated inhaled 
daily doses were accurate for all four drugs. The method of predicting the inhaled daily dose was therefore 
effective. All four drugs shared certain pharmacological and PK properties: reasonable inhaled dose, high 
fraction unbound (Fu) and moderate half-life (t1/2). Of the systemic antibiotics, Temafloxacin met all these PK 
targets, with a Fu of 0.75, t1/2 of 8 hours, and predicted daily dose of 127-177 mg to achieve therapeutic 
concentrations. 
The method of predicting the inhaled daily dose was proven to be effective. Temafloxacin met all the 
predetermined PK targets and was therefore identified as a viable candidate for local delivery via inhalation. 
Future work should focus on lung PK and bioequivalence studies for pharmacological and clinical benefits. 
1. Young S, Zhang M, Freeman JT, Mutu-Grigg J, Pavlou P, Moore GA. The Mark Coventry Award: Higher Tissue Concentrations of 
Vancomycin With Low-dose Intraosseous Regional Versus Systemic Prophylaxis in TKA: A Randomized Trial. Clinical Orthopedics 
and Related Research. 2014;472(1):57-65.  
2. Zarogoulidis P, Kioumis I, Porpodis K, Spyratos D, Tsakiridis K, Huang H et al. Clinical experimentation with aerosol antibiotics: 
current and future methods of administration. Drug Design Development and Therapy. 2013;7(1):1115-1134. 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ZIP7 and breast cancer: use of phosphorylated ZIP7 as a biomarker 
Natasha Green and KM Taylor 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Zinc transporter ZIP7 (SLC39A7) is differentially expressed in anti-hormone resistant breast cancers [1]. 
ZIP7 mediates zinc release into the cytosol from intracellular compartments, leading to activation of tyrosine 
kinases which promote cellular proliferation, thus contributing to the aggressive nature seen in breast cancer 
cells [1,2]. ZIP7 is activated through phosphorylation by protein-kinase CK2 at Ser275-276 residues [3]. This 
study evaluated whether an antibody which detects phosphorylated ZIP7 (pZIP7) could be used as a 
biomarker in anti-hormone resistant breast cancers. Downstream phosphorylation of MAPK and AKT was 
additionally investigated. 
Wild-type MCF-7, tamoxifen-resistant (TamR), long-term tamoxifen-resistant (TamRL), Faslodex-resistant 
(FasR) and long-term Faslodex-resistant (FasRL) breast cancer cells were treated with or without exogenous 
zinc then probed with antibodies against pZIP7, ZIP7, pAKT and pMAPK by Western blot with data 
normalised to β-actin. Immunofluorescence was also carried out on the cells to determine pZIP7 activation. 
Here TamR cells had the greatest ZIP7 activation along with 94% of cells positive for pZIP7, corresponding 
with a previous study [1]. TamR cells additionally demonstrated the greatest AKT and MAPK activation as 
anticipated. TamRL cells showed greater ZIP7 activation compared to MCF-7 cells but this was not as 
pronounced as TamR cells. FasR and FasRL cells showed similar activity to MCF-7 overall. Interestingly, 
FasRL cells displayed higher MAPK and AKT activation compared to FasR cells. 
The present study implies a pZIP7 antibody would be a valuable biomarker in tamoxifen-resistant breast 
cancers along with the potential to be a good indicator of long-term tamoxifen-resistance. Although pZIP7 
may not be as valuable in Faslodex-resistance, it may be a good marker of disease progression. Our 
findings bring us closer to a better understanding of mechanisms involved in anti-hormone resistance along 
with a possible clinical use of a ZIP transporter antibody in the detection of anti-hormone resistant breast 
cancer. 
1. Taylor KM, Vichova P, Jordan N, Hiscox S, Hendley R, Nicholson RI. ZIP7-Mediated Intracellular Zinc Transport Contributes to 
Abberent Growth Factor Signalling in Antihormone-Resistant Breast Cancer Cells. Endocrinology. 2008;149(10):4912-20. 
2. Hogstrand C, Kille P, Nicholson RI, Taylor KM. Zinc transporters and cancer: a potential role of ZIP7 as a hub for tyrosine kinase 
activation. Trends in Molecular Medicine. 2009;15(3):101-11. 
3. Taylor KM, Hiscox S, Nicholson RI, Hogstrand C, Kille P. Protein Kinase CK2 Triggers Cytosolic Zinc Signalling by Phosphorylation 
of Zinc Channel ZIP7. Scince Signalling. 2012 Feb 7;5(210):ra11.   
 
Variability in delivered dose from collapsible infusion containers 
Adam Griffiths1, D McRae2 and R Price-Davies1 
1Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB and 2Prince Charles Hospital, Cwm Taf University Health Board, Merthyr Tydfil CF47 9DT, Wales, UK 
Infusion containers act as a reservoir for drug solution for infusions, usually containing at least 50ml liquid. 
Manufacturers provide different types of containers, which may behave differently. While it is usual for a 
small volume of liquid to be retained at the end of an infusion, there have been reports of significant volumes 
remaining in some Ecoflac® semi-rigid collapsible infusion containers (BBraun) [1]. Ecoflac® are available 
containing sodium chloride 0.9%, commonly used as a diluent, and prefilled with metronidazole solution. We 
investigated whether the total volume retained from the infusions was likely to be clinically significant, and 
possible reasons for the retention. 
Containers and giving sets from finished infusions were collected from the wards and the date, time, ward, 
drug name and dose were recorded. The liquid in the giving set was extracted using a 60ml syringe, and the 
container was sliced open, drained and the fluid measured.  
All containers tested retained some liquid. The average retention in the sodium chloride containers was 
8.91ml, with approximately half (64/124) of the containers with >5ml retention. The greatest retention was 
seen for Tazocin solution, where the potential average under-dose of a 4g/500mg dose was 884mg/110.5mg 
(22.1%). For the metronidazole (pre-filled) containers the potential average under-dose was much less; 
29.8mg of a 500mg dose (6.0%). 
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The study showed that there was a potential clinical problem with the retention of liquid and that there was a 
difference between the volume retained in the pre-filled containers and containers of sodium chloride with 
added drug. 
1. B.Braun. 2014. Technical Characteristics [Online]. Available at: http://www.safeinfusiontherapy.com/cps/rde/xchg/hc-safeinfusion-
en-int/hs.xsl/7289.html [Accessed: 4 March 2014]. 
 
Pharmacists’ views about intra- and inter-professional learning 
Bethan Grove and DH James 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Traditional models of acute care are inadequate for today’s prevalent chronic, multi-pathological health 
problems, requiring healthcare practitioners to work collaboratively together in providing seamless treatment 
across services. Inter and intra professional learning, two forms of collaborative learning designed to prepare 
individuals for collaborative practice, have become important areas for discussion and research. Inter-
professional learning involving individuals from more than one profession, and intra-professional from 
specific disciplines within the same profession, learning together and about each other: the aim being to 
develop functional teams in order to improve patient outcomes.  Information from those taking part in these 
learning initiatives informs education providers when making decisions on education practice. 
This explorative study investigates pharmacists’ perspectives on collaborative learning initiatives run by 
Cardiff University. Twelve semi-structured interviews were conducted with a purposive sample of twelve 
pharmacists. An interview guide was framed around topics of interest generated from a literature review and 
questions relevant to Kirkpatrick/Barr’s education typology [1]. An iterative approach to data collection [2] 
allowed for emergent themes. All interviews were transcribed and analysed using a simple thematic analysis 
involving constant comparison [3]. 
Data highlighted the need for interaction to be guided through purposeful and planned integration for quality 
learning. The whole group benefitted when participants were like-minded in their goals, balanced to allow 
two-way learning and the heterogeneity of groups was acknowledged in terms of activities and topic choice. 
Courses had positive effects in relation to participants’ confidence when interacting with healthcare 
practitioners. Participants felt that although wider organisational changes had not occurred, improved 
consultation skills had resulted in better patient-centred care [4]. 
Implications for practice and improvement are made around the need for collaborative learning opportunities 
to capitalise on the heterogeneity of learner groups, and the need for a variety of teaching approaches. 
1. Reeves, S. and Sully, P. 2007. Interprofessional education for practitioners working with the survivors of violence: Exploring early 
and longer-term outcomes on practice. Journal of Interprofessional Care 21(4), pp. 401-412. 
2. Greenhalgh, T and Taylor, R. 1997. Papers that go beyond numbers (qualitative research). BMJ 315, pp. 740-743. 
3. Charmaz, K. 2000. Grounded theory: objectivist and constructivist methods. In: Denzin, N.K. and Lincoln, Y.S. eds. Handbook of 
qualitative research. 2nd ed. Thousand Oaks, CA: Sage Publications, pp. 509-535. 
4. Pruitt, S. and Epping-Jordan, J. 2005. Preparing the 21st century global healthcare workforce. BMJ 330, pp. 637-639. 
 
SK2 channel is a promising target for blocking cancer cell proliferation 
Razan Gubara, ZA Abdulkareem and KT Wann 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Breast cancer is the most common type of cancer in women, current treatments, e.g. tamoxifen show 
problems with resistance and inefficiency against TNBC [1]. A renowned and established hallmark of cancer 
is limitless proliferation. Reported was a correlation between the cell cycle and Vm, cells with a high 
hyperpolarised potential showed little or no mitotic activity [2]. It is known that K+ channels govern the resting 
potential; hence in this study we seek to investigate pharmacological modulation of SK channels and their 
potential role in controlling cell cycle progression. SK channel expression has been studied in neurons in 
controlling electrical excitability however, little is known about their expression in non-excitable cells [3]. This 
research aims to; (i) determine the presence of mRNA transcripts encoding SK channels in FasR cells, (ii) 
determine the presence of SK channel protein by western blotting (iii) investigate the effects of 
pharmacological modulation by specific SK modulators, NS8593, NS6180 and UCL1684. This project will 
determine the suitability of potential SK blockers as future perspective therapies in inhibiting breast cancer 
proliferation.   
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RT-PCR and microarray data were carried out to determine the presence of the message encoding SK1-4 
channels. Furthermore a western blot was used to establish the presence of a functional channel protein. 
MTS cell proliferation assays were carried out using NS8593 and UCL1684 and NS6180 to determine effects 
of pharmacological blockade on SK channels and effects on cell growth 
Microarray data and RT-PCR confirmed the presence of expression of SK2 and SK4 genes. Western blotting 
showed the functional expression of the SK2 channel. MTS proliferation assays revealed that NS8593 and 
UCL1684 induced cell inhibition. 
In conclusion, the SK2 channel may be a potential target for inhibiting cell proliferation, however more 
selective blockers should be sought to block the target more efficiently and minimise off target binding. 
1. García-Becerra, R., Santos, N., Diaz, L. et al. 2013. Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on 
Signaling pathways, miRNAs and Genetically Based Resistance. International Journal of Molecular Sciences 14(1), pp. 108-145. 
2. Blackiston, D.J., McLaughlin, K.A., Levin, M. et al. 2009. Bioelectric control of cell proliferation. Cell cycle 8(21), pp. 3519-3528.  
3. Grunnet M, Strøbæk, D., Olesen, S-P. et al. 2010. Intracellular ligand-gated ion channels. Ions channels from structure to function, 
pp. 403.  
 
Can food affect adrenoceptor pharmacology in the gastrointestinal tract? 
Conor Guest and WR Ford 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Adrenoceptors are a super-family of G-protein coupled receptors expressed within tissue smooth muscle and 
at nerve terminals [1]. Stimulation of adrenoceptors initiates a range of effects in the gastrointestinal tract, 
including ileum smooth muscle relaxation [2-4]. The aim of the present study was to discover if food alters 
adrenoceptor pharmacology in the gastrointestinal tract. 
Ileum extracted from fed and food restricted guinea-pigs were suspended in 50ml organ baths filled with 
Tyrode's solution. Histamine was used to induce ileum smooth muscle contraction before noradrenaline 
cumulative concentrations were added in the presence or absence of antagonists. The response produced 
by noradrenaline addition in fed and food restricted ileum experiments were compared to determine if food 
affected adrenoceptor pharmacology in the gastrointestinal tract. 
ICI 118,551 (β2-adrenoceptor antagonist) incubation produced a significant antagonist effect on the response 
to noradrenaline in fed ileum experiments but not in food restricted ileum experiments. Prazosin (α1-
adrenoceptor antagonist) incubation produced a significant antagonist effect on the response to 
noradrenaline in food restricted ileum experiments but not in fed ileum experiments. Yohimbine incubation 
(α2-adrenoceptor antagonist) did not produce a significant antagonist effect on the response to noradrenaline 
in either fed or food restricted experiments. 
From the results it can be concluded that β2-adrenoceptors were responsible for ileum smooth muscle 
relaxation when food was present in the ileum, but not when food was absent from the ileum. Furthermore 
α2-adrenoceptors were responsible for ileum smooth muscle relaxation when food was absent from the 
ileum, but not when food was present in the ileum. Therefore α1- and β2-adrenoceptor pharmacology is 
affected by food since their contribution to ileum smooth muscle relaxation varied according to the presence 
or absence of food. 
1. Rang HP, Dale MM. Rang and Dale’s Pharmacology. 7th ed. New York: Elsevier/Churhill Livingstone. 2012. 
2. Horinouchi T, Koike K. Functional identification of b3-adrenoceptors in the guinea-pig ileum using the non-selective b-adrenoceptor 
antagonist (±)-bupranolol. J Auton Pharmacol. 2008 Oct 9;20(4):253-8. 
3. Drew GM. Pharmacological characterization of the presynaptic α-adrenoceptors regulating cholinergic activity in the guinea-pig 
ileum. Br J Pharmacol. 1978 Oct;64(2):293–300. 
4. Bauer V. Distribution and types of adrenoceptors in the guinea-pig ileum: the action of α- and β-adrenoceptor blocking agents. Br J 
Pharmacol. 1982 Aug;76(4): 569–578. 
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Molecular imprinting of prostaglandin E2 using  
1-(4-vinylphenyl)-3-(3,5-bis(trifluoromethyl)phenyl)-urea 
Nicola RM Hankey, JL Bowen and CJ Allender 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB 
Prostaglandin E2 (PGE2) is a lipid implicated in various conditions, for example inflammatory pain. Lipid 
analysis is challenging, due to the complexity and diversity of these biomolecules [1]. Sample clean-up is 
often essential in order to obtain clear, accurate analysis. It is hypothesised molecularly imprinted polymers 
(MIPs) could be used for selective sample extraction to improve reproducibility, sensitivity and reliability of 
analysis [2]. The aim of the project is to develop MIPs capable of selectively binding PGE2. 
A urea monomer (1-(4-vinylphenyl)-3-(3,5-bis(trifluoromethyl)phenyl)-urea) [3] was selected to facilitate 
interaction with the carboxylate group of a tetrabutylammonum salt of PGE2 (PGE2-TBA). A NMR titration 
was performed to determine the affinity of the interaction. MIPs were subsequently synthesised using PGE2-
TBA (0.011mmol), 1-(4-vinylphenyl)-3-(3,5-bis(trifluoromethyl)phenyl)-urea (0.011mmol), and ethyleneglycol 
dimethacrylate (0.22mmol). Polymerisation was initiated at 80°C using 1,1′-azobiscyclohexanecarbonitrile 
(1% w/w). Rebinding assays were performed to establish time to equilibrium and to generate isotherms to 
allow parameters such as MIP capacity and affinity to be established.  
Interaction between the amidic protons of the monomer and the carboxylate group of PGE2 resulted in a 
maximum shift of 3.55ppm during the NMR titrations. This translated to an average Ka of 25,617 M -1. The 
equilibrium assay demonstrated that all PGE2-TBA bound to the MIP within 5 minutes, with little non-specific 
binding observed. Although the MIP bound more than the control in the full rebinding assays, conventional 
isotherms could not be generated and therefore it was not possible to determine capacity and affinity data. 
The urea monomer shows a strong association with the template and equilibrium studies have shown that 
the imprinted polymer demonstrates selective, efficient and rapid binding. These features are desirable and 
confirm the potential for molecular imprinted polymers as tools in lipidomics. The full rebinding results were 
somewhat disappointing and could be due to an inefficient washing protocol / incomplete template removal.  
1.  Gurr, M. et al. (2002) Lipid Biochemistry. EBSCOhost [Online]. Oxford: Blackwell Science Ltd. Available at: 
http://web.ebscohost.com.abc.cardiff.ac.uk/ehost/detail?sid=4a1dea95-104e-4009-8410-
32f8fadaa577%40sessionmgr115&vid=1&hid=122&bdata=JnNpdGU9ZWhvc3QtbGl2ZQ%3d%3d#db=nlebk&AN=181638 
(Accessed: 28/03/14). 
2.  Chen, L. et al (2011) Recent advances in molecular imprinting technology: current status, challenges and highlighted applications. 
Chemical Society Reviews, 40, pp. 2922-42. 
3.  Hall, A.J. et al. (2005) Urea Host Monomers for Stoichiometric Molecular Imprinting of Oxyanions. Journal of Organic Chemistry, 70, 
pp. 1732-1736. 
 
Determining whether VGLL1 and GBP1 are associated with acquired endocrine 
resistance in breast cancer cells that lose oestrogen receptor (ER) 
Ian Harvey, SV Shah, RA McClelland, H Mottram, L Farrow and JMW Gee 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Anti-hormones are effective breast cancer treatments; however 40% of patients acquire resistance [1]. Loss 
of oestrogen receptor (ER) is one cause of acquired endocrine resistance but signalling driving such disease 
is unknown. Cardiff University has developed novel models of acquired endocrine resistance. Preliminary 
Affymetrix arrays suggested VGLL1 and GBP1 are overexpressed in acquired resistant models which have 
lost ER. We aimed to further establish whether these genes are associated with ER loss and any associated 
aggression in acquired endocrine resistance. 
Resistant models were previously derived from responsive MCF-7 and T47D cells cultured with anti-
hormones for 2-3 years. RT-PCR was used to profile ER, VGLL1 and GBP1 expression. Modified Boyden 
chamber assays assessed cell migration. Bioinformatic tools used public clinical breast cancer 
transcriptomes to measure gene interdependence and related expression with survival outcome. Ontology 
sources were searched regarding gene function. 
Three MCF-7-derived resistant models showed significant ER loss and increased migration. Significant ER 
loss was found in two T47D-derived models, with one showing substantially increased migration. VGLL1 and 
GBP1 expression was significantly increased in models which lost ER and were aggressive, but this was 
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more apparent in MCF-7-derived models. Bioinformatic analysis revealed weak inverse correlations between 
both genes and ER in untreated clinical disease, while higher intrinsic expression correlated with aggressive 
earlier relapse. Both were signalling genes contributing to multiple cancers, although GBP1 had reported 
stimulatory and anti-tumour properties. 
Some association between ER loss and increased aggression was established in acquired resistance as in 
de novo ER-ve disease [2]. VGLL1 and GBP1 associated with ER loss and migration in acquired resistance 
but this was dependent on genotypic background. These findings were supported by bioinformatics and 
ontology suggesting both signalling genes related to ER negativity [3,4]. These associations could underpin 
discovery of therapeutic targets for resistance but confirmatory mechanistic studies are needed. 
1. Ring A, Dowsett M. Mechanisms of tamoxifen resistance. Endocrine-Related Cancer. 2004;11:643-58. 
2. Brinkman JA, El-Ashry D. ER Re-expression and Re-sensitization to Endocrine Therapies in ER-negative Breast Cancers. Journal 
of Mammary Gland Biology and Neoplasia. 2009;14:67-78. 
3. Carr J, Hale WB, Rakha EA, Ball GR, Watts SL, Paish EC, et al. VGLL1 expression in triple negative breast cancer. Cardiff 
Pathology 2009 Abstracts. 2009;P22. 
4. Graham K, Ge X, Morenas A, Tripathi A, Rosenberg CL. Gene Expression Profiles of Estrogen Receptor-Positive and Estrogen 
Receptor-Negative Breast Cancers Are Detectable in Histologically Normal Breast Epithelium. Clinical Cancer Research. 
2011;17:236-46. 
 
A systematic review of health-related quality of life and patient preferences in 
patients with urinary stone disease 
Zara Hekmati1, A Raja2, H Joshi2, JS Bice1, GF Baxter1 and MS Salek1 
1Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff  
CF10 3NB and 2School of Medicine, Cardiff University, UHW Main Building, Heath Park, Cardiff CF14 4XN, Wales, UK  
Urinary stone disease is a common, painful and often recurrent condition that can affect kidney function, 
require surgical treatment and has significant impact on patients' health-related quality of life (HRQoL) 
[1].There is limited information on the impact of stone disease or its treatment on patient’s HRQoL and the 
preferences of patients of these treatment options.  The primary outcome of current therapy is to achieve a 
high stone free rate (SFR).  Improving patient’s HRQoL is often a secondary gain [2]. The aim of this study is 
to examine the evidence from all studies including an element of HRQoL measurement and patient treatment 
preference in patients with this disease. 
 
Ovid MEDLINE® 1946 to present, Ovid MEDLINE® In-Process & Other Non-Indexed Citations, EMBASE 
1947-Present, SCOPUS, EconLit and Web of Science 1900-2014 with no language restriction were 
searched.  All study designs with adult participants were included. 2 independent authors individually 
assessed the studies and extracted the data.  Narrative data synthesis was performed.   
 
Nine abstracts and 28 full-text articles were assessed. 24 studies met the inclusion criteria (4 RCTs and 20 
observational studies) from 10 countries, including 3591 patients.11 studies showed that stone formers had 
worse HRQoL than the general population or controls and 1 study showed stone formers were more likely to 
suffer with depression. Women have significant lower HRQoL than men. No studies showed better HRQoL 
scores in women. 18 studies used a generic HRQoL measure and 6 a disease-specific, none of which have 
been validated (one is in the process of validation). Studies with regard to patient preference were 
heterogeneous. 
 
There is a need to shift the paradigm of treatment outcome for urinary stone disease from achieving high 
SFR to a more patient-centric view [3]. A well-constructed, validated, disease-specific outcome measure is 
required for urinary stone disease. 
 
1. Bensalah, K., Tuncel, A., Gupta, A., Raman, J.D., Pearle, M.S. and Lotan, Y. Determinants of quality of life in patients with kidney 
stones. Journal of Urology 179(4), pp. 166-166. 2008. 
2. Modersitzki, F., Pizzi, L. and Grasso, M. Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers. 
Urolithiasis, pp. 1-8. 2013. 
3. Penniston, K. L. and Nakada, S. Y. Development of an instrument to assess the health related quality of life of kidney stone formers. 
J Urol 189(3), pp. 921-930. 2013. 
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What motivates fourth year pharmacy undergraduates in relation to their MPharm 
degree? 
Adnan Higgi and DN John 
Cardiff School of Pharmacy and Pharmaceutical sciences, Cardiff University, King Edwards VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Motivation is a complex concept which underlies the actions and behaviours of an individual. It is linked with 
academic performance with high levels of motivation producing positive academic outcomes [1]. The aims of 
this study were to identify some of the influences that motivate MPharm IV undergraduates and suggest 
ways for the school to facilitate motivation.  
A qualitative investigation using semi-structured, face-to-face, audio recorded interviews with MPharm IV 
students was conducted. Ethical approval was granted and the study design, sampling and piloting were 
undertaken by collaboration between four student researchers and supervisor. A topic guide encompassing 
six topics relating to motivation was developed based on a literature review. Participant recruitment utilised 
purposive, convenience sampling looking for demographic difference. The transcripts from all four students 
were shared and were analysed independently using thematic analysis. A deductive approach implementing 
the self-determination theory (SDT) and a data driven inductive approach were both used as analytic 
approaches [2]. 
In total 24 students were interviewed (6 interviews per researcher). Students were motivated by internal and 
external stimuli demonstrating a consortium of motivation ranging from intrinsic, extrinsic to amotivation [3]. 
Interest in material, relevance to pharmacy, novelty and optimal challenges resulted in motivation, whilst a 
lack of relevance, enjoyment and assessment guidance undermined it. Student motivation was determined 
by three underlying empirical processes of autonomy, competence and relatedness in accordance with SDT 
[4]. 
Motivation is a complex concept with both heightening and undermining influences. It is rarely determined by 
a single aspect and it varies significantly in terms of where it arises from. Intrinsic motivation is observed 
when interest in a topic is present and this drives a self-determined motivation. Where no such interest is 
existent, external impetuses begin to govern motivation or a motivational deficit is observed.  
1. Guay F, Ratelle C, Chanal J. Optimal learning in optimal contexts: The role of self-determination in education. Canadian Psychology 
2008; 49(3): 233-240. 
2. Braun V, Clark V. Using thematic analysis in psychology. Qualitative Research in Psychology 2006; 3(2): 77-101. 
3. Ryan R, Deci E. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. American 
Psychologist 2000; 55(1): 68-78.  
4. Deci E, Ryan R. Intrinsic motivation and self-determination in human behavior. New York: Plenum Press; 1985. 
 
ZIP7 and breast cancer: use of phosphorylated ZIP7 as a biomarker 
Charlotte Hill and KM Taylor 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Zinc is an essential trace element in humans and is required in over 300 enzymes [1]. ZIP7, a zinc 
transporter residing on the endoplasmic reticulum and essential for zinc release [2], is included in the top 
10% of genes overexpressed in breast cancer with diminished prognosis [3]. Protein kinase CK2 
phosphorylates serine residues (275 and 276) to activate ZIP7, causing zinc release. This ZIP7-mediated 
release of zinc leads to increased cell proliferation and migration as kinases and other downstream signalling 
pathways are activated [3]. As resistance to anti-hormones often develops as a result of current breast 
cancer treatments, such as tamoxifen and fulvestrant, new biomarkers of resistance need to be developed 
[4]. We hypothesised that the concentration of pZIP7 in cells is a good indicator of anti-hormone resistant 
breast cancer. 
Using fluorescent microscopy and Western Blotting the activation of ZIP7 was examined in MCF-7, TamR 
(tamoxifen resistant), TamRL (long-term tamoxifen resistant), FasR (fulvestrant resistant) and FasRL (long-
term fulvestrant resistant) cells. Separated by 10% SDS-PAGE, Western Blotting was used to probe samples 
for pZIP7S275/276 to examine ZIP7 activation. Additionally, pAKTS473 and pMAPKT202/Y204 measured the level of 
activation of downstream signalling pathways. Results were quantified by densitometry against β-actin.  
TamR cells have a significantly increased activation of pZIP7 while TamRL cells have a lower activation 
showing how activation decreases over time. FasR and FasRL cells demonstrated lower levels of pZIP7 
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activation. Increased pZIP7 activation led to an increase in pAKT and pMAPK activation demonstrating the 
role of ZIP7 in downstream activation. 
In TamR cells, pZIP7 is highly activated, consistent with increased expression observed by affymetrix 
analysis, highlighting the potential use of pZIP7 as a future biomarker. TamRL cells have less pZIP7 
activation further emphasising its use as a biomarker and means to monitor the progression of the disease. 
This study demonstrates pZIP7 as a potential diagnostic marker leading to novel treatment and improved 
prognosis for patients. 
1. Vallee B, Auld D. Zinc Coordination, Function and Structure of Zinc Enzymes and Other Proteins. Biochemistry. 1990;29(24):5674-
5659. 
2. Taylor K, Hiscox S, Nicholson R, Hogstrand C, Kille P. Protein Kinase CK2 Triggers Cytosolic Zinc Signaling Pathways by 
Phosphorylation of Zinc Channel ZIP7. Science Signaling. 2012;5(210):ra11. 
3. Hogstrand C, Kille P, Nicholson R, Taylor K. Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase 
activation. Trends in Molecular Medicine. 2009;15(3):101-111. 
4. Robinson D, Wu Y, Vats P, Su F, Lonigro R, Cao X. Activating ESR1 mutations in hormone-resistant metastatic breast cancer. 
Nature Genetics. 2013;45(12):1446-1451. 
 
ZIP6 and breast cancer: role of post-translational modification 
Wan H Hng and KM Taylor 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Zinc is essential for human health and has to be tightly regulated. This can be achieved through zinc 
transporters, including ZIP6 (SLC39A6/LIV-1) [1]. ZIP6 is a potential biomarker of oestrogen-receptor 
positive breast cancers metastasising to regional lymph nodes [2]. ZIP6  is always present in small amounts 
suggesting that it may be highly regulated. A number of predicted ubiquitination sites [3] in the ZIP6 
sequence have been observed allowing us to hypothesis that ZIP6 may be degraded by post-translational 
ubiquitination to regulate its level in cells. The project aims to compare whether removal of potential 
ubiquitination sites in ZIP6 can prevent removal of ZIP6 from cells.  
We used MCF-7 cells transfected with ZIP6 and the different mutants in Western Blotting and Fluorescence 
microscopy. Samples were separated by 12% SDS-PAGE. Immunoreactive bands were visualized by 
chemiluminescence using West Femto reagent. For fluorescence, cells were probed with the V5 antibody to 
recognise the V5 tag on the recombinant proteins followed by AlexaFluor®488-conjugated secondary 
antibody.  
Although Western Blot results show no statistical difference between wild-type ZIP6 to each of the mutants, 
the trends of the graphs show ZIP6 to be more abundant for the mutants, with K467A/K468A ubiquitin 
mutant having the highest expression of the protein. Fluorescence results confirmed this where 
K467A/K468A ubiquitin mutant demonstrated twice the amount of transfected cells positive for ZIP6 
compared to wild-type ZIP6. 
This data suggests the potential importance of the residues K467/K468 for ZIP6 degradation via the 
ubiquitination-proteosome pathway. Generally, the mutants did not show much difference from the wild-type 
which, may be due to the low transfection rate of ZIP6. Furthermore, since all mutants suggested some 
effect, cumulative mutation of all potential ubiquitination sites could be performed in the future to give a 
better effect [4]. In conclusion, our study provides some evidence that post-translational modification via 
ubiquitination plays a role in regulation of ZIP6 in cells. 
1. Taylor, K.M. et al. 2003. Structure–function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily   
of zinc transporters. Journal of Biochemistry 375, pp. 51–59. 
2. Taylor, K.M. 2008. A distinct role in breast cancer for two LIV-1 family zinc transporters. Biochemical Society Transactions 36(Pt 6), 
pp.1247–1251. 
3. Kim, W. et al. 2011. Systematic and quantitative assessment of the ubiquitin-modified proteome. Molecular Cell 44(2), pp. 325–340. 
4. Gottwein, E. et al. 2006. Cumulative Mutations of Ubiquitin Acceptor Sites in Human Immunodeficiency Virus Type 1 Gag Cause a 
Late Budding Defect.  Journal of Virology 80(13), pp. 6267-6275. 
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Cardiff University graduates’ preparedness for pharmacy practice measured against 
learning outcomes for undergraduate pharmacy education in the UK: perceptions of 
employers and alumni 
Bridie Humphrey and E Mantzourani 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
The GPhC is the current regulator of pharmacist education and training in the UK [1], they provide learning 
outcomes which schools of pharmacies must ensure students have completed by graduation [2]. The GPhC 
offers accreditation to universities who fulfil the criteria set for training of pharmacists. Cardiff University is 
currently seeking accreditation [3]. This study aims to explore Cardiff University graduates’ perceptions of 
preparedness for practice measures against the GPhC learning outcomes, which will also identify whether 
the learning outcomes are being met.  
Ethical approval was granted for one-on-one interviews with Cardiff University School of Pharmacy 
graduates from 2013 currently in their pre-registration year. Opportunistic sampling was used to recruit 
participants by email and telephone. 14 interviews were conducted and recorded with consent. All interviews 
were transcribed (ad verbatim), coded and then analysed using thematic analysis. Six main themes were 
identified and explored.  
Results of the interviews showed a good overall preparedness for practice. Areas were identified where 
graduates felt they were not adequately prepared for practice and areas where graduates were extremely 
well prepared for practice. The most common areas which graduates did not feel prepared for practice were 
topics which were taught theoretically rather than practically. Areas which were assessed and taught yearly 
led to graduates feeling extremely prepared in these areas namely CPDs and calculations. 
Cardiff University provides students with the knowledge and skills needed for practice. More effort is needed 
to teach areas practically and not just theoretically. More placements throughout the degree in both hospital 
and community pharmacy would improve preparedness. There is a learning curve from university to pre-
registration as with any transition. Suggestions for Cardiff University to improve graduate preparedness for 
practice were identified from the research. 
1. GPhC. 2014. About us. [Online]. Available at: http://www.pharmacyregulation.org/about-us. Last accessed 2nd May 2014. 
[Accessed: 2 May 2014] 
2. GPhC. 2011. Standards for the initial education and training of pharmacists [Online]. London: General Pharmaceutical Council. 
Available at: http://www.pharmacyregulation.org/sites/default/files/GPhC_Future_Pharmacists.pdf [Accessed: 2 May 2014]. 
3. GPhC. 2014b. Accreditation and recognition reports. [Online]. Available at: http://www.pharmacyregulation.org/accreditation-and-
recognition-reports. [Accessed: 2 May 2014]. 
 
ZIP6 and breast cancer: the role of post-translational modification 
Rebecca C Hunter and KM Taylor 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Zinc is vital for life and is involved in many cellular processes, thus regulation is crucial as too much is toxic 
to cells and too little kills cells. ZIP6 belongs to the LIV-1 subfamily of ZIP zinc transporters [1]. It has an 
established involvement in breast cancer [1] and plays a role in EMT, leading to cell migration [2]. ZIP6 
undergoes N-terminal cleavage before moving to the plasma membrane [3] to influx zinc, however, post-
translational modifications controlling its levels remain unexplored. ZIP6 is present in low levels leading to 
the hypothesis that it is degraded by ubiquitination. This study aimed to determine whether removing 
potential ubiquitin sites in ZIP6 prevents its degradation and whether some residues are more important than 
others. 
MCF-7 cells were transfected with ZIP6 ubiquitin mutants (K456AK457A, K467AK468A and K472A) and 
compared to wild-type to determine the effects of the ubiquitination sites. Immunofluorescence examined 
changes in abundance of ZIP6 positive cells by probing for V5, a tag present on all recombinant proteins, 
while Western blotting, using ZIP6 E20 and ZIP6 Y3 antibodies, examined expression levels and size 
changes in the mutants. 
The results revealed increased ZIP6 positive cells in the mutants, suggesting a role for those sites in ZIP6 
degradation, with ZIP6 K467AK468A consistently having the greatest effect. 
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The ubiquitination sites, confirmed by mass spectroscopy [4], demonstrated a high level of evolutionary 
conservation suggesting their potential importance. Cells overexpressing ZIP6 mutants K456AK457A and 
K472A had a preventative effect on ZIP6 degradation, revealing increased ZIP6 levels in cells compared to 
wild-type. Cells overexpressing ZIP6 mutant K467AK468A however, achieved a ten-fold increase in band 
density by Western blotting compared to wild-type, suggesting these ubiquitin sites are of greatest 
importance in preventing ZIP6 degradation. However, as the results were not statistically significant, 
definitive conclusions cannot be drawn and further research is required to determine whether ZIP6 is 
degraded by ubiquitination. 
1. Taylor, K.M., Morgan, H.E., Smart, K. Zahari, N.M., Pumford, S., Ellis, I.O. et al. The emerging role of the LIV-1 subfamily of zinc 
transporters in breast cancer. Mol. Med. 2007;13(7-8):396-406. 
2. Yamashita, S., Miyagi, C., Fukada, T., Kagara, N., Che, Y.S., Hirano, T. Zinc transporter LIV1 controls epithelial-mesenchymal 
transition in gastrula organizer. Nature. 2004;429:298-302. 
3. Hogstrand, C., Kille, P., Ackland, M.L., Hiscox, S., Taylor, K.M. A mechanism for epithelial-mesenchymal transition and anoikis 
resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3). Biochem. 
J. 2013;445:229-237. 
4. Kim, W., Bennett, E.J., Huttlin, E.L., Guo, A., Li, J., Possemato, A. et al. Systematic and quantitative assessment of the ubiquitin-
modified proteome. Mol Cell. 2011;44:325-40. 
 
The frequency of antidepressant use in a South Wales cohort of Parkinson’s 
disease and Benign Essential Tremor patients 
Simran Janjua and EL Lane 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Since the initial account of Parkinson’s disease (PD) its understanding has progressed to encompass non-
motor symptoms (NMS) [1]. Recently, NMS have gained recognition in Benign Essential Tremor (BET) [1]. 
With a growing acceptance of NMS in the PD and BET disease process the need to further understand their 
aetiology and impact has been identified. Depression is the most frequent NMS [1,2]. To explore the 
association of depression in PD and BET the study aimed to establish antidepressant frequency and type in 
a South Wales cohort of patients.  
A retrospective study design was applied. Subjects were PD and BET patients referred by clinicians at The 
University Hospital of Wales and The Princess of Wales Hospital between 2000 and 2010. Data was inputted 
into ‘The Electronic Clinical Network Parkinson Disease and Related Disorders Database’. Depressed 
patients were identified based on antidepressant use, extracted and evaluated for the frequency and type of 
antidepressants used. Comparisons between the two groups were drawn using descriptive statistics. Ethics 
approval was obtained.  
Overall, depression is more frequent in PD patients than BET patients. 37% (n=310) of PD patients and 26% 
(n=110) of BET patients used antidepressants. Further, PD patients used a greater variety of 
antidepressants. Antidepressant initiation was frequent over the entire disease course. Selective serotonin 
reuptake inhibitors (SSRIS) were most prescribed. Examining antidepressant management over the disease 
course revealed various possible outcomes. 13% (n=111) of PD patients and 4% (n=16) of BET patients 
exhibit depressive symptoms without current or past antidepressant use.   
Overall, there is a spectrum of mild to moderate depression. Antidepressant prescribing reflects prescribing 
trends of the general population. Evaluating the safety and efficacy of antidepressants specifically for 
depression in PD and BET is recommended to aid in developing guidelines that will ensure optimal 
management over the disease course. 
1. Louis ED. Essential tremor as a neuropsychiatric disorder. Journal of the Neurological Sciences. 2010;289(1-2):144-8. 
2. Vajda FJE, Solinas C. Current approaches to management of depression in Parkinson's Disease. Journal of Clinical Neuroscience. 
2005;12(7):739-43. 
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Patient experience: satisfaction with their medicines’ management during their 
hospital stay and satisfaction with information about their medicines provided on 
discharge from hospital 
Sophie Jeffery, ML Hughes and RS Dewdney 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Research into patient satisfaction has been conducted for many years and has been of great interest to the 
NHS [1] and it is regarded as being vital to improving services and providing better healthcare to patients [2]. 
Over the last 40 years, different hypotheses have been formulated to attempt to explain patient 
dissatisfaction and these hypotheses include demographics and health status [1,3]. The aim of this study 
was to determine the level of patient medication information satisfaction within the Aneurin Bevan University 
Health Board (ABUHB) and determine if any factors influence them.  
After obtaining ethics approval, an anonymous two-part questionnaire was mailed to 400 patients who had 
been discharged between the 27th January 2014 and 14th February 2014 from The Royal Gwent Hospital, 
Newport or Neville Hall Hospital, Abergavenny. The questionnaire contained a validated tool [4] and sought 
quantitative responses about patient experiences plus optional explanatory qualitative responses. 
Responses were input into SPSS and Kruskal-Wallis and Mann-Whitney U tests were conducted as 
appropriate. 
A questionnaire response rate of 34% was achieved. Overall satisfaction levels were high across the Health 
Board (94% satisfaction overall). Suggestions were made to improve pharmacy services and these mainly 
surrounded dosing schedules. Almost all patients (99%) felt that they were treated with dignity and respect 
whilst an in-patient. Furthermore few patients experienced problems with their medication. Information about 
a patient’s medication was viewed to be sufficient for over half of the patients.  
Satisfaction levels were high within the ABUHB and most patients felt that their experience had been 
positive, nevertheless it is hoped the findings can help the staff to further optimise patients’ experiences in 
future. 
1. Ware J, Snyder M, Wright W, Davies R. Defining and measuring patient satisfaction with medical care. Evaluation and Program 
Planning 1983; 6:247-263 
2. Bruster S, Jarman B, Bosanquet N, Weston D, Erens R, Delbanco T. National survey of hospital patients. BMJ 1994; 309:1542-
1549 
3. Thiedke C. what do we really know about patient satisfaction? Family Practice Management 2007; 14(1):33-36 
4. Horne R, Hankins M, Jenkins R. The satisfaction with information about medicines scale (SIMS): a new measurement tool for audit 
and research. Quality in Health Care 2001; 1(10): 135-140 
 
The impact of urological conditions on family members using FROM-16; 
comparison with the HRQoL impact of a urological condition on the patient using 
SF-36 
Jessica Jenkins1, R Price-Davies1, N Aawar1, MS Salek1 and H Joshi2 
1Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB and 2Urology Clinic, Main Building, Heath Park, Cardiff CF14 4XN, Wales, UK 
The impact of a patient’s condition on a family member’s quality of life is a widespread yet under-recognised 
phenomenon [1]. Research into family quality of life has only been conducted in specialities such as 
dermatology [2], oncology [3] and childhood illnesses [4]. The aim of this study was to assess the impact of 
urological conditions on family members using a generic family quality of life measuring instrument; the 
Family Reported Outcome Measure (FROM-16©), and compare this with the impact of urological conditions 
on patients’ quality of life which was measured using a Short Form Health Survey (SF-36); a generic patient 
quality of life measuring tool. 
The study was conducted in the Urology clinic at the University Hospital of Wales over a six week period.  
Patients were asked to complete the SF-36 (n=47) and family members completed the FROM-16© at two 
separate time points, 5 days apart (test 1 n=47; test 2 n=17). Test-retest reliability was assessed using 
Spearman’s rank correlation coefficient. 
The mean age of patient participants (male, n=35; female, n=12) was 65.58 years (SD=16.01) and the mean 
age of family member participants (male, n=12; female, n=35) was 63.02 years (SD=14.82). Weak to 
moderate correlations (-0.326 to -0.494) were seen between the emotional domain of the FROM-16© with 
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the physical functioning, bodily pain, general health, vitality, social functioning and mental health domains of 
the SF-36. Correlations were also seen between FROM-16© personal and social life domain with physical 
functioning, role-physical and role-emotional domains of the SF-36. Test-retest reliability of the FROM-16© 
was moderate (Spearman’s rank correlation coefficient = 0.533, p=0.028). 
The findings of the study have demonstrated that a correlation exists between urology patients’ quality of life 
and their family members’ quality of life. The test-retest indicates that the FROM-16© is reliable to be used 
on families of patients with urological conditions. 
 
1. Golics CJ, Basra MKA, Finlay AY, Salek S. 2013. The impact of disease on family members: a critical aspect of medical care. 
Journal of the Royal Society of Medicine. 106(10) pp. 399-407 
2. Basra MKA, Sue-Ho R, Finlay AY. 2007. The Family Dermatology Life Quality Index: Measuring the Secondary Impact of Skin 
Disease. British Journal of Dermatology. 156(3) pp. 528–538 
3. Swanberg JE. 2006. Informal Caregiving, Cancer and Employment. Journal of Psychosocial Oncology. 34(3) 
4. Poston D, Turnbull A, Park J, Mannan H, Marquis J, Wang M. 2003. Family quality of life: A qualitative inquiry. Mental Retardation. 
41(5) pp. 313–328 
 
The effects of exogenous administration of NO and NOx in myocardial ischaemia-
reperfusion injury: a review of in vivo animal studies using a systematic approach 
Bethan R Jones, GR Chamberlain, JS Bice and GF Baxter 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Myocardial reperfusion injury (RI) occurs when abrupt reperfusion follows a period of myocardial ischaemia 
[1]. A clinical scenario would be when a patient presents with an acute myocardial infarction caused by 
occlusion of a coronary artery, and is treated to restore blood flow to the ischaemic tissue. Revascularisation 
can increase the degree of cardiac tissue injury, leading to a decline in cardiac function [2]. Studies in animal 
models have shown nitric oxide (NO) to reduce ischaemia/reperfusion injury [3]. The aim was to conduct a 
comprehensive review of the in vivo experimental literature on the role of NO donors in myocardial RI, using 
a systematic approach. We hypothesised that the administration of these compounds as adjuncts to 
reperfusion is cardioprotective. Objectives were set to comprehensively synthesise relevant experimental 
literature, assess articles against a set inclusion criteria and critically analyse the data for inclusion.  
A thorough exploration of the current literature of experimental animal studies was conducted by performing 
searches of the Cochrane library, Medline, Embase, Web of Science and the Clinical Trials databases using 
set search terms. Articles were screened at title and subsequently abstract level using predefined inclusion 
criteria followed by full text critical analysis using a critical appraisal tool. 20 animal studies using NO donors 
(inhaled NO, nitroglycerin, sodium nitroprusside, sodium nitrite, peroxynitrite and novel donating agents) as 
adjuncts to reperfusion were included.  
All NO donors except nitroglycerin afforded cardioprotection against RI, including reductions in infarct size, 
creatinine kinase concentrations, neutrophil accumulation and improved cardiac function. Sodium nitrite and 
peroxynitrite showed concentration dependant protection, which at higher doses proved detrimental.  
NO donors reduce infarct size in experimental in vivo models of RI when given at physiological 
concentrations as an adjunctive therapy to reperfusion. Additional studies are needed to define the most 
appropriate agent, dose, route and timing of administration. 
1. Park, J. L. and Lucchesi, B. R. (1999). Mechanisms of myocardial reperfusion injury. The Annals of Thoracic Surgery 68(5): 1905-
1912. 
2. Ferdinandy, P., Schulz, R. and Baxter, G. F. (2007). Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion 
injury, preconditioning and postconditioning. Pharmacol Rev 59(4):418-458 
3. Schulz, R., Kelm, M. and Heusch, G. (2004). Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 61(3): 402-413 
 
Can food affect trace amine responses in the gastrointestinal tract? 
Lowri Jones and WR Ford 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Tyramine, tryptamine, β-phenylethylamine (β-PEA) and octopamine are examples of trace amines (TAs). 
They are found endogenously at nanomolar concentrations [1]. They are also found in foods such as 
cheeses and chocolate. They have been described as false neurotransmitters and many of their effects are 
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indirectly mediated by the biogenic amines [2,3]. TAs have been identified to cause contraction of the ileum 
by activating trace amine-associated receptors [4]. They are known to produce effects after ingestion e.g. the 
cheese effect. Therefore the aim of this project was to identify whether TAs produce different effects on fed 
and food restricted ileum. 
Isolated ileum (2cm) was suspended in an organ bath filled with Tyrode’s solution that was kept at 37°C and 
aerated (95%O2, 5% CO2). In order to stimulate contraction the ileum was electrically stimulated (0.2Hz, 
5ms pulse width, 10-20 V). Cumulative concentration-response curves (CCRCs) were constructed for all four 
TAs. CCRCs were also constructed for tyramine, β-PEA and tryptamine with the antagonists, atropine, 
mepyramine and ICI 118 551. 
The results of the study were not statistically significant due to the study being underpowered. However, 
qualitatively it can be stated that tyramine did not cause an effect. β-PEA caused the opposite response in 
fed and food restricted ileum and Tryptamine and octopamine produced relaxation. Relaxation was produced 
by all three TAs in the presence of ICI 118 551 which was unexpected and implies that ICI 118 551 has an 
ability to antagonise receptors that cause contraction. Atropine and mepyramine inhibited all responses 
produced by tyramine and β-PEA, and did not affect the responses produced by tryptamine. 
This study failed to show that TAs cause contraction as reported in the literature. At concentrations higher 
than that found endogenously they failed to produce significant responses which imply that targeting them as 
future treatments would not be of great benefit. 
1. Zucchi, R. et al. 2006. Trace amine-associated receptors and their ligands. British Journal of Pharmacology 149 (8), pp. 967-978. 
2. Borowsky, B. et al. 2001. Trace amines: Identification of a family of mammalian G protein-coupled receptors. Proceedings of the 
National Academy of Sciences 98 (16), pp. 8966-8971. 
3. Bunzow, J. R. et al. 2001. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the 
catecholamine neurotransmitters are agonists of a rat trace amine receptor. Molecular Pharmacology 60 (6), pp. 1181-1188. 
4. Broadley, K. J. et al. 2009. Effects of dietary amines on the gut and its vasculature. Britich Journal of Nutrition 101(11), pp. 1645-
1652. 
 
Patient experience: satisfaction with their medicines management during their 
hospital stay and satisfaction with information about their medicines provided on 
discharge within University Hospital of Wales 
Niral Joshi, ML Hughes and RS Dewdney 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Patient satisfaction with medicines management and information provided has been found to increase 
compliance and adherence [1]. NHS standards [2] discuss the importance of patients receiving information in 
a timely and appropriate manner. This is important for a patient’s treatment and can help prevent drug-
related readmission [3]. It is clear that communication is important but little is known about patients’ views so 
this study was designed with the aim of assessing satisfaction and experiences of patients at the University 
Hospital of Wales. 
A research team comprised of University and Health Board staff designed a questionnaire incorporating (with 
permission) a validated audit tool; the Satisfaction with Information about Medicines Scale (SIMS), to assess 
satisfaction [4]. The School of Pharmacy and the hospital research and development department granted 
ethical approval. Questionnaires were sent to eligible patients over a four-week period. Returned 
questionnaire data was input into a database and analysed with SPSS using descriptive statistics, Mann 
Whitney U tests, Kruskal Wallis tests and Chi Square tests. 
A total of 72 questionnaires were returned which is a response rate of 31%. As inpatients, 56% of patients 
came into contact with pharmacy staff, and 49% were able to discuss their medicines. The majority of 
patients (87%) reported no problems with their medicines, and 92% were either satisfied or very satisfied 
with this way their medicines were dealt with. The majority of patients received written (50%) or verbal (65%) 
information on discharge. The mean SIMS score was 10.5 out of 17 and a significant relationship between 
SIMS score and satisfaction with medicines management was found (p=0.003). 
Although the findings were generally positive, there is still room for improvement. Ideally all patients should 
be very satisfied. Hospital staff can use the results to attain and maintain an even higher level of patient 
satisfaction. 
1. Duggan C, Bates I. Medicine information needs of patients: the relationships between information needs, diagnosis and disease', 
Quality Safety Health Care, 2008(17), pp. 85-89.  
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3. Wong F, Chan M, Chow S, Chang K, Chung L, Lee W, Lee R. What accounts for hospital readmission? Journal of Clinical Nursing, 
2010 19(23), pp. 33-34.  
4. Horne R, Hankins M, Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit 
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Does infusion container influence the amount of drug delivered by infusion? 
Helen King and R Price-Davies 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Anecdotal reports were received from a local NHS trust regarding incomplete emptying of Ecoflac® Plus 
100ml containers during infusions. The aim of the study was to investigate why Ecoflac® Plus containers may 
undergo incomplete emptying and compare flow from a semi-rigid Ecoflac® Plus container against a fully 
collapsible Freeflex® bag. 
Methods involved testing height, roller clamp control and additional volumes using a simple intravenous 
setup under gravity infusion. For height, both containers were hung from varying heights under wide open 
flow. For roller clamp control, both containers were hung from a fixed height with the roller clamp taped prior 
to infusion to prevent movement. For additional volumes, fluid from Ecoflac® Plus was delivered from 90cm 
controlled to an initial flow rate of 4ml/min, based on Tazocin® infusion guidelines [1]. 0ml, 20ml, 40ml, 60ml 
and 80ml additional liquid was added, with removal of an equivalent volume of air [2]. 
Increasing infusion height significantly increased flow rate of both containers. With Freeflex®, a 10cm 
increase in height gave a 10% increase in flow rate, whilst Ecoflac® Plus gave a 15.75% increase per 10cm 
height. Freeflex® controlled infusion time ran at 16mins 44secs, slower than the expected time (12mins 
30secs). Ecoflac® Plus’s average infusion time was recorded as 28mins 22 secs, 72% longer than the 
theoretical infusion time. Percentage volume remaining increased with volume added. For the control 8.5% 
of initial volume remained, increasing to 43.3% (78ml) in the 180ml container. 
Freeflex® containers flow quicker than Ecoflac® Plus, but Ecoflac® Plus’s flow is significantly smoother. The 
semi-rigid structure of Ecoflac® Plus is a limiting factor on flow rate delivered. Ecoflac® Plus containers show 
significant residual volumes with additional volumes above 20ml. B.Brauns’ revised literature states a 
maximum addition volume of 40ml [3], raising concern that clinically significant under dosing of patients could 
occur. 
1. Joint Formulary Committee. Appendix 6: Intravenous additives, Piperacillin and tazobactam. British National Formulary. 66 ed. 
London: BMJ Group and Pharmaceutical Press; 2013. P1015 
2. B.Braun Melsungen AG. Ecoflac® Plus. Nr 606 1520. 
3. B.Braun Melsungen AG. Ecoflac® Plus Technical Characteristics: Braun Medical Ltd; 2014 [Accessed 01-Mar-2014]. Available 
from: http://www.safeinfusiontherapy.com/cps/rde/xchg/hc-safeinfusion-en-int/hs.xsl/7289.html 
 
Can food affect muscarinic receptor pharmacology in the gastrointestinal tract? 
Sarah Knight and WR Ford 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Muscarinic receptors throughout the gastrointestinal tract allow smooth muscle contraction. The M3 receptor 
is responsible for 75% of ileal smooth muscle contraction, with the remaining 25% due to the M2 receptor [1]. 
Relationships exist between gut muscarinic response and feeding through the hormone release from 
gastrointestinal cells [2], however no current knowledge exists  to show the effect feeding has upon on 
muscarinic receptor pharmacology. The aim of the study is to assess the shift in concentration response 
curves (CRCs) seen through agonising the muscarinic receptor subtypes in the guinea pig ileum, when 
tissues from fed and food-restricted animals are compared. 
The muscarinic agonist methacholine was used along with muscarinic antagonists pirenzepine 
dihydrochloride, (s)-(+)-dimethindene maleate, and zamifenacin fumarate. Cumulative CRCs were 
constructed with concentrations added in half log intervals. The EC50 value, antagonist shift and antagonist 
affinity were calculated. Two tailed, unpaired T-tests were used to assess statistical significance. 
No statistically significant differences were seen between fed and food-restricted tissues. Qualitative 
differences show the methacholine CRC for fed tissue is positioned to the right of the CRC for food restricted 
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tissue, and a larger antagonist shift in food restricted tissue is induced by atropine. Finally the maximum 
contractile response did not significantly change within the two tissue types. 
The qualitative differences could suggest a lower affinity within the fed tissue, and therefore receptor 
phosphorylation is present. A lack of difference in maximum contractile response shows no change in 
intracellular coupling [3]. In this study no results were statistically significant, suggesting that food has not 
been found to affect muscarinic receptor pharmacology within the guinea pig ileum in this particular study. 
This could be attributed to a low statistical power caused by the small differences seen between the two 
tissue types, the low n number used, and the large variability within the results. 
1. Matsui M, Yamada S, Oki T, Manabe T, Taketo MM, Ehlert FJ.Functional Analysis of Muscarinic Acetylcholine Receptors using 
Knockout Mice. Life Sciences. 2004;75(25):2971-81 
2. Avena NM, Rada PV. Cholinergic Modulation of Food and Drug Satiety and Wihthdrawal. Physiology & Behavior. 2012;106(3):332-6  
3. Haga T. Molecular Properties of Muscarinic Acetylcholine Receptors. The Japan Academy. 2013;89(6):226-56 
 
Investigations of modified release melatonin dosage forms 
Hei Ngan Kong, JC Birchall and G Taylor 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Melatonin is an endogenous hormone mainly secreted by the pineal gland and it is involved in the regulation 
of the circadian rhythm of several biological functions [1]. Melatonin has been used as a hypnotic in treating 
patients with insomnia. Modified release formulation of the drug melatonin was investigated in this research 
project. The aim is to produce novel suppositories in a modified release pattern for rectal delivery.  
A fatty base, Witepsol S55 and hydrophilic base, glycerol suppository base were used respectively for 
extemporaneous preparation of melatonin suppositories. In vitro drug release of suppositories and three 
different commercial oral tablets was studied. Paddle method was used, with a stirring speed of 50 rpm at 
37℃ ±0.5℃ in 400mL of pH 7.4, phosphate buffered saline. Samples were collected at appropriate intervals 
and the concentration of melatonin was assayed spectrophotometrically at 278nm. Dissolution profiles of the 
suppositories were compared against that of the different formulated tablets. Time required for 50% release 
of melatonin and half-life of different formulation were calculated and analysed statistically.  
The suppositories prepared by Witepsol S55 did not completely melt at 37℃ and only deformed. The results 
demonstrated that only 60% of total drug dose was liberated from the suppositories. Whereas, the 
suppositories prepared by glycerol base have fully dissolved in the medium and released the drug. The 
results also showed the release behaviours of the three different formulated tablets were corresponded to 
what they have been claimed on their product labels.  
The dissolution method, test conditions, preparation of suppositories and assay method were discussed and 
evaluated. Complete melting of lipophilic base was found to be essential for total release of drug. Witepsol 
S55 appeared to be a potential suppository base for producing modified release melatonin suppositories for 
rectal delivery, but further investigation is needed to ensure its suitability.  
1. Altun A, Ugur-Altun B. Melatonin: therapeutic and clinical utilization. International Journal of Clinical Practice. 2007 May;61(5):835-
45. 
 
Involvement of canonical Wnt signalling in Alzheimer’s disease 
Sheatha Latif, EJ Kidd and RS Thomas 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
An accumulation of amyloid-beta (Aβ), cleaved from amyloid precursor protein (APP), is thought to drive the 
neuropathology observed in Alzheimer’s disease (AD) [1]. Canonical Wnt signalling is highly involved in 
neuronal development and synaptic plasticity [2], and may be dysregulated by Aβ toxicity. Whether the 
pathway is up- or down-regulated in AD is currently unknown [3]. This study explored whether levels of key 
canonical Wnt proteins are altered in the London APP(V717I) murine model of AD. London APP(V717I) 
mutation mice overexpress APP, demonstrating progressive accumulation of Aβ with age [4].  
Western blotting analysis determined levels of canonical Wnt signalling proteins β-catenin and GSK3β in 
right cortex samples from transgenic (Tg) and wild type (Wt) mice. Comparisons were made between age-
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matched Tg and Wt mice of ages 3, 9 and 18 months. In addition, changes to protein levels with age were 
explored. 
Levels of APP were significantly increased in 9 month and 18 month old Tg mice compared to age-matched 
Wt mice. β-catenin levels were significantly reduced in 9 month and 18 month old Tg mice compared to age-
matched Wt mice. The effect of ageing on the reduction of β-catenin levels was observed earlier in Tg mice 
compared to Wt mice. A significant reduction in GSK3β levels was observed in Tg mice with age (9 months 
vs. 3 months).  
The age-dependent reduction in levels of β-catenin implies decreased Wnt signalling output, which appears 
to be enhanced in Tg mice by Aβ pathology. However, reduced levels of GSK3β in 9 month Tg mice suggest 
the opposite, correlating to increased Wnt signalling output. This study demonstrates that canonical Wnt 
signalling is altered by Aβ pathology and with age, however further investigation is warranted to elucidate 
whether the canonical Wnt pathway is up- or down-regulated in AD.  
1. Hardy, J. and Allsopp, D. 1991. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends. Pharmacol. 
Sci. 12 pp. 383-388. 
2. Clevers, H. 2006. Wnt/β-Catenin Signaling in Development and Disease. Cell 127 pp. 469-480. 
3. Boonen, R.A.C.M. et al. 2009. Wnt signalling in Alzheimer’s disease: Up or Down, that is the question. Ageing Res. Rev. 8(2) pp. 
71-82  
4. Tanghe, A. et al. 2010. Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the 
APP[V717I] London Transgenic Mouse Model. Int. J. Alzheimers. Dis. 2010 pp. 1-9. 
 
Molecular modelling studies on CHKV nsP3 as a possible antiviral target 
Jiun Lung Lee and A Brancale 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Chikungunya fever has influenza-like symptoms caused by Chikungunya Virus (CHKV). CHKV is a genus of 
Alphavirus and transmitted via Aedes mosquito. It was first described during an outbreak in southern 
Tanzania, in 1952. It caused epidemic in tropical and subtropical regions. In 2006, one third of La Réunion 
Island’s population was infected and 237 people died during that CHKV outbreak [1]. It is self-limiting but 
medical attentions is usually required. However, until now no specific drugs and vaccines and treatment 
remains symptomatic. Four non-structural proteins (nsP1-4) were reported. NsP3 has been reported to 
involve in the transcription process at an early stage of the infection [2,3]. The first 160 residue of nsP3 N-
terminal macro domain were crystallised. Two crystal structures, 3GPG and 3GPQ were used in this project 
[4]. 
Virtual screening was used to filter down the SPECS database. Followed by, using Glide docking score, 
binding pose and visual inspection. 10 compounds were selected for each crystal structure. Compound 1 
was the only compound got selected for both crystal structure. After that, molecular dynamics stimulations 
were used to study the behaviour of the compound with the crystal structure over time. 
Compound 1 had a good Glide docking score, fulfil Lipinski’s rule of 5 and did not has chiral centre. The 
ester of compound 1 was mutated to amide, compound 20 to increase the interaction with the protein 
residues. The trajectories of molecular dynamics stimulations showed the compound 1 had a good 
interaction with 3GPQ but not 3GPG and vice versa for compound 20. The results were supported by the 
binding free energy of compound 1 and 20 with correspond crystal structure. The different position of the 
Arg144 caused these results. 
 
This study has demonstrated a potential to identify inhibitors for N-terminal macro domain of nsP3. 
Compound 1 and compound 20 had a completely different response with both crystal structure. 
Nevertheless, biological testing and crystallising is required for biochemical, ligand-protein interaction and 
structural analysis. 
 
1. Renault P, Solet JL, Sissoko D, Balleydier E, Larrieu S, Filleul L, et al. A major epidemic of Chikungunya virus infection on Reunion 
Island, France, 2005-2006. American Journal of Tropical Medicine and Hygiene. 2007;77(4):727-31. 
2. Rathore AP, Haystead T, Das PK, Merits A, Ng ML, Vasudevan SG. Chikungunya virus nsP3 & nsP4 interacts with HSP-90 to 
promote virus replication: HSP-90 inhibitors reduce CHIKV infection and inflammation in vivo. Antiviral Res. 2014;103:7-16. 
3. Pan American Health Organization. Epidemiological Alert: Chikungunya Alert. PAHO/WHO. 2013. 
4. Malet H, Coutard B, Jamal S, Dutartre H, Papageorgiou N, Neuvonen M, et al. The crystal structures of Chikungunya and 
Venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket. J Virol. 
2009;83(13):6534-45. 
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The transurothelial permeability and bladder wall distribution of oxybutynin chloride 
in an ex vivo porcine model 
Kay Lee, NA Williams and CJ Allender 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Oxybutynin is the most commonly used anticholinergic drug for the treatment of the overactive bladder [1]. 
Intravesical instillation of oxybutynin is an effective alternative to systemic treatment with minimal adverse 
effects [2]. The mechanism of action of anticholinergic drugs has recently been reviewed; it is proposed that 
anticholinergics act on bladder mucosal muscarinic receptors to modulate afferent signalling [3]. The exact 
location of where this occurs is unknown, thus we aimed to quantify concentrations of oxybutynin achieved in 
the layers of the bladder wall after local application in an ex vivo porcine model.  
Whole pigs’ bladders freshly excised from the animal were used for instillation of drug solution. Tissue 
samples were serially sectioned by a cryostat and drug quantities analysed using HPLC-MS after chemical 
extraction. Franz-type diffusion cells were used to investigate drug permeation across the bladder 
urothelium. Histology of tissues pre and post-treatment with oxybutynin was also performed. 
Intravesical instillation of oxybutynin after 60 minutes resulted in highest drug concentrations in the 
urothelium and declined through the lamina propria and detrusor. Dilution with urine greatly reduced drug 
quantities achieved in all bladder layers investigated. No histologic alterations of the bladder mucosa were 
observed. 
These drug delivery studies add more weight to the growing argument that antimuscarincs exert their effects 
on the bladder wall through mechanisms other than direct detrusor inhibition. 
1. Jirschele K, Sand PK. Oxybutynin: Past, Present, and Future. Int Urogynecology J. 2013 Apr. 24(4), 595–604. 
2. Madersbacher H, Jilg G. Control of Detrusor Hyperreflexia by the Intravesical Instillation of Oxybutynine Hydrochloride. Paraplegia. 
1991 Feb.  29(2), 84-90. 
3. Andersson K-E. Antimuscarinic Mechanisms and the Overactive Detrusor: An Update. Eur Urol. 2011 Mar. 59(3), 377–86. 
 
MMP expression and activation in breast cancer subtypes 
Yenn Teng Amanda Lee and S Hiscox 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Metastasis is a major cause of death in breast cancer. Matrix metalloproteinases (MMPs) are zinc-dependant 
endopeptidases implicated in the invasion and metastasis of cancer through the degradation of the 
extracellular matrix [1]. Overexpression of the gelatinases (MMP-2 and MMP-9) has been found to correlate 
with increased tumour invasiveness in breast cancer [2,3]. The aim of this study was to test the hypothesis 
that the gelatinases are associated with poorer prognostic subtypes of breast cancer and therefore, may 
represent a suitable therapeutic target in these cases to prevent further metastatic spread. 
MMP-2, MMP-9 and Urokinase Plasminogen Activator (uPA) were evaluated against a panel of four breast 
cancer cell lines: MCF7 (ER+), BT474 (ER+ and HER2+), SKBr3 (HER2+) and MDA-231 (ER-, PR- and 
HER2-). Reverse-Transcription Polymerase Chain Reaction (RT-PCR) and gel zymography were performed 
to analyse the mRNA and protein expression of the gelatinases whereas the enzymatic activity of urokinase 
was screened using an uPA assay. 
In summary, the four cell models expressed varying levels of gelatinases, Strong expression of MMP-2 and 
MMP-9 mRNA was identified in the SKBr3 cells, whilst low protein activity was detected in the same cells. In 
contrast, high MMP-9 protein expression was found in the MCF7 cells. Additionally, MDA-231 cells 
demonstrated strong uPA activity. 
It is concluded that there is no definitive relationship between gelatinase activity and aggressive breast 
cancer subtypes. As the data suggest a role for MMP-2 and MMP-9 in HER2+ breast cancer, this 
observation may be significant in the development of novel MMP-2 and MMP-9 inhibitors for HER2-mediated 
metastasis. In addition, serum levels of uPA may be a prognostic marker for Triple Negative Breast Cancer 
(TNBC). Further studies are warranted to evaluate the regulatory mechanisms underlying the activation of 
these gelatinases and their implications in breast cancer progression to aid the development of successful 
MMP-targeted therapies. 
MPharm 
37 
1. Roy, R. et al. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. Journal of Clinical 
Oncology. 2009;21:5287-10. 
2. Pellikainen, J.M. et al. Expression of matrix metalloproteinase MMP-2 and MMP-9 in breast cancer with special reference to 
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Community pharmacist’s information needs when completing a Discharge Medicine 
Review, for a patient when they are discharged from hospital 
Hannah Leggett1, C Way2 and E Mantzourani1 
1Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff  
CF10 3NB and 2NHS Wales Informatics Service, Brunel House, 12th Floor, 2 Fitzalan Road, Cardiff, CF24 0HA 
Discharge from hospital presents as the time where there is the greatest potential risk for the breakdown in 
the continuity of care for the patient. In Wales a Discharge Medicine Review [1] service has been established 
where community pharmacists review a patient’s medicines on discharge. There has been debate on 
whether patient’s Discharge Advice Letter (DAL) should be provided to community pharmacists. NHS Wales 
Informatics Service and Cardiff University wanted to identify whether all information on a DAL is required. 
The aim of this project was to identify the information required by community pharmacists to complete a 
Discharge Medicines Review for a patient recently discharged from hospital 
A questionnaire was developed using the Royal Pharmaceutical Society (RPS) [2] and Royal College of 
Physicians (RCP) [3] guidance on the content of Discharge Advice Letters. Following a pilot, a copy was sent 
to all 709 registered pharmacies in Wales, along with a cover letter and a pre-paid envelope. Participants 
were invited to complete the hard copy or the online version. 
A 54.0% response rate was achieved. 269 participants stated they wanted to receive a DAL when patients 
are discharged from hospital. Preference of delivery of information was split between electronic means and 
fax.  74.3% wanted to receive information within 48 hours of discharge. Participants’ views reinforced the 
recommendations by the RPS and RCP for the essential content of information in letters. Thematic analysis 
highlighted patient eligibility and service awareness as additional areas of requirement. Lack of 
communication and documentation of medication information, and compliance aids patients were mainly 
linked to medicine-related incidents. 
Deficiencies in these practices lead to patient harm and this study identifies suggestions for improvement. It 
can be used to support the case for the implementation of access for community pharmacists to patients’ 
health care records to improve patient safety and continuity of care. 
1. Community Pharmacy Wales (CPW).2011. Details of the DMR service [Online] Available at: http://www.cpwales.org.uk/Contractors-
Area/Pharmacy-Contact---Services/Advanced-Services/20111111-Details-of-the-DMR-service.aspx 
2. Picton, C and Wright,H 2012 Keeping Patients Safe when they transfer between care providers- getting the medicines right - Final 
Report. London. Royal Pharmaceutical Society 
3. Royal College of Physicians 2008. A clinicians Guide to Record Standards-Part 2. Standards for the structure and content of 
Medical Records and communication, when patients are admitted to hospital. Digital and Health Information Policy Directorate 
 
Exploring the Welsh sponge Halichondria panicea as a source of novel compounds 
for antibacterial treatment 
Fiona Lin and AW White 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Antibacterial resistance is becoming a major health concern [1,2]. It is further aggravated by the uncontrolled 
and improper use of antibiotics [2]. There is an urgent demand for new antibiotics to combat this issue. 
Marine sponges provide rich resources for structurally novel compounds, many of which exhibited a wide 
array of bioactivities [3,4]. The aim of the study was to investigate antibacterial activity of natural compounds 
isolated from Halichondria panicea collected from the Welsh coast.   
Halichondria panicea was extracted with solvents of increasing polarity. The compounds in each extract 
were isolated using analytical TLC and screened for inhibitory activity against Staphylococcus aureus and 
Escherichia coli by TLC-direct bioautographic method. The active compounds were then purified using 
preparative TLC. Preliminary identification of the active components was conducted by low-resolution mass 
spectrometry and followed by high-resolution mass spectrometry. 
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Among the three extracts, hexane extracts showed the most successful extraction profile. A total of 12 
fractions were obtained from hexane extracts and only two fractions that exhibited the highest antibacterial 
activity against S. aureus were selected for further investigation. No inhibition against E. coli was observed. 
The high-resolution MS spectrum revealed three principal peaks with majority of their empirical formulae did 
not match any of the literature values or contaminants and therefore, suggested to be novel. One of the 
compounds was identified as a purine derivative.  
The poor yield of acetone extracts and no good separation of compounds in methanol extracts in addition to 
the negative inhibition against the bacteria have resulted in further analysis of hexane extracts only. No 
inhibition against E. coli suggested that the antibacterial properties of the fractions were less active towards 
Gram-negative bacteria. Purine compounds are commonly found in marine sponges. Based on the findings, 
Halichondria panicea is a potential source of research on novel compounds for antibacterial treatment.  
1. Singh G, Kumar P. Phytochemical study and screening for antimicrobial activity of flavonoids of Euphorbia hirta. Int J Appl Basic 
Med Res. 2013 Jul;3(2):111-6. 
2. Devi P, Wahidullah S, Rodrigues C, Souza LD. The Sponge-associated Bacterium Bacillus licheniformis SAB1: A Source of 
Antimicrobial Compounds. Mar Drugs. 2010 Apr 9;8(4):1203-12. 
3. Orhan IE, Ozcelik B, Konuklugil B, Putz A, Kaban UG, Proksch P. Bioactivity Screening of the Selected Turkish Marine Sponges 
and Three Compounds from Agelas oroides. Rec Nat Prod. 2012 Jul 20;6(4):356-67.  
4. Zhang W, Zhang F, Li Z, Miao X, Meng Q, Zhang X. Investigation of bacteria with polyketide synthase genes and antimicrobial 
activity isolated from South China Sea sponges. J Appl Microbiol. 2009 Aug;107(2):567-75.  
 
Design and synthesis of novel inhibitors of Coxsackie viruses 
Anwen Lumley, A Brancale, and M Cancellieri 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB 
Coxsackie viruses account for 16.4% to 24.3% out of the yearly 10 million symptomatic Enteroviral infections 
[1]. Coxsackie virus B3 can cause life threatening diseases such as pancreatitis and myocarditis [2,3]. A 
novel non-nucleoside inhibitor, GPC-N114, has been discovered which competes with the RNA primer 
template primer for the active site of the Coxsackie virus 3D polymerase blocking the replication of the viral 
genus. Its binding in turn stops the elongation of the RNA. Due to the high lipophilicity of the molecule, the 
aim of the project is to design novel analogues of GPC-N114 with a better solubility and, ideally, improved 
activity. 
Three main modifications of the lead compound were carried out. Validation of the compounds were 
undertaken by flexible alignment and docking procedures to observe the binding within the pocket and 
determine their total energy strain compared to the lead compound. The synthesis involved a one-step 
nucleophilic substitution reaction to form sulphonamido and amido derivatives. Fischer esterification reaction 
was used to produce ethyl ester functional groups. 
Flexible alignment showed that the compounds had a good total energy strain which demonstrated good 
alignment. The docking readings showed that the compounds maintained the same essential binding 
interaction with the amino acids of the 3D polymerase as the lead compound. In total twenty-six designed 
compounds were successfully synthesised with acceptable yields.  
To conclude, modifications to the linker group and lateral functional groups showed an improvement in 
overall binding compared to the lead compound. The yields of the compounds depend on their structure and 
also their polarity. Biological evaluation is ongoing with single-cycle assay and multicycle CPE-reduction 
assay in BGM cells. It is hoped that these results will lead to further research into novel non-nucleoside 
inhibitors of Coxsackie virus 3D polymerase and possibly other Enteroviruses. 
1. Maze SS, Adolph RJ. Myocarditis: Unresolved Issues in Diagnosis and Treatment. Clinical Cardiology. 1990;13:69-79. 
2. Tracy S,  Höfling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ. Group B Coxsackievirus Myocarditis and Pancreatitis: 
Connection Between Viral Virulence Phenotypes in Mice. Journal of Medical Virology. 2000;62:70–81. 
3. Sawyer MH. Enterovirus Infections: Diagnosis and Treatment. Seminars in Paediatric Infectious Disease 2002;13:40-47. 
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Study of the dopaminergic pharmacology of the guinea pig ileum 
Natasha Mather, LWP Topley and EL Lane 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff, CF10 3NB, Wales, UK 
Dopamine receptors, D1-D5, are found throughout the entire GI tract [1] with evidence suggesting varied 
distribution of receptors between different regions [2]. The role of dopamine and its receptors is unclear but 
there is a potential for neuronal adaptations to occur with food withdrawal [3] and links between dopamine 
and GI disorders [4]. The aim of this study was to determine a difference in the dopamine pharmacology of 
the proximal and distal guinea pig ileum and the effects of food restriction.  
Two identical 50ml capacity (overflow system) organ baths were used and average dose-response curves of 
each individual agonist recorded for each tissue type. The tissues were also incubated for 30 minutes with a 
specific antagonist before the agonist was re-tested. Acetyl-β-methylcholine was used to test tissue 
sensitivity and all responses were standardised as a percentage of this control. Student paired and unpaired 
t-tests were used for analysis. 
Proximal food restricted tissue was less sensitive to apomorphine (non-selective dopamine agonist) and 
bromocriptine (D2 and D3 agonist) but more sensitive to SKF 38393 (D1 and D5 agonist). Distal food restricted 
tissue was less sensitive to bromocriptine but more sensitive to apomorphine and SKF 38393. The overall 
responses of proximal free food and food restricted tissue were reduced in the presence of the antagonists. 
Distal free food produced an increased response in the presence of raclopride (D2 antagonist) and distal food 
restricted tissue produced an increased SKF 38393 response in the presence of SCH 23390 (D1 and D5 
antagonist). The difference between proximal and distal tissue response to bromocriptine gave a p value of 
0.002 whilst all other p values were > 0.05. 
The different sensitivities seen between the tissues suggest a change in receptor composition when food is 
restricted with variations found between the different regions of the ileum. However, the lack of statistical 
significance indicates more work is needed to establish a true difference between the tissues and further 
understand the role of dopamine in the gut. 
1. Li, Z. Schmauss, C. Cuenca, A. Ratcliffe, E. and Gershon, M. 2006. Physiological modulation of intestinal motility by enteric 
dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-
type and knock-out mice. The Journal of Neuroscience 26(10), pp. 2798-2807. 
2. Kirschstein, T. Dammann, F. Klostermann, J. Rehberg, M. Tokay, T. Schubert, R and Köhling R. 2009. Dopamine induces 
contraction in the proximal but relaxation in the distal rat isolated small intestine. Neuroscience Letters. 465, pp. 21-26. 
3. Carr, K. Tsimberg, Y. Berman, Y. and Yamamoto, N. 2003. Evidence of increased dopamine receptor signalling in food-restricted 
rats. Neuroscience 119, pp.1157-1167 
4. Furness, J. 2006.  The enteric nervous system. Victoria: Blackwell Publishing. 
 
ABM Health Board patient experience: satisfaction with their medicines 
management during hospital stay and satisfaction with medicine information 
provision on discharge 
Aryan Moin Khan1-3, ML Hughes1 and RS Dewdney1 
1Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff CF10 
3NB, 2Princess of Wales Hospital, Coity Road, Bridgend, CF31 1RQ and 3Morriston Hospital, Heol Maes Eglwys, 
Morriston, Swansea, SA6 6NL 
Patients discharged from hospitals can be vulnerable and susceptible to readmission due to complications, 
adverse drug reactions or medical errors. It is estimated that between 3-11% of patients are readmitted 
within the first 28 days after being discharged [1]. It is essential patients are given appropriate information 
regarding their medications during their stay in hospital and at discharge. Our aim was to assess patient 
satisfaction regarding their experiences with medicines and information provision while in hospital and at 
discharge. 
A bilingual questionnaire was designed which assessed patient satisfaction and included the SIMS tool [2]. 
Patients were selected based on specific selection criteria. Patient discharge forms were studied and their 
information was entered into a database. Questionnaires were coded and packed with a cover letter which 
was mailed to each patient. 396 questionnaires were sent. SPSS was used to record and analyse returned 
questionnaires. 
MPharm 
40 
119 questionnaires were returned. Mean age of responding participants was 64.5 years. Mean number of 
medicines taken was 7.16. 83.2% of participants stated that they were in contact with pharmacy staff while 
only 62.2% specified that they had a chance to discuss their medicines. 78.2% did not experience any 
medical issues. 56.3% were very satisfied and 36% were satisfied with the management of their medicines. 
Overall participant satisfaction is highlighted with a mean SIMS score of 10.06 out of 17. 
It is encouraging that very few participants had a negative experience whilst in hospital. Most were satisfied 
with their care. However, there is room for further improvement. Pharmacists can introduce themselves to 
patients and ensure they have no medical issues. Direct interviews can also be considered for more 
personal and detailed insight [3]. Further research using adaptations of this questionnaire and the SIMS tool 
can be used to establish a standard in assessing patient satisfaction with pharmacy services. 
1. National Health Service. Reduce Readmissions. 2013 [Accessed 30 March 2014]. Available from: 
http://www.institute.nhs.uk/scenariogenerator/tools/reduce_readmissions.html 
2. Horne, R., Hankins, M., Jenkins, R. The Satisfaction with Information about Medicines Scales (SIMS): a new measurement tool for 
audit and research. Quality in Health Care. 2001; 10(3):135-140. 
3. Cox, K. Assessing the quality of life of patients in phase I and II anti-cancer drug trials: interviews versus questionnaires. Social 
Science and Medicine.2003; 56 (5): 921-934. 
 
Investigating the relationship between drug polar surface area and skin penetration 
of topical medications 
Tsan Pang Mok and AW White 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
In recent years, predicting the efficacy of drug candidates has become the main approach of many 
researchers over trial and error. This is where polar surface area (PSA) become an attractive descriptor to 
pharmaceutical companies in recent years. Literatures have shown Literatures have shown that 
consideration of PSA contributes in improving cellular potency, intestinal absorption [1], oral absorption, 
bioavailability, blood-brain barrier permeation and restriction to the peripheral circulation. The overall aims of 
this project are to investigate whether such a correlation can also be observed between polar surface area 
and skin penetration ability of topical medications. 
A quantitative meta-analysis approach was applied where loads of journals were being looked at and 
analysed for datasets containing skin penetration data for topical medications. Due to the complexity and the 
need of special software packages in order to calculate the classic PSA, the method proposed by Ertl et al. 
(topographical PSA) [2] was used in this study. This method did away with the need of generation of 3D 
geometries, and hence it is a much faster calculation method but with a comparable quality. Three different 
software packages were used for calculation of TPSA: ChemDraw, Molinspiration and MarvinSketch. 
Scattered graphs were then plotted with Microsoft Excel 2013 and equations and R2 values were analysed. 
A total of twenty eight datasets were analysed. A wide range and generally low R2 values were observed. 
Results from some datasets were categorised as poor studies due to insufficient data and the fact that TPSA 
is not affected by altering non-polar side chains and molecular sizes. 
In conclusion, this research proved that there is no good correlation between PSA and skin penetration 
ability of topical medications. The wide range and inconsistent R2 values produced shows that using TPSA 
as a predictive tool in this area is unlikely. Furthermore, the difficulty in finding datasets with enough 
structural variety suggests that this method is not fruitful for pharmacophore optimisation. 
1. Palm K, Stenberg P, Luthman K, Artursson P. Polar molecular surface properties predict the intestinal absorption of drugs in 
humans. Pharm. Res. 1997; 14;568-571 
2. Ertl P, Roahde B, Selzer P. Fast contribution of molecular polar surface area as a sum of fragment-based contributions and its 
application to the prediction of drug transport properties. Journal of Medicinal Chemistry. 2000; 43;3741-3717 
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Understanding intra- and inter-individual differences in capsule puncture following 
actuation of a Dry Powder Inhaler 
Cerith Morgan, BE Jones and SA Coulman 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Hard-shell capsules are used as containers for powdered drug for use in single dose Dry Powder Inhalers 
(DPIs) [1]. Capsules are punctured by the DPI, creating openings to allow powder release upon inhalation. 
[2,3] Hard-shell capsules are made from gelatin or hypromellose [2]. Previous studies show that moisture 
loss affects the puncturing properties of gelatin capsules [1]. There has been little investigation into the 
puncture of gelatin and hypromellose capsules by a single dose DPI in the hands of patients. This study 
aimed to investigate intra/inter-individual differences in capsule puncture following actuation of a single dose 
DPI by a user. 
Gelatin and hypromellose capsules were stored in two different conditions; to maintain their moisture 
contents within their standard specified range (13-16% and 4.5-6.5% respectively) [2] and below this range. 
Participants (n=34) were recruited, to puncture 3 of both types of capsule (gelatin and hypromellose), each 
stored in two different conditions (standard and below standard moisture content) using a DPI. Capsules 
were analysed using light microscopy and punctures were characterised by size, shape, zone, and presence 
of flap, using a newly developed methodology.  
The coefficient of variation in puncture size was greater in gelatin capsules with lower moisture content 
(33.96%) than both types of hypromellose capsules and gelatin capsules with standard moisture content 
(12.05-16.27%). Mean puncture size was significantly smaller in gelatin with lower moisture content than 
hypromellose with lower moisture content (Mann-Whitney U, p=0.005).  
The punctures formed by DPI users were reproducible for hypromellose capsules, irrespective of moisture 
content. Lower moisture content reduced the consistency of the DPI punctures in gelatin capsules. Capsules 
can lose moisture during storage [2], therefore appropriate storage is important to ensure reproducible 
patient puncture of gelatin capsules by a DPI. Further studies are required to investigate the effect of 
puncture size on powder release from capsules.  
1. Jones, BE. Quali-V®-I: a new key for dry powder inhalers. Drug development and delivery. 2003 Sep;3(6):52–57. 
2. Torrisi BM, Birchall JC, Jones BE, Díez F, Coulman SA. The development of a sensitive methodology to characterise hard shell 
capsule puncture by dry powder inhaler pins. International Journal of Pharmaceutics. 2013 Nov;456(2):545–552. 
3. Birchall JC, Jones BE, Morrissey A. A comparison of the puncturing properties of gelatin and hypromellose capsules for use in dry 
powder inhalers. Drug Development and Industrial Pharmacy. 2008 Aug;34(8): 870–876. 
 
Developing a novel solid phase extraction method for the isolation of natural 
products 
Hannah Morgan and AW White 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales 
With recent decline in drug development, industrial focus is reverting back to biological sources for the 
identification of new chemical entities. Marine sponges are hugely unexploited and increasingly 
acknowledged for their pharmaceutical potential. Sponges’ sedentary nature has resulted in evolutionary 
development of extensive chemical defence mechanisms enabling the synthesis of biologically active and 
structurally diverse compounds [1]. Limitations in efficient isolation strategies exist and innovative 
approaches are required [2].  The focus of this project is to develop a novel solid phase extraction method to 
isolate marine sponge compounds based on covalent bonding mechanisms carried out by chemoselective 
electrophilic resins. 
Two sponge species (Aplysina aerophoba and Halichondria panicea) were prepared for exposure to an 
isothiocyanate coated polymer, which targeted nucleophilic functional groups of compounds within crude 
extracts. Polymer bound compounds were subject to traceless cleavage conditions and collected for further 
investigation. Method development was driven by review of thin layer chromatography and mass 
spectrometry. Additional antibacterial activity of isolated compounds was investigated. 
Method development proved successful. The most optimised extraction procedure resulted in a di-
brominated compound in sufficient quantity and purity for further analysis. High-resolution MS confirmed 
findings, and de-replication strategies suggest a novel compound has been isolated. Additional testing of 
MPharm 
42 
antibacterial activity was also positive. Considerable contamination and difficulties in obtaining sufficient 
purity and yields proved difficult to over-come. However, mixtures of compounds were successfully isolated 
in various quantities, with a range of molecular weights.  
Initial hypothesis focused on the probable isolation of low molecular weight compounds which could act as 
precursors in fragment based drug design, but deviation of hypothesis occurred as larger drug-like molecules 
were isolated. Successful isolation of marine sponge compounds was proven. This research highlights the 
potential of a functional-group targeted approach and provides sufficient evidence for the continual 
investigation of this novel solid phase extraction method. 
1. Kunze K, Niemann H, Ueberlein S, Schulze R, Ehrlich H, Brunner E et al. Brominated Skeletal Components of the Marine 
Demosponges, Aplysina cavernicola and Ianthella basta: Analytical and Biochemical Investigations. Mar. Drugs. 2013 Apr; 11 (4): 
1271-1287.  
2. Newman D, Cragg G. Natural Products as Sources of New Drugs over the 30 Years from 1981 to 2010. J. Nat. Prod. 2012 Feb; 75 
(3): 311–335.  
 
Evaluation of recent molecular and target-based trends in approved cancer drugs 
Randy Ng Kai Sheng and AD Westwell 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Natural and synthetic products had both contribute different scope to overall drug discovery and 
development process. However, it was believe that there is a substitution of synthetic products to replace 
natural products and its derivatives in drug discovery. Hence, my project was aim to critically evaluate the 
recent molecular and target-based trend in approved cancer drugs and identify the similar chemical motifs in 
each cancer drugs.  
A list of approved cancer drugs between 2009 to 2014 was identified from FDA and drugs were categorized 
into small molecules (180g/mol MW) vs. biologics (150,000 g/mol MW)), old drugs vs. new drugs, and the 
origin of each approved cancer drugs [1]. Old drugs are drugs that approved previously by FDA >5 years. A 
montage structure was generate using ACD/Chemsketch and sorted by year of approval. Tables and figures 
are used to further illustrate the drug classes, indication, and chemical motifs to improve understanding of 
researchers and readers. 
According to my research, the amount of small molecules drugs approved was almost twice the amount of 
biologics approved by FDA. Besides, there are total 37 small molecule drugs that were approved by the FDA 
and 14 of them were old drugs. Out of these 37 small molecule drugs, protein kinase inhibitors had occupied 
57%, followed by 8% of androgen receptor antagonists. Interestingly, out of the 57% of protein kinase 
inhibitor, 32% were VEGFR kinase inhibitor, followed by 18% of Bcr-ABL kinase inhibitor and EGFR kinase 
inhibitor. 
Despite the fact that synthetic products stands the majority of approved cancer drugs, natural products and 
its derivatives have actually occupied 44% of total approval and some of the synthetic compounds structure 
were actually inspired by natural products. Therefore, this fall into the grey area that cause undervalue of 
natural products and its derivatives in drug discovery. Hence, natural products still serve as a novel 
foundation of anticancer drug discovery and development. 
1. FDA. 2013. Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review. Available: 
http://www.fda.gov/forconsumers/byaudience/forpatientadvocates/speedingaccesstoimportantnewtherapies/ucm128291.htm#summ
ary. Last accessed 26 Feb 2014. 
 
Does the TRPM7 channel play a significant role in breast cancer cell proliferation? 
Katharine Nicholas, ZA Abdulkareem and KT Wann 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK   
The TRPM7 channel is a member of the TRP superfamily, specifically the TRPM sub-family. There are hints 
that these channels have a role in governing cancer progression and survival [1], however little is known 
about their precise role in cell proliferation. The aim of this research is to assess the role the TRPM7 plays in 
breast cancer cell proliferation; this is achieved by confirming that the cells possess the relevant mRNA for 
the TRPM7 channel, ensuring they express the protein channel and establishing growth assays to determine 
if inhibition of the channel affects proliferation.  
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RT-PCR was conducted to confirm that the relevant mRNA is expressed in FasR cells; RNA was extracted, 
then transcribed to form cDNA, which was amplified using primers. Ethidium bromide gels were run to 
confirm the product size of the desired gene. This was quantified by consulting the Affymetrix database. 
Protein extraction was also conducted, and using TRPM7 antibodies Western Blotting was undertaken to 
assess expression of the channel protein. An MTS fluorometric cell proliferation assay was used to assess 
cell viability using a control and treatment with NS8593, a TRPM7 channel blocker [2]. 
RT-PCR showed that the TRPM7 channel mRNA was expressed in this cell line, this being confirmed by the 
Affymetrix results. Western Blotting also confirmed that the channel protein for TRPM7 was expressed. MTS 
assay demonstrated that 10μM and 30μM NS8593 produced a significant decrease in cell number after 3 
days.  
Intriguingly, results show that the TRPM7 channel does play a significant role in breast cancer cell 
proliferation in FasR cells, as blocking of the channel causes a significant reduction in cell numbers. Future 
work must focus on the specific role of this channel in cancer cell growth with a view to assessing its target 
value for prospective development of new anti-cancer agents.  
1. Ouadid-ahidouch, H. et al. 2013. TRP channels: diagnostic markers and therapeutic targets for breast cancer? Trends in molecular 
medicine 19(2), pp. 117. 
2. Chubanov, V. et al. 2012. Natural and synthetic modulators of SK ( K ca 2) potassium channels inhibit magnesium-dependent 
activity of the kinase-coupled cation channel TRPM7. British Journal of Pharmacology 166(4), pp. 1357-1376. 
 
The general public’s view about patient registration with a community pharmacy 
Ruhena Noor and DH James 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Patient registration can be described as the process by which new patients register their personal 
information at a healthcare practice which is used to either update or generate clinical health records [1]. In 
community pharmacy it has been implemented in two services, the minor ailments service (MAS) and 
chronic medication service (CMS). A review of the Scottish NHS pharmaceutical care in 2013 envisioned 
person centred care upheld by a patient registration system [2]. As a new concept to the profession there is 
limited information available to how this could be employed to a wider scale. The aim of this study was to 
explore the general public’s view on registering with a community pharmacy.  
A total of twelve participants engaged in one-to-one audio recorded interviews. A semi-structured interview 
schedule divided into four sections was used to explore the views on the community pharmacy, registration 
with them and views on a proposed patient registration model involving the use of patient health records. 
Interviews were transcribed verbatim and thematic analysis applied to analyse the data which derived four 
main themes: 1) The community pharmacy, 2) Views on the community pharmacist, 3) General 
understanding of ‘patient registration, 4) Views about registering with community pharmacy. Feedback on 
proposed model was categorised into themes. 
There was overall support for registering with community pharmacy. One finding suggested patient 
registration could be used to provide a service for the management of minor illnesses as pharmacists were 
recognised as suitably trained and accessible for this role.  
These initial findings support the Welsh minor ailments service using a registration system currently being 
piloted and can be further implemented to the design of large scale study via a questionnaire However 
further qualitative research with a larger sample size would be beneficial to obtain more representative views 
of the general public. 
1. South Eastern Sydney Local Health District. 2006. Patient registration handbook; a subset of the area policy PD 101 patient 
registration policy [Online] Available at: 
http://www.seslhd.health.nsw.gov.au/Policies_Procedures_Guidelines/Corporate/UPI/documents/HB-006-
PatientRegistrationHandbook.pdf [Accessed: 24 April 2014]  
2. Wilson, H and Barber, N. 2013. Review of NHS Pharmaceutical Care of Patients in the Community in Scotland [Online] Available at: 
http://www.scotland.gov.uk/Resource/0043/00430209.pdf [Accessed: 24 April 2014] 
3. South Wales Cardiac Network. 2013. New Choose Pharmacy Scheme [Online] Available at: 
http://www.wales.nhs.uk/sitesplus/986/news/29092 [Accessed: 25 April 2014] 
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Early experience with paliperidone: a novel, long-acting antipsychotic injection 
Kathryn Norris1, RDE Sewell1 and P Deslandes2 
1Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff, CF10 3NB, and 2Pharmacy Department, Whitchurch Hospital, Park Road, Cardiff, CF14 7XB, Wales, UK 
Schizophrenia is a neurodevelopmental disorder, characterized by symptoms including delusions, 
hallucinations, grossly disorganized behaviour, catatonic behaviour and negative symptoms. It is managed 
by a variety of medications, including atypical antipsychotics such as risperidone and paliperidone. 
Paliperidone, also known as 9-hydroxyrisperidone, is one of the active metabolites of risperidone [1]. The 
main aim of the study was to assess the effectiveness of paliperidone long-acting injection (PLAI) in the 
treatment of schizophrenia over its first year of use, by establishing characteristics associated with 
continuation or discontinuation of treatment. 
The records of PLAI dispensed from Whitchurch Hospital Pharmacy were used to identify patients who had 
received treatment. A naturalistic, retrospective case note review was then conducted in a six week period 
by use of the P.A.R.I.S system.  A data collection tool was designed based on previous studies and used to 
obtain information on PLAI use 12 months prior to initiation up until present day [2,3]. 
Out of a total of 28 patients, six (21.4%) discontinued treatment due to side effects (P=0.0237), the most 
prevalent being insomnia. Five patients who discontinued treatment had previously been treated with 
clozapine (83.3%), an indicator of treatment resistance (P<0.0001).(4) 
Factors that contributed to treatment continuation included licensed use (i.e. in schizophrenia or 
schizoaffective disorder) and those who were not treatment resistant. The presence of side effects 
suggested a stronger likelihood that treatment would be discontinued. Further investigations, with a larger 
sample, are needed in order to evaluate the time spent as an inpatient with PLAI use.  
1. Dolder C, Nelson M, Deyo Z. Paliperidone for schizophrenia. American Journal of Health-System Pharmacy 2006 Mar 1;403:403-
13. 
2. Deslandes P, Lewis A, Thomas A, Sewell RDE. Risperidone long-acting injection: findings of a 2-year retrospective follow-up study. 
International Journal of Psychiatry in Clinical Practice 2009;13:298-302. 
3. Dwivedi, M. Aripiprazole and risperidone long-acting injection: 5-year outcomes in a retrospective naturalistic follow up study 
[MPharm dissertation]. Cardiff: Cardiff University, 2013. 
4. Joint Formulary Committee. British National Formulary. London: BMJ Publishing Group Ltd; 2014 [accessed 6 May 2014]. Available 
from: http://www.medicinescomplete.com/mc/bnf/current/PHP2194-antipsychotic-drugs.htm. 
 
Using meta-analysis to shed some light on the imprinting of proteins 
Huw Padfield and CJ Allender 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Molecular imprinting is the process that is used to create artificial receptors by forming an interlinked polymer 
around a template. Essentially the polymer is a snapshot of the interactions between the various monomers 
and cross linkers and the template at the moment of polymerisation. This has led to a great deal of research 
into their use in sensors and as separation media. The aim of this study is to use meta-analytical processes 
to evaluate the current state of protein molecular imprinted polymers utilising the ever increasing number of 
published articles, isolate trends in the field of work to inform on future research. 
The research papers that have been selected and analysed in this study were derived from a broad literature 
search of the Imprints dBase.  Where useful rebinding data was recoverable from the paper, it was 
converted into the form of µM concentration in free solution against nmoles/mg bound.  
Of the initial sample, 83 papers in size, 30 papers were found to contain useable data for comparison, 
allowing accurate Kd and Bmax values to be calculated. It was observed that the proteins most commonly 
imprinted were lysozyme, bovine serum albumin and haemoglobin.  
It is seen that differing molecular weight of proteins does not impact on the ability to create an imprint of the 
protein. Polymers that have been constructed using dopamine as the monomer make them suited for sensor 
usage. The reporting of protein polymers on the whole is poor. This lack of available data has hampered this 
study's ability to come to conclusions about trends in imprinting. It is problematic that such similar polymers 
seen in this study generate such contrasting isotherms. The lack of reproducibility between researchers 
implies that the field of protein imprinting is still in its early phases which further work and publication may 
improve upon.  
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Development and evaluation of a computer-assisted learning (CAL) package on 
hepatitis C 
Anish Patel and RDE Sewell 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB 
Computer Assisted Learning (CAL) is an effective and supplementary learning aid which provides an 
interactive learning environment [1]. In addition CAL can also be useful for healthcare professionals when 
completing their Continual Professional Development (CPD) [2]. This study aimed to evaluate the potential of 
a CAL package on the topic of hepatitis C for teaching and CPD within the MPharm III year. 
The CAL package was based upon current guidelines and evidence based management for hepatitis C. 
Information was presented in a manner to retain students’ interest and attention, through the use of 
animation, colour and diagrams. A chapter set out to clearly explain the role of the pharmacist in hepatitis C 
aiming to make the package relevant to pharmacy as a profession. A questionnaire-based survey was 
conducted on the MPharm III cohort to obtain feedback on the presentation, content and impressions of 
CAL. Quizzes were included at the end of each chapter to test the students’ understanding of the concepts 
taught. The questionnaire was presented on GoogleDocs®, with a 5-point Likert Scale and a free space for 
comments was present at the end of the questionnaire. 
Fifteen questionnaires were completed and received (11%). Feedback obtained was generally positive; 
participants agreed that the package was presented well (73% n=11) and that the content included was 
relevant and easy to understand, particularly with the use of diagrams (100% n=15). Further positive 
comments were obtained regarding the role of the pharmacist. However, use of CAL for CPD showed a 
varied response. 
The majority believed that the package would be an effective revision aid but nor a replacement for 
traditional learning methods. Several improvements were suggested including the use of audio, video and 
case studies. The value of CAL for CPD needs to be further analysed using a sample of postgraduate 
pharmacists. 
1. Lisha J. (2013). A Review of Computer Assisted Learning in Medical Undergraduates. Journal of Pharmacology & 
Pharmacotherapeutics. 4 (2), p86-90. 
2. Childs, S; Blenkinsopp, E; Hall, A; Walton, G. (2005). Effective e-learning for health professionals and students—barriers and their 
solutions. A systematic review of the literature—findings from the HeXL project. Health Information & Libraries Journal. 22 (2), p20-
32. 
 
Ease of use and reproducibility of nasal sprays 
Shriti Patel, JL Bowen and G Taylor 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales  
Currently the majority of nasal preparations are delivered via metered-dose spray pumps which allow 
administration of a defined dose with high accuracy in comparison to older systems [1]. However there is 
doubt around the reproducibility of nasal sprays left unused for a period of time, non-compliance of storage 
instructions and improper use and technique handling devices. The aim of this study was to determine 
reproducibility and ease of use for the following nasal sprays; Rhinocort, Nasobec, Flixonase and Avamys in 
an attempt to address the issues. 
The study was split into two main areas; storage and reproducibility. Shot weight was assessed by weighing 
the spray pumps prior to and after each actuation. Thereafter consistency of sprays were evaluated by high 
performance liquid chromatography. Colleague’s opinions on understanding of patient instructions and 
overall ease of use of sprays was also assessed.  
Results revealed the average mass/spray prior to and after storage for the four sprays was fairly consistent. 
Inconsistency arose when bottles of Rhinocort and Nasobec were stored on their side or when doses were 
fired at a 45 degrees, with certain values greater than the +/-10% margin.  The reproducibility study 
displayed consistent mass/spray when a differing number of sprays were fired, with only two exceptions 
outside the 10% margin. However there was larger variation in actual drug content of sprays than mass fired, 
but majority of values were still inside the +/- 10% margin. 
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In conclusion change in mass or percentage variation just outside +/-10% margin are likely to have no 
clinical implications on the patient. A number of parameters may have affected spray characterization, most 
importantly acceleration and force of actuation [2] could have affected the reproducibility of results. This 
study also highlighted the importance of storage instructions and patient instructions to ensure reliable doses 
are administered.  
1. Aulton M. Aulton's pharmaceutics [electronic resource]. London: Elsevier Health Sciences; 2013. p. 622-25. 
2. Williams R, Taft D, McConville J. Advanced drug formulation design to optimize therapeutic outcomes. 1st ed, New York: Informa 
Healthcare; 2008.  
 
The views of the pharmacy and pharmaceutical based sectors on the viability of 
drug repurposing 
Jonathan Piggford and AD Westwell 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales 
Drug repurposing is a method of drug discovery by which established drugs are re-looked at to find new 
indications. It is an alternative form of drug development, and it seeks to avoid the problems of traditional 
drug design, such as high time and money cost. The area is relatively new, but as of the last few years there 
has been an increasing amount of research into the field. However, there were few papers discussing 
perception of repurposed drugs. Without a positive perception of drug repurposing, it is unlikely that industry 
will invest heavily into it to produce new therapeutic advantages. Hence, this project was devised with the 
objective of exploring people related to the pharmaceutical sector's opinions on drug repurposing. 
The participants in the project were recruited by the student and the supervisor, and consisted of teacher 
practitioners, academics, students, and personnel related to other pharmacy – linked areas. In all, ten 
participants were recruited. Participants were asked questions in interviews regarding their opinions of drug 
repurposing, it's strengths, and it's weaknesses. The interviews took a semi – structured format and followed 
a script, although questions additional to the script were also asked depending on opportunity.  
The project found that 90% of participants had a positive outlook towards drug repurposing. There were 
slight differences between the groups interviewed, as most of them generated the same themes. The most 
common positive snoted were the decrease in cost and time as well as the advantage of safety data, while 
the most common negative encountered was legal and patenting issues. 
The study found that despite the profile of drug repurposing being fairly low, most members of the 
pharmaceutical sector were looking forward to the possibility of drug repurposing and despite this knowledge 
being difficult to generalise, the area warrants further research. 
 
What are the factors that motivate fourth year pharmacy undergraduate students in 
relation to the MPharm degree? 
Jenna Preston and DN John 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Motivation has been defined as “what moves people to act, think and develop” [1]. The aim of this study was 
to gain understanding into the factors which motivate students in relation to the Master of Pharmacy 
(MPharm) degree at Cardiff University. This was established as an unexplored area, thus qualitative study 
methods were used. 
Ethics approval was granted by the School’s ethics committee. A sample of fourth year pharmacy students 
was recruited by four researchers in collaboration by means of purposive and convenience sampling [2]. A 
topic guide was developed together by the researchers, to aid the conduction of audio-recorded one-to-one, 
semi-structured interviews with participants. Interviews were anonymously transcribed by each investigator 
alone, the transcripts shared, and individually thematically analysed [3] using an inductive approach. 
Analysis involved repeated reading of transcripts, development of codes, identification of themes, and then 
theme refinement and subsequent naming [3] as to accurately reflect the data set. 
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Eight main themes were identified together with a number of associated sub-themes. Themes 
“Assessments” and “Lecture Attendance” were discussed in detail to depict the factors which motivated 
students to complete assessments and attend lectures. Word constraints meant that other themes could be 
commented upon in brief. Considerations for the school were suggested and tabulated e.g. increasing 
guidance for assessments, and giving positive feedback. The study was conducted with one cohort from one 
UK school of pharmacy, limiting the research. Future work may thus include cohorts from other universities. 
The addition of quantitative research in this area e.g. questionnaires may be an additional prospect. 
The findings of this study unveil a number of factors which motivate some students in relation to the MPharm 
degree at Cardiff University, and that individual beliefs varied. As a previously unexplored area, this research 
enables further investigation into the topic of motivation regarding students and the MPharm degree. 
1. Deci, E. and Ryan, R. 2008. Facilitating Optimal Motivation and Psychological Well-Being Across Life’s Domains. Canadian 
Psychology 49(1), pp. 14-23. 
2. Flick, UWE. 2009. An Introduction to Qualitative Research. London: SAGE Publications Ltd. 
3. Braun, V. and Clarke, V. 2006. Using Thematic Analysis in Psychology. Qualitative Research in Psychology 3(2), pp. 77-101. 
 
Development of an interactive e-Book to support communication skills for 
pharmacy students at Cardiff University 
Shivani Raghvani, E Mantzourani and MW Smith 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
As effective communication skill is a skill that many healthcare professionals and students struggle to learn 
and develop [1], it is only fitting to find a learning approach that will help them achieve it to satisfactory 
standards. Since the integration of e-Books into education is a growing trend [2], this study focuses on 
creating an interactive e-Book to aid the learning and development of communication skills, posing as a 
learning tool to complement lectures and workshops. The three key objectives were to explore the students’ 
perceptions on a previously developed e-Learning package to determine what aspects are necessary to aid 
their learning and development, create an interactive e-book based on their feedback and evaluate it and 
lastly, make the necessary improvements.  
Participants that were purely first year pharmacy students at Cardiff University were obtained and via focus 
group interviews, introduced to a computer-based e-Learning package to bring to light the key aspects that 
would enrich their learning experience based on a technology derived tool. Using the results from the 
interview, an interactive e-Book was created by means of the iBooks author on a Mac platform, which 
enabled the interactive e-Book to be viewed via an Apple iPad. The same participants were called back for a 
second focus group interview, this time to evaluate the interactive e-Book. 
Overall, the participants enjoyed learning through this method; especially the interactive aspect of it was well 
received including tap-commanded animations, videos and multiple-choice questions. They found the device 
easy to use and navigation wasn’t an issue. 
The main limitation is that it is available on iPads and not every student owns one and many still prefer the 
traditional textbook approach to education [3]. Despite these drawbacks, the e-Book era is rapidly drawing 
close and it is only sensible to start incorporating them into education. 
1. Francis R. Report of the Mid Staffordshire NHS Foundation Trust Public Inquiry [Executive Summary]. 2013 Feb 6; London. p. 3-
117. 
2. Heinrich P. The iPad as a Tool For Education - a case study; 2014 [accessed 24 April 2014]. Available from 
http://www.naace.co.uk/publications/longfieldipadresearch. 
3. ProCon.org. Tablets vs Textbooks; 2012 [accessed 6 May 2014]. Available from: http://tablets-textbooks.procon.org/#background. 
 
Optimising patient care: exploring stakeholders’ perceptions of the Common 
Ailments Scheme (CAS) in community pharmacies 
Thomas G Richards and E Mantzourani 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Common ailments place a huge demand on primary care, accounting for around 75% of A&E admissions 
and 40% of GPs time [1]. Since October, the Welsh Government has been piloting the All Wales CAS in two 
health boards. The scheme allows patients to consult their pharmacist who can provide, free of charge, 
MPharm 
48 
treatment or advice for a range of 26 conditions [2]. This study aims to explore the perceptions of 
stakeholders involved in the implementation of the All Wales CAS. 
Ethical approval was obtained from CSPPS Ethics Committee. Semi-structured interviews were conducted 
with stakeholders in Cwm Taf UHB. The sampling frame was defined as any individual involved in the CAS 
development or delivery. Purposive and snowball sampling were used to identify stakeholders. Interviews 
were audio-recorded and transcribed verbatim. Resulting transcripts were thematically analysed using codes 
and the principles of constant comparison. 
11 interviews were conducted, with stakeholders comprising 7 pharmacists, 2 practice managers and 2 key 
informants. Data analysis identified 11 key themes. Pharmacists are perceived to benefit from an improved 
professional image, GPs from time saved and patients by increased access to medicines. A number of 
issues were identified concerning referral pathways, formulary limitations and time. Other themes that 
emerged include remuneration, IT systems, inter-professional relationships and promotion of self-care. 
This study has acted as the first qualitative evaluation of the All Wales CAS. Stakeholders perceive the 
scheme to be working towards its intentions to make community pharmacy the first port of call and promote 
self-care. A number of suggestions were made that could be considered to help develop the service. These 
include improved training to support GP receptionists, allowing non-pharmacist staff to help implement the 
service and revised service advertisement. Further research should explore the perceptions of patients who 
continue to consult their GP for minor ailments despite the presence of a pharmacy-based ailments scheme. 
1. Department of Health. Self Care – A Real Choice. Self Care Support – A Practical Option. [pdf]. London: Department of Health. 
Available at: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4100717  
[Accessed 31 January 2014]. 
2. All Wales Medicines Strategy Group. 2013. All Wales Common Ailments Service Formulary. [pdf]. Available at: 
http://www.awmsg.org/docs/awmsg/medman/All%20Wales %20Common%20Ailments%20Service%20Formulary.pdf [Accessed 7 
February 2014]. 
 
Delivery of plasmid DNA to skin cells via coated microneedles 
Maura Rogers, P Porta and JC Birchall 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Microneedles (MNs) are an attractive proposition for the delivery of plasmid DNA (pDNA) and other 
therapeutics. Advantages of their small size include pain-free administration [1]. pDNA’s negative charge 
prevents effective skin cell uptake, consequently a cationic liposome was used in this study to complex 
pDNA for cell delivery. Previous studies have successfully delivered functional MN-coated pDNA to skin cells 
[2,3]. This project investigated the feasibility of delivering functional MN-coated liposome-pDNA complexes 
(lipoplexes) to the skin for gene therapy applications. A secondary aim was to investigate gold nanoparticles 
as a potentially novel transfection agent. 
To determine the optimum complexing procedure and lipoplex ratio, different methods were designed to 
complex a fixed quantity of pDNA encoding EGFP reporter with various liposome amounts. The resulting 
complexes were compared using gel electrophoresis and zeta potential analysis. Transmission electron 
microscopy (TEM) was used to assess MN-coated and non-coated lipoplex properties. MNs were coated 
with lipoplexes and functionality assessed by performing a cell transfection in HaCaT keratinocyte cells using 
fluorescent microscopy and flow cytometry to determine gene expression. Different ratios of nanoparticle-
pDNA complexes were compared using electrophoresis and zeta potential analysis. Functionality was 
assessed by performing cell transfection in HaCaT cells.  
Electrophoresis showed changes to complex migration following preparation by both methods, suggesting 
complexes were negatively charged or had condensed to exclude ethidium bromide. Zeta potential was 
affected by the complexation method employed. The optimum method was chosen to determine the optimum 
Lipofectamine: pDNA ratios; found to be 4:1 and 6:1 w/w. TEM images of MN-coated and non-coated 
lipoplexes were morphologically dislike. MN-coated lipoplex-treated cells did not express EGFP. Cell 
transfection by nanoparticle-pDNA complexes was unsuccessful. 
Evidence from TEM indicates that the MN-coating procedure destroys lipoplexes, resulting in unsuccessful 
cell transfection. Results from electrophoresis and zeta potential analysis indicated that it is also likely that 
lipoplex complexation did not fully occur; refinement of the complexation method is required to confirm this. 
Supplementary work is required to optimise nanoparticle-pDNA complex properties.  
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1. Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: an emerging transdermal drug delivery system. Journal of Pharmacy 
and Pharmacology. 2012;64:11-29. 
2. Jin SE, Kim CK. Charge-mediated topical delivery of plasmid DNA with cationic lipid nanoparticle to the skin. Colloids and Surfaces 
B: Biointerfaces. 2014;116:582-90. 
3. Pearton M, Saller V, Coulman SA, Gateley C, Anstey AV, Zarnitsyn V et al. Microneedle delivery of plasmid DNA to living human 
skin: Formulation coating, skin insertion and gene expression. Journal of Controlled Release. 2012;160:561-69. 
 
Optimisation of the expression and purification of recombinant protective antigen 
from Escherichia coli 
Thomas Rowlands, E Lis and L Baillie 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Protective antigen (PA) is the principal immunogen of current vaccines against anthrax [1]. Recent efforts 
have focused on developing a subunit vaccine based on recombinant PA (rPA) which can better safeguard 
the public against the biological threat of Bacillus anthracis [2]. The bacterium Escherichia coli has been 
established as a suitable expression host for rPA production [3, 4]. This study aims to produce an optimised 
high-level expression system for rPA production using E. coli to obtain sufficient amounts of purified rPA for 
use in further studies. 
 
E. coli M15 and SG13009 cells were transformed with pQE30 plasmid containing a codon-optimised PA 
gene. rPA was expressed as a fusion protein with a 6xhistidine affinity tag. High-level expression yielded 
insoluble protein aggregating to form inclusion bodies. Inclusion bodies were solubilised in buffer containing 
8 M urea and purified under denaturing conditions using immobilised metal ion affinity chromatography 
(IMAC). Four different IMAC resins (cobalt, copper, nickel and zinc) were compared for single-step 
purification of rPA. The yield and purity of the rPA recovered by each resin was determined by Bradford 
assay, SDS-PAGE and Western blot analysis.  
 
E. coli strain M15 expressed the highest amounts of rPA. Purification with the copper resin yielded the 
highest quantity of rPA (approx. 14 mg per litre of culture) but this contained substantial impurities. The 
cobalt resin yielded rPA with the highest purity but in a lesser amount (approx. 3 mg per litre of culture).  
 
The aim of the study was achieved as a sufficient quantity of high-purity rPA for potential use in toxin 
challenge studies in animals was yielded. This was achieved by expressing rPA with E. coli strain M15 and 
purifying the protein using cobalt IMAC resin. Further optimisation of this expression system and specifically 
the purification procedure is required to further improve the yield and purity of rPA. 
 
1. Baillie LW. Is new always better than old?: The development of human vaccines for anthrax. Hum Vaccin. 2009; 5(12):806-16. 
2. Williamson ED, Hodgson I, Walker NJ, Topping AW, Duchars MG, Mott JM, et al. Immunogenicity of recombinant protective antigen 
and efficacy against aerosol challenge with anthrax. Infect Immun. 2005; 73(9):5978-87. 
3. Gupta P, Waheed SM, Bhatnagar R. Expression and purification of the recombinant protective antigen of Bacillus anthracis. Protein 
Expr Purif. 1999; 16(3):369-76. 
4. Chauhan V, Singh A, Waheed SM, Singh S, Bhatnagar R. Constitutive Expression of Protective Antigen Gene of Bacillus anthracis 
in Escherichia coli. Biochemical and Biophysical Research Communications. 2001; 283(2):308-15. 
 
Anti-cancer activity of disulfiram combinations in breast cancer cells 
Kristina Saba, H Wiggins and AT Jones 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Cancer cells are showing resistance to anti-cancer therapy and thus the need for more effective treatments 
is imperative [1]. The thiocarbamate drug, disulfiram, has been known to have anti-cancer activity since the 
1960s. Disulfiram is a good drug for anti-cancer therapy as it is safe in the human body, achieving high 
concentrations in the blood without toxicity. Many studies have also proven that disulfiram has synergistic 
abilities when used in combination with other anti-cancer drugs [2,3]. The aim for this project is to explore the 
effects of disulfiram in combinations with other drugs on MCF-7 breast cancer cells. From this it can be 
determined which combination has the most potential for further exploration.  
The drug treatments used a serial dilution of disulfiram or metformin or cyclophosphamide and the cells were 
then incubated for 24 hours. The cell titre-blue assay was used to determine the extent of cyctotoxicity after 
drug treatment. In the assay, the viable cells produce a fluorescence from the reduction of resazurin to 
resorufin and so the extent of fluorescence produced is proportional to the extent of viable cells. 
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The results show that cytotoxicity of the cancer cells were dose related. The greatest toxicity observed was 
at the highest drug concentrations used. There were statistically significant (p=<0.05) synergistic results with 
the use of disulfiram with metformin or cyclophosphamide. Additionally, observed in several experiments was 
an increase in cell viability. From the assumption that it was autophagy, chloroquine was used to stress the 
cancer cells. However, this did not potentiate anti-cancer activity, but showed disulfiram to have protective 
properties due to the increase in cell viability.  
The data is encouraging, confirming with literature that disulfiram has synergistic activity when used in 
combination with other anti-cancer drugs. However, results also showed that disulfiram had protective 
properties, causing an increase in cell viablilty. 
1. Vazquez-martin, A. et al. 2009. Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal 
Antibody Trastuzumab. PLoS ONE 4(7), p. e6251. 
2. Ketola, K. et al. 2012. Chemical Biology Drug Sensitivity Screen Identifies Sunitinib as Synergisitic Agent with Disulfiram in Prostate 
Cancer Cells. PLOS ONE 7(12). 
3. Liu, P. et al. 2012. Cytotoxic effect of disulfiram/ copper on human glioblastoma cell lines and ALDH-positive cencer-stem-like cells. 
British journal of cancer 107(9), p.1488. 
 
Identification of antibacterial factors within Welsh honey with activity against 
methicillin-resistant Staphylococcus aureus (MRSA) and the bee pathogen 
Paenibacillus larvae 
Victoria Sewell and L Baillie 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Honey has been used medicinally for thousands of years. Modern medicine veered away from using honey 
with the advent of antibiotics. However, in recent years there has been a resurgence of interest in its 
antimicrobial potential due to growing problems of antimicrobial resistance [1]. Honey has a wide spectrum of 
antimicrobial effects including some derived from phytochemicals. The aim was to investigate honey samples 
from three different origins (Manuka, Southampton and Wales) and to study their antimicrobial activity 
against MRSA and P. larvae, a bee pathogen and causative agent of American Foulbrood (AFB) [2]. 
Organic solvent extractions of honey of varying polarities (n-hexane, ethyl acetate, methanol) were used to 
perform thin layer chromatography. Amberlite XAD-2 resin was used to further extract any potential 
phytochemical components in the methanol extractions. Thymol was used as internal control to validate 
results. Direct and indirect bioautography was used to overlay MRSA (~106 CFU/ml) and P. larvae 
respectively to assess activity of the honey samples. Identification of factors responsible for potential 
antimicrobial activity were additionally analysed using mass spectrometry (MS). 
Honey solvent extracts of hexane (excluding Southampton honey) and ethyl acetate exhibited activity 
against MRSA (10mg/ml). Hexane extractions exhibited activity against P. larvae (10mg/ml). Amberlite XAD-
2 extracts displayed no activity against MRSA or P. larvae though potentially active components may have 
been present at sub-threshold concentrations [2]. The antimicrobial flavonoids chrysin and a derivative of 
quercetin were ubiquitous in all MS samples [3].  
Further studies are warranted using MS coupled with other spectroscopic techniques (e.g. UV and NMR) for 
a detailed elucidation of the flavonoid content [4]. The phytochemical content could represent novel leads in 
drug development as well as providing a better understanding of the role of honey in the preservation of bee 
brood against bee diseases such as AFB. 
1. Zumla A, Lulat A. Honey - a remedy rediscovered. J Roy Soc Med. 1989;82:384-385. 
2. Kwakman PHS, Zaat SAJ. Antibacterial components of honey. IUBMB Life. 2012 Jan;64(1):48-55 
3. Kassim et al., Ellagic acid, phenolic acids, and flavonoids in Malaysian honey extracts demonstrate in vitro anti-inflammatory 
activity. Nutr. Res., 2010, 30, 650-659 
4. Pyrzynska K, Biesaga M. Analysis of phenolic acids and flavonoids in honey. Trends Anal. Chem. 2009;28:893–902. 
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Profiling VGLL1 and MID1, genes associated with ER loss in novel models of 
endocrine resistant breast cancer 
Saloni Shah, ID Harvey, RA McClelland, H Mottram, L Farrow and JMW Gee 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Relapse on endocrine treatment remains a clinical problem in breast cancer. 20% of these patients with 
acquired resistance lose oestrogen receptor (ER) resulting in poorer prognosis [1]. Lack of acquired resistant 
models has made it difficult to study this resistance. MCF7-derived and T47D-derived acquired anti-hormonal 
resistant models have been recently developed representing different treatments and genetic contexts. 
Affymetrix mRNA array profiling of the MCF7-derived lines suggested two genes, VGLL1 (vestigial 1) and 
MID1 (midline1) expression increased where ER loss was seen. This studied aimed to further investigate 
VGLL1 and MID1 relationship to ER loss and aggressiveness in resistance, using the MCF7 and T47D-
derived model panels. 
PCR was used to examine expression of VGLL1, MID1 and ER in the resistant model 
panels.Aggressiveness of the cells was assessed using 2D Boyden chamber migration assays. KM Plotter, 
GenExMiner and GOBO were used to assess MID1 and VGLL1 in online clinical transcriptomes, while their 
biology was explored using Genecard and Pubmed. 
Five models showed ER loss as well as increased migration although, there was some variation seen 
according to model panel. VGLL1 and MID1 expression was increased, where ER was lost and appeared to 
relate to aggressiveness particularly in MCF7-derived models. Tumours with inherently-higher VGLL1 or 
MID1 showed earlier relapse and weakly-correlated with ER negativity in patients. Both were signalling 
genes linked to growth or progression in some cancer types. 
As seen in the clinic, models that lost ER had a more aggressive phenotype in acquired resistance [2]. 
VGLL1 and MID1 relate to ER-ve and aggressive behaviour in acquired endocrine resistance but this is 
dependent on genetic context.  Clinical and ontology data supported that these genes can have adverse 
functions [3,4]. Continued research to understand how these genes relate to the biology of tumours losing 
ER may reveal new therapeutic avenues to improve patient outcome.   
1. Drury SC, Detre S, Leary A, Salter J, Reis-Filho J, Barbashina V, et al. Changes in breast cancer biomarkers in the IGF1R/P13K 
pathway in recurrent breast cancer after tamoxifen treatment. Endocrine-related cancer. 2011;18:565-577. 
2. Bayliss J, Hilger A, Vishnu P et al. Reversal of the Estrogen Receptor−Negative Phenotype in Breast Cancer and Restoration of 
Antiestrogen Response. Clinical Cancer Research 2007;13:7029-7036. 
3. Pobbati AV, Hong W. Emerging roles of TEAD transcription factors and its coactivators in cancer. Cancer Biology and Therapy. 
2013;14(5):390-398. 
4. Du H, Huang Y, Zaghlula M, Walters E, Cox TC and Massiah. MA. The MID1 E3 ligase catalyzes the polyubiquitination of alpha4 
(a4), a regulatory subunit of protein phosphatase 2A (PP2A). The Journal of Biological Chemistry. 2013;288(29):21341-21350. 
 
End product testing of parenteral nutrition (PN) admixtures – exploration of current 
thoughts and practices in the NHS 
Yatri Shah and AG Cosslett 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Parenteral nutrition (PN) is the supply of daily nutrient needs to patients who are unable to use their gastro-
intestinal system [1]. This complex mixture, administered via intravenous infusion into the blood [2], needs to 
be sterile and of appropriate composition. The aim of this project was to understand the current testing 
procedures used to avoid errors and pharmacist’s views on end product testing of PN admixtures in the 
hospital setting. 
Using Survey Monkey, an online survey tool, a list of questions was constructed into a survey, accompanied 
by a cover letter; to send out to an email list containing 411 addresses of hospital pharmacists dealing with 
PN in the NHS. The responses were collated and handled using spreadsheet (MS-Excel) and database (MS-
Access) software. 
49 surveys were successfully completed by a variety of hospital staff from all across the UK. Most commonly 
dispensed PN to adults and neonates, the majority of PN was unlicensed and made by hand. Hospitals 
experienced errors in PN due to labelling, formulation and compounding processes. Popular testing 
parameters of PN included visual inspection (98%) and sterility (62%) whereas electrolyte and trace element 
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content were less common. 62% of the respondents stated that the testing currently carried out is sufficient 
however constraints on quality testing include time taken and cost burden. The general consensus was that 
end product testing of PN admixtures is a good idea and a useful tool, though it is unrealistic as it is a 
retrospective process producing delayed results following the need for immediate use. A few opinions stated 
it to be irrelevant. 
Errors have occurred compromising patient safety, however the views are plausible. Other robust systems 
like GMP need to ensure quality throughout the entire manufacture process. Basic standard physical tests 
need to be made mandatory to spot potential errors. 
1. Dunnett JS. Clinical Pharmacy and Therapeutics. 3rd ed. Edinburgh: Edinburgh : Churchill Livingstone; 2003 
2. Fresenius Kabi Australia. Parenteral Nutrition.  2014 [accessed 15 Apr 2014]. Available from: http://www.fresenius-
kabi.com.au/3947.htm. 
 
Evaluating the numeracy skills of undergraduate students using a contextualised 
formative diagnostic numeracy tool 
Abigail Shii and SA Coulman 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
The importance of numeracy, especially in healthcare, is irrefutable. However, the numeracy skills of entry 
level pharmacy undergraduates have raised concern [1,2]. Little is known about changes in the numeracy 
skills of pharmacy students as they progress through the MPharm programme. The aim of the study was to 
characterise the inherent numeracy skills of a cohort of undergraduate pharmacy students between entry to 
and the final year of the MPharm.  
Ethics approval was obtained from the Cardiff School of Pharmacy and Pharmaceutical Sciences Research 
Ethics Committee. A contextualised diagnostic numeracy test was administered to a single cohort of MPharm 
students in the first week of MPharm 1 (2010) and again in MPharm 4 (2013) without prior notification. The 
test contained 25 medicines-based calculations questions to be completed in 45 minutes without a 
calculator, with a confidence assessment after each question. An accompanying questionnaire was 
administered to collect demographic data and obtain data on students’ feelings. The data was analysed 
using nonparametric tests with SPSS. 
Only students who sat the test in both the first year (Y1) and fourth year (Y4) were analysed (n=104). The 
students performed significantly better (p=0.000) in Y4 (mean 22.13/25) than in Y1 (mean 20.13/25). 
Students’ mean confidence increased from 20.51/25 in Y1 to 23.83/25 in Y4 (p=0.000). Students were least 
competent in unit conversion despite being highly confident in both years. Students with an A-Level scored 
significantly higher in first year than those without (p=0.002). Forty-four (42.3%) students had incorrectly 
gauged their numeracy skills to have improved, worsened, or remained the same. While students expressed 
a mix of feelings towards numeracy, the responses were generally positive.  
The increase in students’ competence and confidence may be attributed to effective teaching and learning 
strategies. Students’ incompetence in unit conversion and inaccurate perceptions of their skills echo 
previous studies [2,3,4] and could potentially cause errors in practice. The numeracy diagnostic test should 
be used by entry-level undergraduates to identify areas of weakness and tailor interventions accordingly.  
1. Malcolm, R. K. and McCoy, C. P. 2007. Evaluation of numeracy skills in first year pharmacy undergraduates 1999-2005. Pharmacy 
Education 7(1), pp. 53-59. 
2. Meyler, L. et al. 2011. Evaluation of the ability of pharmacy and medicine students to calculate drug dosage. Pharmacy Education 
11(1), pp. 186-189. 
3. Hitch, G. et al. 2010. A novel visually-displayed test for assessing numerical skills in pharmacy undergraduates. Pharmacy 
Education 10(2), pp. 144-148. 
4. Barry, J. G. et al. 2007. Attitudes of pharmacy students and community pharmacists to numeracy. Pharmacy Education 7(2), pp. 
123-131. 
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Synthesis of a novel precursor for 18F-labelled gemcitabine 
Hui Yeng Sze, J-P Meyer and AD Westwell  
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Gemcitabine is a potent anticancer drug used in the treatment of various solid tumours. However, its 
treatment efficacy is often compromised due to the poor treatment response and severe side effects [1].  
With the use of 18F-labelled gemcitabine as positron emission tomography (PET) radiotracer, responders and 
non-responders to gemcitabine can be distinguished, potentially personalised gemcitabine treatment, 
resulting in better treatment outcome. Objectives of this project include the synthesis and characterisation of 
an advanced precursor for 18F-labelled gemcitabine; first trial on late-stage fluoride introduction using novel 
precursor (cold fluorination). 
Two different routes are used to synthesise novel gemcitabine precursor. Route 1 involves intra-molecular 
cyclisation of N4-acetylcytidine, followed by acetylation of 3’- and 5’-hydroxyl groups. Then, hydrolysis and 
Dess-Martin periodinane (DMP) oxidation at 2’-position of nucleoside furnished gemcitabine precursor [2]. 
Route 2 involves protection of 3’- and 5’-position of N4-acetylcytidine using 1,3-dichloro-1,1,3,3-
tetraisopropyldisiloxane (TIPDSCl2) protecting group, followed by DMP oxidation at 2’-hydroxyl group. Then, 
deprotection and acetylation at 3’- and 5’-position of nucleoside furnished gemcitabine precursor. Using 
gemcitabine precursor as starting material, novel late-stage deoxofluorination with 4-tert-butyl-2,6-
dimethylphenylsulfur trifluoride (FluoleadTM), followed by deacetylation is proposed to furnish radioactive 18F-
labelled gemcitabine [3]. Proof of principles with non-radioactive 19F-labelled gemcitabine was carried out 
prior to translation to radiosynthesis. Several purification and characterisation techniques were used in 
between steps. 
A stable 2’-activated gemcitabine precursor with 98% purity was successfully synthesised via both routes in 
similar yield, which is 7.24% and 6.1%. Whereas characterisation of reaction mixture after fluorination 
showed that starting material has decomposed; gemcitabine intermediate was not detected.  
After comparison, route 1 is preferred because it is cost-effectiveness and less time-consuming. The failure 
in the first trial of late-stage fluorination is possibly due to inadequate FluoleadTM used. In summary, this 
project provides a good base for the development of an efficient synthetic route towards 18F-labelled 
gemcitabine.  
1. Mini E, Nobili S, Caciagli B, Landini I, Mazzei T. Cellular pharmacology of gemcitabine. Ann Oncol. 2006;17(Suppl 5):v7–12. 
2. Kjell DP, inventor; Eli Lilly and Company, assignee. Process for the preparation of 2,2’-anhydro- and 2’-keto-1-(3’,5’-di-O-protected-
beta-d-arabinofuranosyl) nucleoside. European Patent. EP 0 735 045 A1 [Online]. 1996 Mar 12. [accessed: 10 Mar 2014]. Available 
from: http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT= 
D&date=19961002&CC=EP&NR=0735045A1&KC=A1.  
3. Kjell DP, inventor; Eli Lilly and Company, assignee. Process for the preparation of a 2-substituted-3,3-difluorofuran. European 
Patent. EP 0 735 043 A1 [Online]. 1996 Mar 12. [accessed: 10 Mar 2014]. Available from: 
http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19
961002&CC=EP&NR=0735043A1&KC=A1. 
 
An evaluation of interprofessional education (IPE) between pharmacy and medical 
students: basic life support 
Kimberly Tan and MW Smith 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
IPE has been defined as ‘...occasions when two or more professionals learn with, from and about each other 
to improve collaboration and the quality of care' [1]. With the support of the General Medical Council (GMC) 
and the General Pharmaceutical Council (GPhC), IPE is now a required element of both medicine and 
pharmacy undergraduate degrees [2-4]. The Basic Life Support (BLS) session was introduced for the first 
time in 2013 between 1st year medicine students and 4th year pharmacy students of Cardiff University. The 
aim of this study was to evaluate the views of students who participated in the IPE session.  
An anonymous two-part questionnaire, consisting of questions with Likert-item responses, and a free-text 
response section, was distributed using total population sampling at the end of a 2.5-hour session where 
participants worked through BLS scenarios in interprofessional groups of 3. Responses to quantitative data 
were analysed using the IBM SPSS programme, while qualitative responses were analysed using thematic 
analysis. The Mann-Whitney U statistical test was also used to compare student groups. Ethics approval was 
obtained from the Cardiff School of Pharmacy and Pharmaceutical Sciences. 
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A questionnaire response rate of 87% (n=383) was achieved. More than 90% of all respondents strongly 
agreed or agreed that the session was helpful and well conducted, with constructive feedback. More than 
90% of medical and pharmacy students also exhibited positive attitudes about the IPE component. However, 
the positive attitudes expressed were not translated into positive changes in behaviour, and this was shown 
by the significant difference between the two student groups in response to IPE, with medical students 
showing a higher level of disagreement that they have learnt something from the other profession during the 
session. 92% of medical students and 90% of pharmacy students agreed more IPE should be conducted in 
the future. The most commonly stated benefit was ‘working with another healthcare professional in a hands-
on session’ while ‘timing of session for pharmacy students’ was the component most students thought could 
be improved on.  
Overall, students found the session beneficial and should be continued. Evaluation of future IPE sessions 
using a pre-post test questionnaire will identify changes in attitudes and knowledge that have occurred as a 
direct result of it.  
1. CAIPE 2013. Introducing interprofessional education [Online]. Available at: caipe.org.uk/silo/files/introducing-interprofessional-
education.pdf [Accessed: 15 April 2014]. 
2. General Medical Council 2009. Outcomes and standards for undergraduate medical education. Tomorrow’s Doctors [Online]. 
Available at: http://www.gmc-uk.org/education/undergraduate/tomorrows_doctors_2009_foreword.asp [Accessed: 16 April 2014]. 
3. General Pharmaceutical Council 2011. Future pharmacists: standards for the initial education and training of pharmacists. General 
Pharmaceutical Council[Online]. Available at: http://www.pharmacyregulation.org/sites/default/files/GPhC_Future_Pharmacists.pdf 
[Accessed: 16 April 2014]. 
4. GPhC 2010. GPhC launches consultation on education and training [Online]. Available at: pharmacyregulation.org/gphc-launches-
consultation-education-and-training [Accessed: 15 April 2014]. 
 
Trace element precipitaton in parenteral nutrition (PN) admixtures – is it a risk? 
Shu Wai Tang and AG Cosslett 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Parenteral nutrition (PN) provides nutrients in the form of amino acids, glucose, lipid, electrolytes such as 
phosphate, vitamins, trace elements (TEs) and water via the intravenous route when oral or enteral feeding 
cannot be given [1,2]. However, addition of TEs to PN admixtures may result in physical incompatibility. 
Formation of iron phosphate precipitates had been reported [3]. Many factors could influence both the 
occurrence and extent of precipitation [3,4]. The objectives of this study are to establish the presence of iron 
phosphate precipitation, determine precipitation curves to propose a safety margin for iron and phosphate 
concentrations and examine the main factors that affect precipitation. 
To establish formation of iron phosphate precipitates, iron chloride solution was tested with three different 
phosphate solutions. Concentrations of iron (1 to 140μmol/l) were prepared with Addiphos® (5 to 80mmol/l), 
potassium dihydrogen phosphate (KDP) 13.6%w/v (0.3 to 10mmol/l) and Glycophos® (0.4 to 80mmol/l) 
respectively. Various components include water, glucose 50%w/v and Aminoven® 25 were added either 
separately or together with iron phosphate complexes to make up 100ml solutions in five sets of regimens. 
Investigations were tested at either room temperature, 37°C or 2-8°C. At 0 and 24 hours, samples were 
visually inspected with illumination, turbidity and pH readings were also measured. 
Based on the precipitation curves, maximum concentrations of iron with Addiphos®; KDP and Glycophos® 
should be 20μmol/l and 60mmol/l; 70μmol/l and 5mmol/l and 140μmol/l and 20mmol/l respectively to ensure 
no precipitates form and hence safe for patient use. 
In general, increases in iron and phosphate concentrations increase the risk of precipitation. Organic 
phosphates including Glycophos® are least likely to form precipitates compared to inorganic phosphates 
including KDP and Addiphos® which are not recommended. The presence of glucose and/or amino acid 
reduces the risk. Samples at room temperature had a greater risk compared to 37°C and 2-8°C which was 
the safest. However, no single factor should be used in isolation to predict compatibility. 
1. Minton AR. Studies on the stability of parenteral nutrition admixtures [PhD Thesis]. Cardiff: Cardiff University; 1998. 
2. Cosslett AG. Basic Requirements: Making total parenteral nutrition complete. European Journal of Hospital Pharmacy Practice. 
2008; 14(2): 85-6. 
3. Allwood MC, Martin M, Greenwood M, Maunder M. Precipitation of trace elements in parenteral nutrition mixtures. Clinical Nutrition. 
1998; 17(5): 223-6. 
4. Allwood MC, Kearney MCJ. Compatibility and stability of additives in parenteral nutrition admixtures. Nutrition. 1998; 14(9): 697-706. 
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Welsh marine sponge as a potential source of novel antibacterial lead compounds 
Tengku Noraishikin Tengku Zainal Abidin and AW White 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Marine sponges are well known for producing novel metabolites for various pharmaceutical uses [1-2]. Being 
grown in a temperate region, and scarcely explored, investigation into Welsh marine sponges provides a 
greater opportunity to isolate a novel drug candidate especially for the pressing need of antibacterial 
treatment [3-4]. This study aimed to isolate and characterise a novel antibacterial lead compound from a 
Welsh marine sponge, and investigate the effect of sponge growing conditions on the production of active 
compounds. 
Sponge materials of Halichondria panicea collected from competitive and non-competitive environments 
were extracted in solvents of increasing polarity to yield three crude extracts (hexane, acetone and 
methanol). Antibacterial activity for each extract was determined using a thin layer chromatography-direct 
bioautography technique against S. aureus (Gram-positive) and E. coli (Gram-negative). Active compounds 
were isolated and further purified into simpler fractions. Isolated fractions were finally subjected to high 
resolution electrospray ionisation-mass spectrometry (HRESI-MS) for compound identification. 
Results showed that sponges growing in a non-competitive environment separated into more 
bands/compounds compared to those in a competitive environment. Six out of ten compounds isolated from 
hexane extracts displayed significant inhibition against both S. aureus and E. coli. Upon identification, one 
isolated fraction from hexane extract of a non-competitive sponge (1N4.6) was found to be a 
monobrominated compound, with isotope peaks of m/z 669/671 in HRESI-MS.  
Database screening of empirical formulae suggested for the peak at m/z 669 had resulted in no known 
marine natural product, which proved the compound’s novelty. However, full structural elucidation of the 
novel isolated compound was not possible due to a very low yield being recovered. In conclusion, this study 
demonstrated the promising potential of a Welsh marine sponge as a reservoir of novel antibacterial lead 
compounds, since most compounds isolated had shown significant antibacterial activities. This study also 
suggested evidence of possible variation in compounds produced in the sponges of different growing 
conditions. 
1. Mayer AM, Glaser KB, Cuevas C, Jacobs RS, Kem W, Little RD, et al. The odyssey of marine pharmaceuticals: a current pipeline 
perspective. Trends Pharmacol Sci. 2010 Jun;31(6):255-65. 
2. Cragg GM, Grothaus PG, Newman DJ. New Horizons for Old Drugs and Drug Leads. J Nat Prod. 2014 Feb 5. [Epub ahead of print]. 
3. O’Connell KMG, Hodgkinson JT, Sore HF, Welch M, Salmond GPC, Spring DR. Combating multidrug-resistant bacteria: Current 
strategies for the discovery of novel antibacterials. Angew Chem Int Ed Engl. 2013;52:10706-10733. 
4. European Centre for Disease Prevention and Control. ECDC/EMEA Joint Technical Report: The bacterial challenge: time to react. 
Stockholm: ECDC; 2013. 
 
What are the factors that motivate MPharm IV pharmacy undergraduate students in 
relation to the MPharm degree? 
Charles Thomas and DN John 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Motivation is a driving force that causes an individual to act towards a goal [1]. It is an important predictor of 
academic achievement, sometimes considered more important than intelligence [2]. The paucity of available 
research means little is known about UK pharmacy student motivation. The aim of this study was to 
determine the factors that motivate MPharm IV students at Cardiff University in relation to their on-going 
studies, the type of motivation (intrinsic or extrinsic), how students perceive their motivation to have changed 
and the reason(s) for such change(s). This could help develop strategies to improve motivation. 
An interview topic guide was developed through literature review and research team discussion and tested 
using mock interview and pilots. Non-probability (purposive and convenience) sampling was used to recruit a 
sample of MPharm IV students. Audio-recorded, semi-structured one-to-one interviews were anonymously 
transcribed ad verbatim. The transcripts were shared with the other three student researchers of this study. 
The transcripts were analysed by deductive thematic analysis [3] using self-determination theory (SDT) [4] as 
theoretical framework. 
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Twenty-four interviews were conducted on MPharm IV students. Many factors were reported including 
assessment weighting, perceived relevance, task interest, personal goals, placements, university staff, peers 
and family. Three main themes were identified; “student factors affecting motivation”, “non-staff MPharm 
factors affecting motivation” and “the effect of others on motivation”. Pharmacy undergraduate motivation is 
not constant throughout the degree and is influenced by a variety of factors including gaining a pre-
registration position. 
Students are motivated by a combination of intrinsic and extrinsic factors although extrinsic factors appear to 
prevail. Extrinsic motivation appears to increase as undergraduates near completion of the degree. Future 
research using quantitative methods and expanding the scope of the study to other year groups and/or UK 
universities may be useful. Suggestions have been made to help improve undergraduate motivation. 
1. Martin GN, Carlson NR, Buskist W. Psychology. 5th ed. Harlow, UK: Pearson; 2013. 500-501. 
2. Côté JE, Levine CG. Attitude versus aptitude: Is intelligence or motivation more important for positive higher-educational outcomes? 
Journal of Adolescent Research. 2000. 15(1), 58-80. 
3. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006; 3(2): 77-101. 
4. Ryan RM, Deci EL. Overview of self-determination theory: An organismic dialectical perspective. In: Deci EL, Ryan RM, editors. 
Handbook of Self-Determination Research. Rochester, NY: University of Rochester Press; 2002: 3-33 
 
The potential link between ageing, endocytosis and Alzheimer’s disease 
Emma Thomas, RS Thomas and EJ Kidd 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Alzheimer’s disease (AD) is a neurodegenerative disorder and ageing is the greatest risk factor [1]. The 
amyloid hypothesis states the accumulation of β-amyloid (Aβ) in the brain causes neuronal loss and 
dementia [1]. APP is synthesised in the cell, then transported to the cell surface. Clathrin-mediated 
endocytosis (CME) is implicated in internalising APP into the endocytic pathway [1,2]. Aβ is cleaved from 
amyloid precursor protein (APP) by secretases in the endocytic pathway [1,2]. This study aimed to determine 
how ageing affects the expression of proteins involved in CME and how AD pathology influenced the 
expression of proteins involved in CME. 
Mice aged 3, 9 and 18 months represented the ageing process. Cortices were extracted from wild-type (Wt) 
and transgenic (Tg) London mutation mice; which overexpress APP and consequently Aβ with increasing 
age. The levels of APP, PICALM, and clathrin were compared across the age range in both genotypes. 
These proteins, and also dynamin I, were compared between genotypes of the same age. Western blotting 
was used to quantity protein expression and appropriate statistical analysis was conducted.  
Unlike the Wt mice, Tg mice showed increased APP expression after 3 months. PICALM expression 
decreased in ageing Wt mice, but increased in ageing Tg mice. Clathrin expression decreased in ageing Wt 
mice only. No significant differences in dynamin I expression were observed in any group. 
Tg APP results correspond with other research.[3] Decreased PICALM and clathrin expression with ageing 
in Wt mice suggests reduced CME. Decreased CME in ageing Wt mice suggests reduced APP 
internalisation and Aβ production which contradicts established AD pathology. In Tg mice, increased 
PICALM expression with ageing suggests increased CME. This indicates increased conversion of APP to Aβ 
which corresponds with AD pathology. Alterations in CME protein expression were observed with ageing in 
both genotypes, which suggests CME may be crucial to AD pathology. 
1.  Vardy E, Catto A, Hooper N. Proteolytic mechanisms in amyloid-β metabolism: therapeutic implications for Alzheimer's disease. 
Trends in Molecular Medicine. 2005;11(10):464-472. 
2. Selkoe D. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends in Cell Biology. 
1998;8(11):447-453. 
3. Dewachter I, van Dorpe J, Spittaels K, Tesseur I, Van Den Haute C, Moechars D et al. Modeling Alzheimer's disease in transgenic 
mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice. Experimental Gerontology. 
2000;35(6-7):831-841. 
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Investigating automated methods for inhaler testing 
Stuart Thomas1, CH Tran2, SJ Warren2 and G Taylor1,2 
1Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB and 2Cardiff Scintigraphics, Cardiff Medicentre, Heath Park, Cardiff CF14 4UJ, Wales, UK 
Inhaled therapy is the mainstay of treatment for many respiratory diseases, especially asthma and chronic 
obstructive pulmonary disease (COPD). Asthma is a chronic condition affecting 5 million patients within the 
UK [1], which makes it harder for the patient concerned to breathe normally. Asthma is currently costing the 
UK £752.6 million pounds a year [2]. With inhaled medication being the cornerstone of the pharmacological 
treatment of patients with asthma and COPD, it is essential that we are able to test the inhalers to maintain a 
high standard for individual inhalers. This study aimed to analyse factors affecting delivered dose to the 
patient, from inhaler technique to the valve used on the canister.  
Shot weights were studied using an MDI FD10. Shot weight was used to analyse the delivered dose of drug. 
A number of different inhalers were used with 2 main types of valve being used, one a fast fill fast empty 
valve (Vari valve) and a dose retention valve. The inhalers also varied in composition of drug and excipients.  
The results from analysis of the Vari valves and dose retention valves showed the Vari valves had a 
decreased shot weight percentage, as well as being more variable than the dose retention valve per 
actuation. The variables in inhaler technique were all found to be significantly different. 
The results indicated that the excipients were having an effect on the way that the metering chamber was 
filling within the Vari valves which caused the variability and the decreased shot weight percentages. 
However, observations made in the study, show the benefits of the Vari valves with drug delivery to the lungs 
[3]. Overall this study suggests the possibility of improved drug delivery to patients with the new Vari valves, 
but more research is needed to improve reliability with volume of drug delivered.  
1. Asthma http://www.blf.org.uk/conditions/detail/asthma: British Lung Foundation;  [cited 2013 07/11/2013]. Overview of asthma]. 
2. Price D, Bosnic-Anticevich S, Briggs A, Chrystyn H, Rand C, Scheuch G, et al. Inhaler competence in asthma: common errors, 
barriers to use and recommended solutions. Respir Med. 2013;107(1):37-46. doi: 10.1016/j.rmed.2012.09.017. Epub  Oct 23. 
3. Clarke D. The Benefits of Fast Fill Fast Empty Valves to Patient Compliance. 2012. 
 
The dopaminergic pharmacology of the guinea pig ileum 
Luke WP Topley, NA Mather and EL Lane 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Dopamine is catecholamine neurotransmitter with function throughout the Central Nervous System (CNS) 
and Enteric Nervous System (ENS) [1]. Dopamine acts on G-protein coupled receptors to exert its action [2]. 
The gastrointestinal tract (GIT) is the body system responsible for digestion. It is innervated by a large 
number of stimuli. Dopamine is known to have certain effects within the GIT and five receptor subtypes have 
been identified [3]. The aim of this study was to examine the effect of dopamine within the proximal and 
distal ileum and to test if restriction of food altered contractile responses [4]. 
The experimental procedure used guinea pig ileum (GPI) to determine the pharmacological effects of 
dopamine agonists and antagonists on contractile response. GPI was suspended within an organ bath of 
Tyrode’s solution. Dopamine agonists and antagonists were added and the contractile response was 
measured. Statistical analysis was employed to test for differences between proximal and distal ileum and 
between free food and food restricted animals. 
The dopamine agonists all produced a dose-dependent contractile response. When comparing the free food 
and food restricted animals, none of the results were found to be statistically significant (P>0.05). For 
comparisons between proximal and distal ileum, the agonist, bromocriptine, produced statistically significant 
results in free food (P=0.0016) and food restricted (P=0.0470) tissues. In most cases, antagonists decreased 
the contractile response of agonists. In distal, food restricted animals the agonist, SKF 38393, produced the 
highest average contractile response. 
In conclusion, the data demonstrate that there was a difference in responses of the proximal and distal ileum 
to dopamine agonists and antagonists. However, despite there being a difference between free food and 
food restricted results, these were not statistically significant. Moreover, there is evidence of an increased 
activation of D1 receptors in the proximal ileum and of D2 receptors within the distal ileum. 
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1. Hornykiewicz. 2002. Dopamine miracle: from brain homogenate to dopamine replacement. Mov Disord 17(3), pp. 501-508. 
2. Missale, C. et al. 1998. Dopamine receptors: from structure to function. Physiol Rev 78(1), pp. 189-225. 
3. Li, Z. S. et al. 2004. Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation. J 
Neurosci 24(6), pp. 1330-1339. 
4. Carr, K. D. 2007. Chronic food restriction: enhancing effects on drug reward and striatal cell signaling. Physiol Behav 91(5), pp. 459-
472. 
 
The development of an effective computer assisted learning package on Lyme 
disease 
Nathan Tyrrell and RDE Sewell 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Computer Assisted Learning (CAL) is an independent or supplementary method of self-teaching with many 
possible applications. One proposed application is its use in Continued Professional Development (CPD) [1]. 
The aim of this research project is to develop an effective CAL package on Lyme disease to be used by both 
pharmacy undergraduates and postgraduate pharmacists as a CPD entry. 
An up-to-date CAL package was designed using Microsoft PowerPoint 2010. The package contained 
information on Lyme disease relevant to its prevalence, diagnosis, prevention and treatment. The role of the 
pharmacist was also discussed and various teaching methods such as; animations, diagrams, self-testing 
and case studies were employed. A questionnaire was also designed in order to test the usefulness of the 
package, using GoogleDocs and a link was incorporated onto the final slide. A hard copy was also made 
available using Microsoft Word 2010. Both were then distributed amongst MPharm I at Cardiff University. 
Overall feedback on the package was positive. 100% (n=20) agreed it was well presented and easily legible. 
Respondents also said it was well supplemented with diagrams and a manageable length. 85% (n=17) 
responded that the content was pitched at an appropriate level and 100% (n=20) agreed it was relevant to 
pharmacy. 100% (n=20) found CAL to be a useful learning tool with mixed responses as to whether it should 
replace other methods. The package was said to be useful for CPD entry with 80% (n=16) in agreement. 
 
Participants found the package to be beneficial and useful but would appear to view CAL as a 
supplementary tool [2]. However interactive, self-teaching aspects were viewed positively [3] and such 
packages appear to be promising for CPD fulfilment. As well as the suggested improvements, it may be 
effective to use slides in a more supplementary role, for example by incorporating audio for further 
expansion. 
1. Blenkinsopp E, Childs S, Hall A, Walton G (2005). Effective e-learning for health professionals and students, barriers and their 
solutions. A systematic review of the literature, findings from the HeXL project. Health Informational and Libraries Journal. 22(2), pp. 
20–32 [Online]. Available at: http://onlinelibrary.wiley.com/doi/10.1111/j.1470-3327.2005.00614.x/full (Accessed: 12/4/2014). 
2. Conroy S.P, Daunt L.A, Umeonusulu P.I, Gladman J.R.F, Blundell A.G, Gordon A.L. (2013). Undergraduate teaching in geriatric 
medicine using computer-aided learning improves student performance in examinations. Age and Ageing. 42(4), pp. 541-544 
[Online]. Available at: http://ageing.oxfordjournals.org/content/42/4/541.long (Accessed: 2/3/2014). 
3. Downes S (2005). E-learning 2.0, Available at: http://elearnmag.acm.org/featured.cfm?aid=1104968 (Accessed: 22/4/2014). 
 
The effect of the presence of food on cannabinoid pharmacology in the guinea-pig 
ileum 
Rajnish Veerappa and WR Ford 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Redwood Building King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Cannabinoids have shown potential therapeutic benefit in treating gastro-intestinal (GI) conditions such as 
Irritable Bowel Disease (IBD) [1]. One of these benefits is relaxation of the GI smooth muscle; thought to be 
mediated via cannabinoid receptors (CB1 and CB2) located presynaptically, that reduce acetylcholine release 
when activated [2]. This study aimed to investigate whether fed or fasted states could alter cannabinoid 
pharmacology in the isolated guinea-pig ileum. 
The ilea of fed and fasted guinea-pigs were cut into 2 cm strips and suspended in an organ bath containing 
Tyrode’s buffer, aerated with carbogen and maintained at 37°C. Electrical field stimulation [3] induced 
regular ileal contractions and the mean of force of tension was recorded. (+)-WIN (cannabinoid agonist) was 
dosed alone cumulatively up to 30µM initially, then dosed in the presence of 1µM AM 281 (CB1 selective 
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antagonist). A 50% ethanol vehicle was used for (+)-WIN based on preliminary experiments that showed 
100% ethanol vehicles significantly suppressed twitch height. 
In fed guinea-pig ileum: (+)-WIN suppressed twitch height by up to 71±6.24%. AM 281 shifted the 
concentration-response curve (CRC) of (+)-WIN to the left (0.23 mean log shift), thus potentiated the (+)-
WIN-induced inhibition of twitch height. In fasted guinea-pig ileum: The (+)-WIN effect was abolished due to 
the ethanol vehicle alone substantially suppressing twitch height (65.7±11.51%) and preventing any (+)-WIN 
effect. AM 281 had no effect on (+)-WIN in fasted guinea-pig ileum. 
This study shows (+)-WIN has cannabinoid-like effects on smooth muscle of the guinea-pig ileum. AM 281 
potentiates (+)-WIN-induced suppression of twitch height suggesting potentiation via CB1 receptors, or 
possible involvement of non-CB1 targets. AM 281 enhanced (+)-WIN affinity (shown by a CRC shift left) for 
its receptors. Fasted guinea-pig ileum is more sensitive to the effects of high vehicle concentrations; 
highlighting the practicality difficulties when assaying the highly lipophilic cannabinoids.  
1. Izzo AA, Mascolo N, Capasso F. The gastrointestinal pharmacology of cannabinoids. Current opinion in pharmacology. 
2001;1(6):597-603. 
2. Schlicker E, Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends in pharmacological 
sciences. 2001;22(11):565-72 
3. Paton WD. The response of the guineapig ileum to electrical stimulation by coaxial electrodes. The Journal of physiology. 
1955;127(2):40-1P 
 
The design and synthesis of Bcl3 inhibitors as anti-metastatic agents 
YeeLing Wee and AD Westwell 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Metastatic cancer is cancer that has spread from the primary tumour to the other part of the body through 
either the bloodstream or the lymph system. Approximately 90% of cancer-associated deaths are caused by 
cancer metastasis and breast cancer has been identified as the most common cancer in the UK, despite the 
fact that it is rare in men [1-3]. Through a recent series of studies by researchers in Cardiff University, 
researchers confirmed that a potential cancer causing gene, which is Bcl3, plays a critical role in the 
development of metastatic breast cancer. They revealed that the spread of cancer was reduced by more 
than 80% if Bcl3 gene is suppressed in mice with metastatic disease [4]. Hence, the main aim of this 
investigation was to design and synthesis small chemical inhibitors of Bcl3 that might have potential 
therapeutic value in metastatic breast cancer. 
The synthetic pathway provides 2–step synthesis pathways that have similar mechanism, which is the 
nucleophilic substitution. Step 1 is the synthesis of intermediates while Step 2 is the synthesis of final 
compound where the heterocyclic is substituted by either morpholine or phenyl ring. Purification techniques 
such as filtration, extraction, silica gel column chromatography and crystallisation were used to ensure the 
pureness of our compounds. H-NMR, C-NMR, F-NMR, mass spectrometry and melting point were used to 
characterize the final compounds obtained.   
12 putative Bcl3 inhibitors were prepared and fully characterised. It was justified by the results obtained from 
the NMR spectrometry. Good yield for all the compounds have been obtained. These final compounds were 
sent for biological evaluation to test for biological activities and toxicity.  
In conclusion, all the Bcl3 inhibitors have been successfully synthesised and its potential therapeutic value 
will be discovered in later stage. The exact mechanisms of how Bcl3 inhibitors work in metastatic breast 
cancer are not fully understood at this stage. However, researchers are working hard in finding more 
therapeutic options in order to reduce the mortality rate and improve the quality of life of patients with 
metastatic diseases. 
1. Elvin P, Garner AP. Tumour invasion and metastasis: challenges facing drug discovery. ScienceDirect. 2005,5(4):374-381. 
2. American Cancer Society. What is metastatic cancer?. 2012. [accessed: 20 April 2014]. Available from: 
http://www.cancer.org/treatment/understandingyourdiagnosis/advancedcancer/advanced-cancer-what-is-metastatic 
3. Cancer Research UK. 2014. Cancer incidence for common cancers [Online]. Available at: http://www.cancerresearchuk.org/cancer-
info/cancerstats/types/breast/mortality/ Accessed: 29 March 2014].  
4. ScienceDaily. Drug to reverse breast cancer spread in development. 2014. [accessed: 20 April 2014]. Available from: 
http://www.sciencedaily.com/releases/2014/01/140125224927.htm  
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Investigating the potential link between ageing, endocytosis and Alzheimer’s 
disease 
Harriet J Whitaker, RS Thomas, M Hvoslef-Eide and EJ Kidd 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative diseases of our ageing population. 
It is characterised by accumulation of amyloid-beta (A) plaques formed from the cleavage of amyloid 
precursor protein (APP) [1]. Abnormalities in endocytic pathways have been implicated in the early stages of 
AD, with evidence of enlarged endosomes leading to increased amyloidogenesis resulting in neurotoxicity 
[2,3]. This study was undertaken to explore the potential link between ageing, endocytosis and AD - in 
particular to look at proteins involved in non-clathrin-mediated endocytosis; caveolin-1, caveolin-2, flotillin-1 
and flotillin-2. The primary aims were to investigate whether these proteins were up or down-regulated with 
age and compare their expression within the brain tissue of transgenic London mutation mice 
(overexpressing human mutated APP V717I) and wild-type mice. 
Western blotting was used to establish levels of proteins within the cortex of 3, 9 and 18 month wild-type and 
transgenic mice. Results were normalised against levels of -actin to produce semi-quantitative data which 
were analysed using unpaired t-tests or one-way ANOVA and Tukey’s post-hoc tests. 
Results confirmed an over-expression of APP in transgenic animals at all ages. A significant decrease in 
levels of caveolin-1 was seen in transgenic animals compared to the wild-type animals at 9 and 18 months, 
with p values of 0.019 and 0.0054 respectively. There were no significant differences observed between the 
levels of caveolin-2, flotillin-1 or flotillin-2 in the wild-type and transgenic animals and no significant 
differences observed with increasing age. 
Further experimentation in different animal models and repetition of this study are necessary in order to draw 
any firm conclusions. However, findings suggest that a decrease in caveolin-1 levels may be linked to an 
increase in amyloidogenesis and hence could be implicated in the pathology of AD – presenting a potential 
target for drug treatments.  
1. Burns, A. and Iliffe, S. 2009. Alzheimer’s Disease: Clinical Review. British Medical Journal 338, pp.467-471. 
2. Nixon, R. 2005. Endosome function and dysfunction in Alzheimer’s disease and other neurodegenerative diseases. Neurobiology of 
Aging 26(3), pp.376-382. 
3. Koo, E. and Squazzo, S. 1994. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. The 
Journal of Biological Chemistry 269(26), pp.17386–17389. 
 
Development of HIV RT model to be included in NAOMI 
Chung Kuen Wong, A Brancale and IM Trist 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
Scientists have been trying to reduce the cost and speed up the drug discovery process of nucleoside 
analogues by using computational techniques. NAOMI, which is a computer program for prediction the 
activation, and metabolism of nucleoside analogues, has developed [1]. In order to improve the current 
functions of NAOMI, viral targets were aimed to be included for future novel nucleoside predictions. HIV 
reverse transcriptase (HIV RT) was chosen, as it is one of the most popular viral targets with Wildtype and 
mutant (M184V and K65R) structures. A consensus score system of each HIV RT structure was aimed to 
build based on the present inhibitors and ligands activities. 
Computational molecular modeling strategies were used to validate binding and interactions between ligands 
and the target protein pocket. The differences in docking conformations and molecular behaviours of 
substrates, non-active inhibitor and inhibitors were identified for building the scoring functions. Meanwhile, 
the pharmacophores for each viral structure (Wildtype, M184V mutant, K65R mutant) were built and the 
molecular docking patterns between Wildtype and mutants were investigated for scoring functions. The 
scoring criteria for pharmacophore searches, docking and rescoring were developed. 
The models of 5 scoring functions were developed for the consensus score system. The overall results of 
Wildtype and M184V mutant showed that the activity data matched the consensus score results with minimal 
errors. However, K65R mutant showed less correlation between the activity data and the consensus score 
results because the consensus score system is restricted to conformational binding without “conformational 
restriction” mechanism resistance [2]. 
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In conclusion, the consensus score system for HIV RT wildtype and M184V mutant was successfully built to 
distinguish inhibitors and non-active inhibitors. The consensus score system needs to be modified and 
improved for K65R mutant due to the lack of accuracy on discrimination. 
1. Avancini, Daniele. "Naomi: a molecular modeling tool for the prediction of nucleoside analogues activation." (2012). 
2. Das, Kalyan, et al. "Structural basis for the role of the K65R mutation in HIV-1 reverse transcriptase polymerization, excision 
antagonism, and tenofovir resistance." Journal of biological chemistry 284.50 (2009): 35092-35100. 
 
MMP expression and activation in drug-sensitive versus drug-resistant breast 
cancer 
Rebecca Young, F Cameron and S Hiscox 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
The majority of breast cancers express the oestrogen receptor (ER) and antihormone therapies such as 
tamoxifen, faslodex and aromatase inhibitors have been clinically successful in ER-positive patients. 
However, tumours can acquire resistance to this treatment which is associated with disease relapse at 
distant sites. In vitro models of acquired resistance have demonstrated that resistance is accompanied by a 
significant gain in invasive capacity [1]. Matrix Metalloproteinases (MMPs) are proteolytic enzymes involved 
in many physiological processes, however their expression can become deregulated and this subsequently 
implicates them in cancer spread with MMP2 and 9 particularly involved in the latter [2]. The aim of this 
project was to investigate the hypothesis that acquired antihormone resistance in breast cancer is associated 
with an increase in pro-invasive pathways that rely on the expression of MMP 2 and/or 9.  
Antihormone-sensitive MCF7 cells and their tamoxifen and faslodex-resistant counterparts along with a 
model of oestrogen deprivation resistance (used to model aromatase inhibitor resistance) were examined for 
MMP2 and 9 at the gene and protein level by RT-PCR and zymography respectively. A colorimetric assay 
was also performed to investigate the expression of urokinase-plasminogen activator (uPA), an upstream 
MMP activator.  
Our results show that neither MMP2 nor uPA appear to be involved in acquired resistance as MMP2 was 
absent in every cell line, and uPA concentration was very low across all cell lines. Contrary to published 
observations, no relationship between MMP and ER status was observed [3]. A statistically significant 
increase of the MMP9 gene was seen in tamoxifen-resistant cells compared to MCF7 which was reflected at 
the protein level, however the most aggressive faslodex-resistant cells exhibited the least MMP9 signal.  
In summary, the data suggests that MMP9 overexpression is implicated in acquiring resistance to tamoxifen 
but not to faslodex. Conversely, neither MMP2 nor uPA appeared to correlate with invasive behaviour. 
1. Zhou C, Zhong Q, Rhodes LV, Townley I, Bratton MR, Zhang Q et al. Proteomic analysis of acquired tamoxifen resistance in MCF-7 
cells reveals expression signatures associated with enhanced migration. Breast Cancer Research. 2012; 14 (2): R45. [Accessed 
01/04/14] Available from:  http://breast-cancer-research.com/content/14/2/r45 
2. Figueira RC, Gomes LR, Neto JS, Silva FC, Sogayar MC. Correlation between MMPs and their inhibitors in breast cancer tumor 
tissue specimens and in cell lines with different metastatic potential. BMC Cancer. 2009; 9: 20. [Accessed 25/03/14] Available from: 
http://www.biomedcentral.com/content/pdf/1471-2407-9-20.pdf 
3. Sullu Y, Demirag GG, Yildirim A, Karagoz F, Kandemir B. Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive 
ductal carcinoma of the breast. Pathology - Research and Practice. 2011; 207 (12): 747-753. [Accessed 05/04/14] Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/22030137 
 
Patient experience: satisfaction with their medicines management during their 
hospital stay and satisfaction with information about their medicines provided on 
discharge from hospital 
Asjad Yousif1, J Harries2 and ML Hughes1 and RS Dewdney1 
1Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB and 2Cwm Taf Health Board,Ynysmaerdy, Pontyclun, Wales, CF72 8XR 
Satisfaction is the ‘fulfilment of ones wishes, expectations or needs’ [1]. Satisfaction with medicines 
information is a key determinant in influencing adherence. The study aim was to assess in-patient 
satisfaction within the Cwm Taf Health Board, with their medicines and information provided on discharge. 
The main objectives were to assess if providing patients with sufficient information with regard to their 
medicines management and on discharge affected overall satisfaction. Furthermore, if receiving clear written 
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and verbal information affected satisfaction and evaluating information provided to patients using the 
satisfaction with information about medicines scale (SIMS) [2]. 
The study was conducted at the Royal Glamorgan and Prince Charles Hospitals after ethical approval was 
obtained. Patients aged over 18 discharged a week prior to data collection, on one or more medications 
were eligible for participation. An anonymously coded, two part bilingual questionnaire (English and Welsh) 
incorporating a validated tool2 was distributed with a covering letter and free-post envelope. Patient 
demographics were inputted into an Excel spreadsheet. Kruskal-Wallis and Mann-Whitney U statistical tests 
were used to compare variables to overall satisfaction. 
There were 366 eligible patients and 118 participated. Overall, 95% (n=112) of patients were satisfied with 
the way their medicines were dealt with during their hospital stay and the information provided on discharge. 
Only 39% (n=46) of the study population received clear written information and 60% (n=71) received clear 
verbal information. Verbal information did not impact on satisfaction however, not sufficiently receiving clear 
written information did. The SIMS tool showed that more information about the actions and usage of 
medications was provided compared to their potential problems. 
Information gaps were seen with the formatting of information on discharge and the potential problems of 
medications. However, this did not affect patient satisfaction ratings as it may have not been relevant to 
patients a week after discharge. 
1. The Oxford English Dictionary.2013. [Online] Available at: http://www.oxforddictionaries.com/definition/english/satisfaction 
[Assessed: 13 February 2014]. 
2. Horne, R. et al. 2001. The satisfaction with information about medicines scale (SIMS): a new measurement tool for audit and 
research. Quality in Health Care. 10, pp.135-140. 
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Design and synthesis of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1) inhibitors 
Dania Altuwairgi and C Simons 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
 
e-Books to enhance learning in the pharmaceutical sciences 
Yu-Chun Cheng and M Gumbleton 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
 
Determination of hydrogen peroxide in pomegranate rind extract with luminol 
chemiluminescence assay 
Hong Tho Choo, JY Lai and CM Heard 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
 
Identification and characterisation of methicillin-resistant Staphylococcus aureus 
(MRSA) 
Emma Davies, H Siani and J-Y Maillard 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
 
A novel complex with potential as a new topical microbicide 
Catherine Edwards and CM Heard 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
 
The effect of bile salts on the ability of the spore of hypervirulent strains of             
C. difficile to adhere to clinically relevant surfaces 
Elin Evans and LT Joshi 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
 
Probing interactions between tannins with metal ions 
Jo Yen Lai and CM Heard 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
 
Novel 6-modified-5-fluorouridine phosphoramidate prodrugs: design, synthesis and 
biological evaluation as potential anticancer drugs 
SuKee Ngan, M Slusarczyk and C McGuigan 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
 
Design and synthesis of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1) inhibitors 
Adeline Siew Ting Ngu and C Simons 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
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The design and synthesis of novel inhibitors of Mycobacterium tuberculosis 
CYP121 
Dhiran Patel and C Simons 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
 
Is caveolin-1 a possible cancer stem cell marker in renal cell carcinoma? 
Thomas Potter, R Gutteridge and M Gumbleton 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, 
Cardiff CF10 3NB, Wales, UK 
 
Kinetic study of nanoparticle transport across porcine mucus barrier 
GS Rajaratnam, A Mutanna and M Gumbleton 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
 
An investigation into the efficacy of detergent wipes in controlling microbial 
bioburden on surfaces 
Lauren Ramm, R Wesgate, H Siani and J-Y Maillard 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, 
Cardiff CF10 3NB, Wales, UK 
 
Fabrication and evaluation of a novel microbicide-loaded gauze as a wound healing 
aid 
Vlad Roman, SP Denyer, DM Houston and CM Heard 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
 
Synthesis and characterisation of silica pH-responsive nanomaterials 
Jerome Ryan and P Prokopovich 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
 
Synthesis and characterisation of antimicrobial releasing silica pH responsive 
nanomaterials 
Thomas Sauter, P Prokopovich and S Perni 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
 
Development of CYP121 inhibitors as potential tuberculosis therapeutics: docking 
study and synthesis 
Victoria Shaw and C Simons 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edwards VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
 
Use of an ex-vivo test method to assess the efficacy of wash cloth in incontinence-
associated dermatitis 
Sofhatun Nur Subhi, H Siani and J-Y Maillard 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
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Design and synthesis of novel anti-DENV nucleoside analogues 
Grant Sugiura, C Cima and A Brancale 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
 
Antimicrobial activity of silica-based nanoparticles conjugated with antibiotics 
against Staphylococcus epidermidis 
Joanne SK Tan and P Prokopovich 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
 
Testing antimicrobial effect of silica-based nanoparticles conjugated with 
antibiotics against Staphylococcus aureus 
Vuan Zhin Tan, P Prokopovich and S Perni 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
 
The production of fluorescently labelled exosomes, visualisation of their 
interactions with cells and optimisation of their cellular uptake 
James Van Gemeren1, E Sayers1, A Clayton2 and AT Jones1 
1Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB and 2Cancer Research Wales, Velindre Hospital, Whitchurch, Cardiff, CF14 2TL 
 
The Role of Cav 1 in CAKI – 1 cells in renal cell carcinoma 
Mohamed Hussein Varvani, R Gutteridge and M Gumbleton 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
 
Synthesis and biological evaluation of 5-azacytidine ProTides as anticancer drugs 
Mei See Wong, M Serpi and C McGuigan 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK  
 
Developing an ex-vivo test method to assess efficacy of chlorhexidine washcloth 
Wah Soon Justin Wong, H Siani, R Wesgate and J-Y Maillard 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
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An evaluation of the scatter of Indium-111 (111In) photons in to the Technetium-99m 
(99mTc) energy window during the measurement of gastric emptying studies using 
radiolabeling scintigraphic techniques 
Kirsty Davies, G Taylor and RDE Sewell 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
During dual isotope gastric emptying studies it has been observed that the higher energy radioisotope can 
scatter down into the lower energy radioisotope window, giving a misleading count rate for the low energy 
radioisotope.  One example of this is when a 99mTc radiolabeled meal is administered, followed by an 111In 
dosage form in a gastric emptying study.  This scatter is particularly problematic for pharmaceutical gamma 
scintigraphic studies where accurate quantification of each isotope is necessary. The objective of this study 
was therefore to estimate subject specific scatterdown values (in to the 99mTc energy window) in order to 
correct for the interaction of 111In with soft tissues during gastric emptying studies.  In addition, the 
relationship between subject BMI and % scatter was evaluated.  
Subject thickness was estimated from transmission scans, in this process an image of an external 
radioactive flood source (57Co) was acquired in the presence and absence of the test subject.  The reduction 
of signal in the presence of the subject provided a transmission factor related to the subject’s total body 
thickness.  A source of 111In source was placed on an appropriate stand in-between the gamma camera 
heads (180° orientation) and imaged  using a standard pre-set Tc/In window in the presence of 0-16 1cm 
thick Perspex sheets. 
15 Subjects with a BMI range of 21.3-26.9 were evaluated and % scatter values of 66.25 – 75.25 calculated 
from the results of experimental testing. When accounting for the % scatter and applying these values to the 
99mTc geometric mean counts as a percentage of the 111In counts (following 111In administration), a more 
appropriate emptying profile was observed.  In addition, it was found that subject BMI is related to % scatter.  
In general, the larger a subject’s BMI, the greater is the percentage scatter of the higher energy isotope. 
I suggest that in future studies, it may be beneficial to evaluate the scatter from anterior and posterior images 
separately, as the anterior and posterior images obtained during a scintigraphy study will result in different 
attenuation of the radioisotope. 
 
A system search to investigate similarities and differences between genetic and 
environmental risk factors to determine the cause of multiple sclerosis. 
Lauren Edwards, RDE Sewell and MS Salek 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Background- Multiple Sclerosis (MS) is a disease which effects millions of people all around the world.  
There are several variations such as Relapsing Remitting Multiple Sclerosis (RRMS), Primary Progressive 
Multiple Sclerosis (PPMS) and Secondary Progressive Multiple Sclerosis (SPMS).  The common identifier of 
MS is the sclerotic plaque, which essentially is the demyelination of myelin.  In a healthy individual, the 
myelin provides a covering which insulates and protects the nerves, this keeps them healthy and aids the 
conduction of impulses along the nerves.  In MS, inflammation causes the myelin to disappear. 
There are several risk factors which cause this disease of the central nervous system (CNS).  Genetics and 
the environment are well known factors that cause the disease, for example ethnicity, familial links, the 
Epstein-Barr Virus and location/vitamin D.  Most people with MS are able to live a normal, or near normal life, 
however, there is no known cure for MS or for demyelination.  MS sufferers can receive treatments to help 
manage the disease and reduce their symptoms.  
Aims- The aim is to compare the significance of genetic factors and environmental factors. 
Objective – The objective is to search multiple systems for papers investigating the causes of multiple 
sclerosis to find out which factor is more likely to be the main cause of MS. 
Methods – An extensive search of databases such as PubMed, EMBASE, Cochrane library and Scopus to 
find papers on case control studies, epidemiology studies and reports on the risk factors of Multiple 
Sclerosis. 
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Conclusion – Both genetic and environmental factors play a huge part in the onset of multiple sclerosis.  
Genetics have a dominant role when it comes to gender and familial links amongst siblings, however, 
evidence suggested that MS can lay dormant until triggered by an environmental factor.  There is no one 
predominant factor that has proved to be a cause, but a combination of different contributory factors is the 
most plausible pathogenesis. 
 
A critical analysis of the publication of randomised controlled trials: the use of the 
CONSORT statement 
Hazel Anne Harris, WR Ford and RDE Sewell 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
It has been widely noted that clinical trial reporting is suboptimal. The CONSORT statement 2010 and its 
preceding versions were introduced to try and improve the situation. The aim of this dissertation was to 
assess the current use of and adherence to the CONSORT statement 2010 checklist. In addition, any 
changes that could be made to the CONSORT checklist in order to enhance both its impact and its 
prevalence were examined and explored.  
A PubMed search identified 12 biomedical journal articles of Randomised Controlled Trials for analysis. All 
were published in 2013 in peer reviewed journals. The CONSORT statement 2010 checklist was used, and 
each of the 37 subcategory items were marked as reported or not reported for each article. In addition the 
recording of a number of other items were noted, such as ethical approval, informed consent and conflict of 
interest.  
The number of CONSORT items reported ranged from as little as only 14 (approximately 41%) per article up 
to 30 (approximately 81%). No article reported all CONSORT checklist items thus showing that clinical trial 
reporting remains suboptimal. In addition, some of the other topics looked at were also incompletely and 
inconsistently reported.  
As a result of looking at the current reporting of the CONSORT 2010 checklist items and other salient 
information that could and should be included in clinical trial reports, a revised CONSORT checklist was 
produced. More work is needed to improve the publication of all clinical trials, their methodology, results and 
hopefully in the not too distance future, raw data. The amended CONSORT checklist may just be one small 
step towards making this happen. 
 
The role pharmacovigilance and spontaneous reporting play in healthcare system 
Laura López Gómez, MW Smith and RDE Sewell 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Healthcare professionals have long been concerned about adverse drug reactions reporting mechanisms. 
The aim of this thesis is to review and analyse some of the current methodologies used for monitoring drug 
safety during post marketing authorization, an essential step when considering the limited awareness of the 
safety profile of new licensed medicinal products. Strengths and weaknesses of some of the current 
methodologies available together with future developments in pharmacovigilance are here discussed. This 
introduction is followed by a deeper analysis about attitudes towards adverse events reporting among 
general practitioners in Wales.  
Nowadays, the Yellow Card Scheme is well recognized for being the most common Spontaneous Adverse 
Drug Reaction (ADR) system within the United Kingdom (UK). Despite its importance, one of the biggest 
drawbacks this system presents is underreporting. There are many of controversies about the reasons why 
healthcare professionals are not reporting ADRs to Medicines and Healthcare products Regulatory Agency 
(MHRA).  
UK is currently on leading positions within respect to ADR reporting rates. Apart from the number of 
structured databases which systematically monitors healthcare events, surveys like the one here  aim to 
evaluate General Practitioners (GPs) knowledge about pharmacovigilance and their attitudes towards ADR 
reporting, data obtained from a multiple-choice survey questionnaire carried out by Welsh Medicines 
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Resource Centre (WeMeReC) has been analysed. The survey questionnaire was part of a distance-learning 
module launched by WeMeReC targeting all healthcare professionals registered on its website in May 2013. 
However, only answers given by GPs who had completed the 5-year post graduate studies were taken into 
account in this thesis. In total, the distance learning module was sent out to 411 GPs. Out of this only 364 
properly answered the questionnaire which reflects a response rate of 87%.  
As a result of the analysis performed, this resource aims to reinforce the importance of pharmacovigilance on 
the protection of public health. To ensure a successful pharmacovigilance system, this should be effectively 
used and its importance is to be continually highlighted. 
 
Assessment of quality of life in gastroesophageal reflux disease using generic and 
disease-specific measures 
Rebecca Allison McCaffery, MS Salek and RDE Sewell 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Gastroesophageal reflux disease (GERD) is a common and costly condition affecting between 10-30% of the 
Western population, and is becoming increasingly more common worldwide. One area of GERD which is 
often overlooked or underappreciated is the affect it can have on a patient’s quality of life (QOL). However, 
using standardised questionnaire/instruments such as the generic Short Form – 36 (SF-36) or disease 
specific Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaires, QOL of such patients can easily 
be measured.  
Using the SF-36 questionnaire, QOL data was collected from 86 subjects who were split into 2 cohorts; 43 
healthy patients, and 43 subjects suffering with GERD. Subjects for the ‘healthy’ cohort were recruited 
through friends, family and colleagues, whilst subjects for the ‘GERD’ cohort were recruited via se lf help and 
support groups on the social networking site, Facebook. The data collected from both cohorts was then used 
to determine whether GERD affects QOL, and if the effect differs based on age/gender. Comparisons were 
also made to identify whether certain areas of daily life are affected more than others. In addition to the SF-
36 questionnaire, the GERD cohort were also asked to complete the QOLRAD questionnaire in order to test 
for internal and construct validity of responses.  
Data processing was carried out using Microsoft Excel. Data was analysed using Mann-Whitney analysis 
testing, student T-Test, Pearson’s correlation coefficient, and Cronbach’s alpha. The highest mean SF-36 
score was observed in the Emotional Well-being domain in the GERD cohort (66.9) and Role Limitation – 
Physical for the healthy cohort (98.3). The lowest scores were observed in General health domain (42.5) and 
Energy / Fatigue (66.9) respectively. Overall, the results showed that GERD does significantly affect the 
QOL. When testing for internal consistency reliability, a score of ≥0.8 was considered desirable and the 
majority of SF-36 domains scored this or greater, with the greatest score (0.94) being achieved in the 
physical functioning domain of the GERD cohort. The lowest score (0.40) was seen in the role limitations – 
emotional domain of the healthy cohort. All scores for the QOLRAD questionnaire were ≥0.90. The 
correlation between the SF-36 and QOLRAD scores for the GERD cohort was also calculated using 
Pearson’s correlation coefficient and a iv score of ≥0.30 was considered significant and demonstrating 
positive correlation. All scores calculated were above this.  
In conclusion, patients suffering with GERD have a significantly reduced QOL, with different areas of daily 
life being affected to differing extents, in comparison with healthy individuals. Its impact is affected by the 
patient’s age however, gender does not affect its impact. 
 
Childhood eczema: do parents and children suffer similar levels of stress? 
Wendy Toner-Beggs, MS Salek and RDE Sewell 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Atopic eczema is an inflammatory skin condition that is common among children; it can be a debilitating 
condition that can have widespread implications for both the child and their family. Much research has been 
carried out on the effect of this illness on families but little comparing the actual implications felt by both the 
child and the parent/main carer. The primary objectives of the research: to assess the level of stress 
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experienced by parents caring for a child with atopic eczema. To assess the level of stress experienced by 
children suffering from atopic eczema and then compare the results. 
Method was by means of a qualitative questionnaire distributed to both adults and children. Families were 
recruited through private day care nurseries, playgroup and pre-school and parent and child groups. Word of 
mouth also accounted for some of the returns. Before completing the questionnaires parents were asked to 
read an information sheet and sign a consent form. The questionnaires used were FDLQI and CDLQI. The 
questionnaire distributed to children was a modification of the adult questionnaire presented in cartoon form. 
A demographic information sheet was also circulated to these parents in order to meet secondary objectives 
of comparing the following: age of diagnosis; duration of disease; perceived disease severity; and family 
history of allergies. 
Other questions such as age, gender, number of children and whether they would be willing to pay for better 
disease control were also included on the demographic data sheet. These questionnaires were then checked 
for accuracy and the scores were calculated.  Higher scores represent greater impairment of QoL. Primary 
outcome measure showed that in terms of mean scores, children scored higher than their parent’s 
equivalent. Secondary outcome showed that in terms of the CDLQI score vs severity, these two were not 
related.  The CDLQI did not always correlate with the severity of the child’s eczema. Furthermore, the use of 
a demographic data sheet allowed further comparison of variable such as age of diagnosis, previous medical 
conditions and socio-economic status. 
Complete comprehension of the impact of eczema on children and their parents could not be established, 
further research into this area needs to be carried out, a larger sample population may show the 
differences/similarities between parent and child. Introduction of a control group would be of benefit in 
comparing a ‘healthy’ child’s responses against those with more complex health needs. 
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The identification of therapeutic targets and virulence factors of Clostridium difficile 
Harsha Siani and L Baillie 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Clostridium difficile, a Gram-positive spore forming bacteria, is the leading cause of healthcare-associated 
diarrhoea in the UK and represents a major healthcare challenge. The vegetative form of the bacterium 
colonises the gut mucosa and produces two exotoxins, which are responsible for the pathology associated 
with the bacterium. We thus sought to characterise the host immune response directed against the surface 
of the bacterium and toxins A and B.  
Our studies revealed that the vegetative form of the pathogen is capable of altering its physiology in vitro to 
produce two distinct colony morphotypes. The differences observed in the cell surface, autolytic activity and 
bile salt sensitivity; suggest that the M2 morphotype may be better equipped to survive in the hostile 
conditions encountered in the gut. The mechanisms by which these changes are mediated are as yet 
unclear; however given the characteristics of the morphotypes it may involve one or more phase variable 
proteins. The identification of immunogenic proteins, including pyruvate-flavodoxin oxidoreductase, an 
anaerobic metabolism enzyme associated with oxidative stress warrants further investigation. To be 
effective, a future immuno-therapeutic should target the form of bacteria which is most often encountered 
during infection.  
Toxins A and B remain the primary virulence factors of C. difficile, with toxin neutralising antibodies targeting 
the receptor binding domains conferring protection and reducing recurrent infection. To characterise the 
antibody response directed against toxins A and B, the cell binding and translocation domains of each toxin 
were expressed in Escherichia coli. To identify immunogenic regions, the native, recombinant and toxoided 
proteins were subjected to enzymatic digestion with clostripain and probed with toxin neutralising animal 
sera and sera from C. difficile infected patients. The immune sera consistently identified two fragments of 40 
and 60 kDa within both toxins A and toxin B, which may contain toxin neutralising epitopes and thus warrant 
further investigation. 
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Computer-aided design, synthesis and evaluation of potential anti-HCV agents  
Marcella Bassetto and A Brancale 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Hepatitis C virus (HCV) is a major cause of chronic liver disease, leading to hepatic steatosis, fibrosis, 
cirrhosis and hepatocellular carcinoma. A vaccine is currently not available, while the standard of care is 
effective in only 50% of treated patients. The first specific anti-HCV drugs have been recently approved, and 
new classes of targeted agents are under clinical trials/investigation. Nevertheless, improved treatment 
strategies are needed, in order to bypass the rapid emergence of resistance. All the viral non-structural 
proteins are a possible target for the identification of novel and selective antivirals. Among them, the NS3 
helicase is still underexploited, with no known inhibitor under pre-clinical or clinical development. This 
enzyme plays a crucial role in the virus life cycle: it catalyses the separation of double-stranded RNA 
strands, which is necessary for genome amplification and translation. Due to its essential function, the NS3 
helicase was chosen as a target for the identification of new, specific anti-HCV compounds. 
Different computer-aided techniques were employed to identify potential small molecule inhibitors of the 
enzyme. Two structure-based virtual screenings of commercially available compounds were performed on 
the main nucleic acid binding site. A series of candidate inhibitors was evaluated in the HCV replicon assay, 
yielding two primary hits with low µM activity. Secondly, the model of the one known inhibitor co-crystallised 
with the enzyme was used as a starting point for a shape-comparison screening of small molecule libraries. 
A new series of compounds was selected and evaluated for anti-HCV activity, and one of them was found to 
inhibit the viral replication at a low µM concentration. Several new derivatives of the initial hits were 
synthesised, belonging to four main structural families: bis-aromatic piperazine derivatives, symmetrical 
phenylendiamine compounds, differently substituted thieno-pyrimidines, and triphenyl-pyrrolone analogues. 
Inhibition of HCV replication in the replicon assay was evaluated for the new compounds prepared and 
several structures showed a range of activity from low-µM to nM. 
 
Viral infection in a murine model of allergic airways inflammation: actions of 
corticosteroids 
Zakky Cholisoh, EJ Kidd, WR Ford and KJ Broadley 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Viral respiratory infection exacerbates asthma symptoms in almost all patients with allergic asthma. Asthma 
symptoms in viral associated asthma exacerbation are often severe and require urgent care as well as 
hospitalisation. Corticosteroids are the mainstay treatment for asthma. However, they are less effective in 
treating virus associated asthma exacerbation. The main aim of the thesis is to determine the role of virus 
infection in airway allergic inflammation and then define the effects of corticosteroids in virus associated 
exacerbations of airway allergic inflammation.  
Mice sensitised and challenged with ovalbumin demonstrated most of the main features of asthma including 
lung cellular inflammation with eosinophilia, early phase asthmatic responses (EAR), late phase asthmatic 
responses (LAR), and airway hyperresponsiveness (AHR) to methacholine provocations. Treatment with 
either systemic (dexamethasone: DEX) or inhaled (fluticasone propionate: FP) corticosteroids in the murine 
ovalbumin allergic airways inflammation model attenuated inflammatory cells influx and eosinophilia, LAR, 
and the AHR. 
Influenza A (H1N1/PR8) is the most infective to mice compared to human parainfluenza virus type 3 
(HPIV3), and a synthetic dsRNA, poly (I:C). Influenza infection in mice caused a significant increase of 
inflammatory cell influx in the airways with marked neutrophilia, and AHR. Ovalbumin challenge in the acute 
course of influenza infection on a murine model of allergic airways inflammation exacerbated the 
inflammatory cells influx, LAR, and AHR. Treatment with either DEX or FP attenuated the airway cellular 
inflammation, LAR, but not the AHR. Mice only infected with influenza were resistant to the corticosteroids 
(DEX and FP) treatment. DEX but not FP showed antiviral activity against HPIV3 and influenza A in vitro. 
These data suggest that influenza infection in a murine model of allergic airways inflammation exacerbates 
the inflammation and alters the sensitivity toward corticosteroids. It is also suggested that some elements in 
the influenza associated exacerbation of murine model of allergic airways inflammation are refractory or not 
regulated by corticosteroid treatment.  
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Examination of viral and bacterial exacerbations of airways inflammation and 
function  
Ceri Mark Davies, KJ Broadley, WR Ford and EJ Kidd 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Chronic obstructive pulmonary disease (COPD) is an umbrella term that encompasses chronic bronchitis, 
emphysema and airway obstruction. COPD patients are also prone to acute exacerbations (AECOPD) 
caused primarily by viral and bacterial infection, which leads to an increase in inflammation, a worsening of 
symptoms and can lead to death. There is an unmet clinical to better understand and treat AECOPD as well 
as COPD in general, but this is hindered by unreliable animal models of COPD and AECOPD. The aim of 
this thesis was to establish an animal model of COPD that could be exacerbated by an infectious agent.  
Firstly an LPS model of COPD was established in the guinea pig, which resulted in a macrophage and 
neutrophil inflammatory profile, emphysematous changes, a decrease in lung function and partial steroid 
insensitivity that could be partially reversed with low dose theophylline. Human parainfluenza 3 virus failed to 
cause any infection in the guinea pig, so a model of AECOPD could not be established in this model.  
A chronic cigarette smoke model in the mouse was established, which again demonstrated a similar 
phenotype to COPD. This model was able to be exacerbated by the bacteria nontypeable Haemophilus 
influenza (NTHi) with increases in neutrophils and the neutrophil chemoattractant CXCL1. However, it was 
also observed that while NTHi could exacerbate the model, responses to NTHi in cigarette smoke 
challenged mice compared to sham challenged animals were impaired, with significant decreases in CXCL8, 
TNF-a, IFN-γ and IL-10. This impairment was also observed in monocyte derived macrophages (MDMs) 
challenged with cigarette smoke extract (CSE) with significant impairment of IL-1ß, while chronic LPS 
challenge also impaired IL-6 and phagocytosis.  
The data in this thesis highlights a possible increase in steroid responses by low dose theophylline in an LPS 
model in the guinea pig. It has also demonstrated chronic cigarette smoke exposure in the mouse can be 
exacerbated by NTHi, however the inflammatory response is impaired compared to sham challenged 
animals suggesting that cigarette smoke impairs the innate immune response. MDMs also demonstrated an 
impaired response to NTHi after CSE or LPS challenge. 
 
Development and validation of a generic instrument for assessing the quality of 
decision-making 
Ronan Donelan, MS Salek and R Walker 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Decision-making per se can be regarded as part art and part science in the development of new medicines. 
In the area of pharmaceutical development, decision-making plays a pivotal role in the continuation or the 
termination of further development or withdrawal of medicinal products. The decisions made at each stage 
have a direct impact on all stakeholders namely, pharmaceutical companies, regulators, payers and patients. 
What is lacking at present is a qualified understanding of the subjective decision-making approach, 
influences, behaviours and other factors which impact the decision-making of individuals and organisations 
involved in the delivery of new medicines. The aim of this study was, therefore, to develop and validate a 
generic instrument for appraising the quality of decision-making.  
Semi-structured interviews were carried out with 29 key decision-makers from the pharmaceutical industry, 
regulatory authorities and contract research organisations (CROs). They were invited to discuss all aspects, 
including their perception of decision-making and its role in drug development and regulatory review; 
decision making within their organisation; awareness and use of decision-making techniques; and impact 
and monitoring of decisions. Thematic analysis was carried out using NViVO 8©software. A preliminary 94-
item instrument was developed from the themes and the sub-themes that emerged from the interviews. 
Content validity was assessed using qualitative and quantitative data from an expert panel involving six key 
decision makers. A separate international cohort of 120 individuals working in the pharmaceutical industry, 
regulatory authority or CROs was recruited for factor analysis to reduce items. A further 78 individuals 
completed the final version of the QoDOS for construct validity and reliability.  
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Most individuals interviewed were male (55% -n=16) and their level of experience ranged from 7 to 35 years. 
32 themes and 90 sub-themes of aspects of decision-making were identified from the interviews. The 
median numbers of themes reported by experts was 6 (range = 1-10). The key themes included: quality and 
validity of the data; political, financial, competitor and reward influences; analytical and logical approach; 
overconfidence in own judgement; plunging in or procrastinating with decision-making; impact analysis of 
decisions; education and awareness of evolving decision-making techniques; and SWOT and alternate 
outcome planning. Relationships between the themes were identified.  
A 94-item generic instrument for assessing the quality of life decision-making, Quality of Decision-Making 
Orientation Scheme (QoDOS)©, with a 5-point Likert response scale was developed. The content validity 
panel’s rating of each item on a 4-point scale for the 4 attributes showed “strongly agreed” or “agreed” (88%) 
with an ICC value of .89 (CI = 0.56 –0.99) suggesting a high agreement between the panel members’ 
responses. This led to the reduction of 20 items and addition of two items as a result of cross-referencing 
with the qualitative data. Thus, the 76 items (version 2) emerged from content validation. Factor analysis 
produced a 47-item measure with four factors. The QoDOS showed high internal consistency (n = 120, 
Cronbach’s alpha = 0.89), high reproducibility (n = 20, ICC = 0.77) and a mean completion time of 10 
minutes. 10 hallmarks of “Good Decision-Making Practice” (GDMP) were identified.  
The QoDOS is a valuable addition to the decision-making tool box of drug developers and regulators and 
has the potential to fill the missing gap of the entire process which is building quality into the lifecycle of 
medicine. The identification of ten hallmarks and generation of a framework for GDMP are also important 
contributions of this study to the field. 
 
An evaluation of the contribution of pharmacy sales data for purposes of public 
health 
Hank C-T Du, DN John and R Walker 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
The contribution of over-the-counter (OTC) medicines sales data from pharmacies for public health has 
previously attracted interest in the UK. In this study, data for several OTC medicines were utilised to explore 
their contribution to (a) understand the impact of medicine reclassification or increased regulation on supply 
and (b) the surveillance of infectious diseases in the community in Wales.  
Following the reclassification of ophthalmic chloramphenicol (June 2005) an increase in primary care supply 
(OTC and via prescription) of 54% (47,026 units) in eye drops and 29% (15,657 units) in eye ointment were 
observed (2004 to 2010). Despite this increase the items of eye drops prescribed were similar 12 months 
before and five years after the reclassification. The impact of regulatory changes concerning the non-
prescription sale of opioid-containing analgesics was studied. In the 12 months following September 2009 
legislative changes there was a significant fall in sales of codeine- and dihydrocodeine-containing solid oral 
dosage forms (p<0.05). Similarly, following the pack size restriction of non-prescription pseudoephedrine and 
ephedrine products (April 2008), significant (p<0.05) year-on-year reductions in the total weight of 
pseudoephedrine sold were observed. Sales of non-prescription ophthalmic chloramphenicol were monitored 
on a small area basis in two areas with known outbreaks of infective conjunctivitis. In both areas sales data 
did not demonstrate the required sensitivity. When monitoring seasonal influenza, significant positive 
correlations were observed between cough/cold/flu medicines sales and indicators of influenza activity in 
Wales. 
In alignment with the professional standards for public health practice for pharmacy produced by the Royal 
Pharmaceutical Society, the work undertaken demonstrated a number of potential uses of medicines sales 
data for public health. Routine data collection, particularly if captured at time/point of sale, would further 
enhance its usefulness in detecting and tracking public health incidents. 
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Small molecule inhibitors of CYP24A1 for the treatment of various cancers  
Salvatore Ferla, C Simons and A Brancale 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
In the last three decades vitamin D, or calcitriol, has been found to have important anticancer role in different 
cancer types. Unfortunately, a therapy using calcitriol remains a challenge due to increased drug resistance 
as a consequence of the up-regulation of CYP24A1, which metabolises and inactivates calcitriol. Moreover, 
the hypercalcaemia associated with an elevated dose of calcitriol does not allow the use of vitamin D at a 
high concentration. Analogues of calcitriol have enhanced anti-tumour activity, reducing the calcaemic 
undesired effect. The use of CYP24A1 selective inhibitors could be the appropriate strategy to increase the 
lifetime and thereby the anti-cancer functions of calcitriol and its derivatives. Consequently, the aim of this 
project is to develop new, potent and selective inhibitors of CYP24A1 that could be used in the treatment of 
different types of cancer in order to enhance endogenous vitamin D levels and favour its anti-tumour activity.  
Through molecular modelling studies, a new CYP24A1 homology model has been prepared  and the active 
site has been characterised examining the disposition of (R)-VID400, a CYP24 inhibitor, (E)-N-(2-(1H-
imidazol-1-yl)2-phenylethyl)-4-styrylbenzamide (MCC165), a compound previously synthesised in our 
laboratory that showed a potent CYP24A1 inhibitory activity (IC50= 0.3µM), and the natural substrate 
calcitriol. Different series of potential CYP24A1 inhibitors were designed in order to mimic completely the 
calcitriol disposition in the binding pocket and to interact with the haem iron of the enzyme catalytic site. For 
each series a synthetic pathway was developed. The synthesis was followed by a CYP24A1/CYP27B1 
inhibition assay.  
All the compounds occupy the same hydrophobic tunnel as calcitriol and access the active site through the 
same channel. Moreover the substituents in the lateral chain bind directly to the haem iron via a lone pair of 
electrons. The different syntheses were obtained after several optimisations of reactions and routes. The 
CYP24A1/CYP27B1 inhibitory activity (IC50) using a cell-free assay and the value of the Ki (dissociation 
constant) of the different series of compounds, compared with ketoconazole (Ki= 0.030 µM, IC50= 0.47 µM) 
as the standard, were evaluated. Selectivity of CYP24A1 over CYP27B1 was also calculated. New potent 
CYP24A1 inhibitors were found. Selectivity gave a range from poor to moderate results with selectivity 
improved in some case compared with ketoconazole (selectivity: 1.6). 
 
Characterising response and resistance mechanisms to Faslodex in  
breast cancer 
Hayley Francies, E Anderson, N Laing, RA McClelland, L Farrow, D Barrow,  
S Ali, L Buluwela, RI Nicholson and JMW Gee 
 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff  
CF10 3NB, Wales, UK; AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK; and Dept. Surgery and 
Cancer, Imperial College London, W12 0NN, UK 
In ER+ breast cancer initial responses to antihormones are variable, complete responses are rare and 
resistance is eventually acquired by many patients. It is important to model these events to discover 
predictive markers of antihormone outcome and so targeted strategies can be developed to maximise 
antihormone effectiveness. To date, most studies have employed the MCF-7 cell line which fails to represent 
the variability of ER+ disease. Focusing on Faslodex (fulvestrant), the thesis objective was to use 4 cell lines 
in vitro encompassing ER+/HER2- (MCF-7/T47D) and ER+/HER2+ (BT474/MDA-MB-361) disease to (i) 
characterise the magnitude of initial antihormone response, (ii) monitor the onset of resistance by prolonged 
treatment and (iii) detail gene expression changes during Faslodex treatment.  
All models were initially growth-inhibited by Faslodex, with superior responses in HER2- lines. Microarray 
analysis revealed gene cohorts affected by Faslodex treatment differed between HER2+ and HER2- models. 
While MCF-7, BT474 and MDA-MB-361 cells acquired Faslodex resistance, this failed to develop in the 
T47D line, providing a model of complete response. A filtering process identified genes involved in the 
varying Faslodex responses and clinical relevance was determined using the NEWEST Faslodex clinical trial 
dataset.  
Of interest was the Faslodex-induction of CXCR4, as a potential mediator of acquired resistance, while 
suppression of the RET signalling pathway related to improved initial response in the ER+/HER2- setting. 
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Importantly up-regulation of DCN by Faslodex was associated with improved Faslodex response in T47D 
cells and also with proliferation (Ki67) fall in the NEWEST clinical trial. shRNA knockdown of DCN reduced 
the sensitivity of T47D cells to Faslodex and enabled development of resistance.  
This thesis has successfully identified novel elements of Faslodex response and resistance and further work 
is now required to clarify the importance of these mediators and to determine if DCN could prove a useful 
clinical biomarker of Faslodex response. 
 
Development, validation and clinical application of a patient-reported outcome 
measure in hyperhidrosis: The Hyperhidrosis Quality of Life Index (HidroQoL ©) 
Paul Kamudoni and MS Salek 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Consideration of broader outcomes of disease, especially those exclusively experienced and reported by the 
patient, such as HRQOL, is not only consistent with the ‘whole person’ view of health contained in the 1948 
WHO definition, but is also a prerequisite to building health-care systems that are responsive to the needs of 
the patients. For chronic skin diseases, such as hyperhidrosis, these provide a useful indicator of how a 
patient feels and functions disease for both practical and methodological reasons. The aims of this study 
therefore were to investigate the impact of hyperhidrosis on patients’ HRQoL using a mix of qualitative and 
quantitative methods. In addition, a further aim was to develop and validate a disease-specific instrument for 
assessing HRQoL in hyperhidrosis. In pursuing the above aims, the feasibility of applying online social 
networking sites for outcomes research in dermatology was assessed.  
Patients were recruited through online social networking communities related to hyperhidrosis for all stages 
of the study. Interviews, focus groups and surveys were used for collecting qualitative data from patients (n = 
71) to understand quality of life issues of patients, and to provide the content of the new instrument. 
Dermatologists (n= 5) and patients (n=7) took part in the content validation of the HidroQoL©. Item reduction 
and the development of the scale’s structure was carried out through several field-testing studies (n: USA, 
559; UK, 115), using the item response theory (IRT) Rasch model and factor analyses. Further psychometric 
testing was performed in a separate study (n = 241). Distribution-based methods were applied in establishing 
minimum clinically important difference (MCID). 
A thematic analysis of the qualitative data collected produced 29 quality of life themes and 102sub-themes, 
forming the content for the initial 49-item HidroQoL©. The two expert panels judged the instrument as 
content valid, with a few suggestions. The Rasch analysis modelling led to the collapsing of response 
categories (from five to three) and the reduction in number of items (from 49 to 18), to ensure a perfect 
model fit. Factor analyses supported both a single- and a two-factor structure. In subsequent construct 
validation study the HidroQoL correlated with the DLQI (rs=0.572, p < 0.01) and the Skindex-17 (rs= 0.551, p 
< 0.01). Reliability was high (Cronbach alpha = 0.9; test-retest ICC = 0.93). The scores were sensitive to 
change in patients’ disease severity (standard response mean = 0.8, 95% C.I: 0.34-1.27). The scale banding 
proposed for the HidroQoL score is as follows: 0 – 1, no effect at all; 2 – 11, small effect; 12 – 22, moderate 
effect; 23 – 32, large effect; 33 – 36, very large effect. The MCID values were 1.94 – 3.07, for generalised 
hyperhidrosis, 2.16 – 4.36, for axillary hyperhidrosis, 2.15 – 3.39, for palmo-plantar hyperhidrosis. An MCID 
of three is currently being proposed for all types of hyperhidrosis.  
This study has provided the initial evidence supporting the appropriateness of the content of the HidroQoL 
and validity of inferences from its scores for assessing HRQoL in hyperhidrosis. In addition, the availability of 
MCID estimates for the HidroQoL will facilitate its clinical interpretation in both research and routine clinical 
practice. This study has also demonstrated how CTT and IRT can be integrated in the development and 
validation of a new generation of HRQoL instruments, using social network for patient recruitment. 
 
 
 
 
PhD 
75 
Development of a universal benefit-risk assessment framework and its application 
for regulatory agencies 
James Leong, MS Salek and R Walker 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
The assessment of medicines has moved from efficacy and safety to that of a benefit-risk balance and 
regulatory agencies and pharmaceutical companies are improving their processes in order to achieve 
greater consistency and transparency in decision-making. However, their efforts are largely independent and 
do not address the lack of consistency in decisions by different countries, albeit for the same medicine, 
resulting in the potential inaccessibility of important medicines. The aim of this study was the development 
and validation of a universal benefit-risk framework for use by regulatory authorities.  
A questionnaire, specifically developed for this study, was used to evaluate the current approaches to 
benefit-risk assessment of medicines by14 regulatory agencies and 24 pharmaceutical companies. None of 
the 11 agencies (79%) and 20 companies (83%) that responded used a fully quantitative approach, but the 
majority used a qualitative system for benefit-risk assessment. The development of a universal benefit-risk 
framework for use by both regulators and industry, with the involvement of all stakeholders, was supported 
by the study participants.  
A comparison of the existing benefit-risk assessment frameworks used by agencies and companies 
identified the common elements. As no major differences were observed, an 8-step universal framework was 
developed which incorporated the other frameworks. To support the framework in the assessment of benefits 
and risks, a template for documenting the benefit-risk decision together with a user manual was also 
developed. Four regulatory agencies conducted a retrospective pilot study to investigate the feasibility of this 
framework, the benefit-risk template and user manual.  
Subsequently, a prospective study was conducted by TGA of Australia, Health Canada and HSA of 
Singapore. The agencies found the benefit-risk template was ‘fit for purpose’ in terms of the relevance of 
information supporting the benefit-risk decision, the documentation and communication and the relative 
importance and values of the benefits and risks. The results showed that the benefit-risk summary template 
was adequate to document benefits and risks, relevant summaries and conclusions for the emerging 
markets. The applicability and validity of the summary component of the benefit-risk template was evaluated 
by sixteen HSA clinical reviewers in a retrospective study. They found that the BR Summary Template was 
adequate to document benefits, risks, relevant summaries and conclusions. However, a revision of the BR 
Summary Template should include technical improvements and more details of safety information. The BR 
Summary Template was thought to be a useful tool for communicating benefit-risk decisions to a variety of 
stakeholders.  
The formats of publicly available reports from major regulatory agencies were compared and found to be 
generally similar. When compared to the BR Template, the listing of benefits and risks, assigning of weights 
and values, visualisation and a more detailed, systematic standardised structure were found to be absent. 
This research has demonstrated that the 8-step universal framework is of value for the assessment of 
benefits and risks of medicines by regulatory agencies and the template was found to be useful for 
documenting and communicating benefit-risk decisions. 
 
Synthetic routes to the tumour proliferation biomarker FLT and ProTide analogues 
for PET imaging 
Winnie Velanguparackel and AD Westwell 
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue,  
Cardiff CF10 3NB, Wales, UK 
Being one of the most rapidly advancing cancer imaging techniques in recent years, Positron Emission 
Tomography (PET) represents a standard of excellence with respect to sensitivity and resolution for the non-
invasive in vivo molecular imaging of solid tumours via the detection of radiotracer molecules. Amongst these 
radiotracers, radiolabelled fluorinated nucleosides such as 3’-Deoxy-3’-[18F]-fluorothymidine (18F-FLT) has 
been widely recognized as a key, specific biomarker for tumour cellular proliferation. Current methods for the 
commercial production of [18F]FLT are characterized by low overall yields and time-consuming high-
performance liquid chromatography (HPLC) purification. These disadvantages could be rectified by the 
development of a fast, efficient synthetic route to FLT that could enhance the productivity and reduce the 
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reaction time of the fluoridation step necessary for the synthesis of short-lived radioisotope, 18F (t1/2=110 
min) installed nucleoside.  
This project focussed mainly on the development of a new efficient chemical synthetic route to FLT. The 
synthesis and in vitro evaluation of a series of pro-nucleotide (ProTide) analogues of FLT as new potential 
therapeutic agents was also carried out.  
Various studies regarding FLT synthesis have been carried out on the cold (non-radioactive) 19F and 
radioactive 18F isomer by varying and optimizing conditions for the incorporation of different protecting 
groups and also different fluoridation reactions by nucleophilic displacement.  
Further optimization studies were made for the fluoridation step and the synthesis of [18F]FLTProTide 
analogues as new diagnostic PET imaging agents by variation of different chemical parameters on the 
phosphoramidate group was attempted.  
The synthesis of 19F- FLT based ProTides as new therapeutic agents were initiated by the introduction of 
the phosphoramidate group at the 5’-position of the furanosyl group of thymidine under basic conditions 
followed by fluoridation to generate the desired analogues.  
In addition to that, biological evaluation of the newly developed 19F-FLT ProTide analogues for anti-HIV 1 
and anti-HIV 2 activities was undertaken on CEM cells. The results in those models indicated that the 
synthesized compounds were less potent than the parent nucleoside FLT. However in TK- (HIV-2) cells, the 
analogues retained biological activity in contrast to FLT. This suggested that the FLT ProTides bypassed the 
first phosphorylation step.  
However, the therapeutic in vitro evaluation for anti-tumour activity on L1210, CEM and HeLa cells showed 
no significant activity. 
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